0001171843-17-006795.txt : 20171109 0001171843-17-006795.hdr.sgml : 20171109 20171109091900 ACCESSION NUMBER: 0001171843-17-006795 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 60 CONFORMED PERIOD OF REPORT: 20170930 FILED AS OF DATE: 20171109 DATE AS OF CHANGE: 20171109 FILER: COMPANY DATA: COMPANY CONFORMED NAME: UFP TECHNOLOGIES INC CENTRAL INDEX KEY: 0000914156 STANDARD INDUSTRIAL CLASSIFICATION: PLASTICS FOAM PRODUCTS [3086] IRS NUMBER: 042314970 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-12648 FILM NUMBER: 171188520 BUSINESS ADDRESS: STREET 1: 100 HALE STREET CITY: NEWBURYPORT STATE: MA ZIP: 01950 BUSINESS PHONE: 978-352-2200 MAIL ADDRESS: STREET 1: 100 HALE STREET CITY: NEWBURYPORT STATE: MA ZIP: 01950 10-Q 1 f10q_110917p.htm FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 10-Q

(Mark one)

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended SEPTEMBER 30, 2017

[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ____ to ____

Commission File Number: 001-12648

UFP Technologies, Inc.

(Exact name of registrant as specified in its charter)

Delaware	04-2314970
(State or other jurisdiction of incorporation or organization)	(IRS Employer Identification No.)

100 Hale Street, Newburyport, MA 01950, USA

(Address of principal executive offices) (Zip Code)

(978) 352-2200

(Registrant's telephone number, including area code)

_________________________________________

(Former name, former address, and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes X ; No ____

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes X ; No ____

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

	Large accelerated filer		☐
	Accelerated filer		☒
	Non–accelerated filer		☐ [Do not check if a smaller reporting company]
	Smaller reporting company		☐
	Emerging growth company		☐

If an emerging growth company, indicate by checkmark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes ____; No X

7,267,662 shares of registrant’s Common Stock, $0.01 par value, were outstanding as of November 6, 2017.

UFP Technologies, Inc.

Index

	Page

PART I - FINANCIAL INFORMATION	3

Item 1. Financial Statements	3

Condensed Consolidated Balance Sheets as of September 30, 2017 (unaudited) and December 31, 2016	3

Condensed Consolidated Statements of Income for the Three and Nine Months Ended September 30, 2017 and September 30, 2016 (unaudited)	4

Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2017 and September 30, 2016 (unaudited)	5

Notes to Interim Condensed Consolidated Financial Statements	6

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations	12

Item 3. Quantitative and Qualitative Disclosures about Market Risk	17

Item 4. Controls and Procedures	17

PART II - OTHER INFORMATION	17

Item 1A. Risk Factors	17

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	17

Item 6. Exhibits	17

Signatures	18

Exhibit Index	18

PART I:

FINANCIAL INFORMATION

ITEM 1:

FINANCIAL STATEMENTS

UFP Technologies, Inc.

Condensed Consolidated Balance Sheets

(In thousands, except share data)

	September 30, 2017			December 31, 2016
Assets	(Unaudited)
Current assets:
Cash and cash equivalents	$	37,246		$	31,359
Receivables, less allowance for doubtful accounts of $602 at September 30, 2017 and $567 at December 31, 2016		22,044			21,249
Inventories		13,136			14,151
Prepaid expenses		2,234			2,281
Refundable income taxes		979			807
Total current assets		75,639			69,847
Property, plant and equipment		103,797			96,806
Less accumulated depreciation and amortization		(51,815	)		(48,290	)
Net property, plant and equipment		51,982			48,516
Goodwill		7,322			7,322
Intangible assets, net		79			318
Other assets		2,069			1,931
Total assets	$	137,091		$	127,934

Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable	$	4,958		$	4,002
Accrued expenses		5,356			4,698
Short-term debt		84			856
Total current liabilities		10,398			9,556
Deferred income taxes		3,713			3,459
Non-qualified deferred compensation plan		1,949			1,682
Other liabilities		118			184
Total liabilities		16,178			14,881
Commitments and contingencies
Stockholders’ equity:
Preferred stock, $.01 par value, 1,000,000 shares authorized; zero shares issued or outstanding		-			-
Common stock, $.01 par value, 20,000,000 shares authorized; 7,299,721 and 7,270,162 shares issued and outstanding, respectively at September 30, 2017; and 7,242,023 and 7,212,464 shares issued and outstanding, respectively at December 31, 2016		73			72
Additional paid-in capital		26,580			25,216
Retained earnings		94,847			88,352
Treasury stock at cost, 29,559 shares at September 30, 2017 and December 31, 2016		(587	)		(587	)
Total stockholders’ equity		120,913			113,053
Total liabilities and stockholders' equity	$	137,091		$	127,934

The accompanying notes are an integral part of these condensed consolidated financial statements.

UFP Technologies, Inc.

Condensed Consolidated Statements of Income

(In thousands, except per share data)

(Unaudited)

	Three Months Ended September 30						Nine Months Ended September 30
	2017			2016			2017			2016
Net sales	$	35,684		$	37,220		$	110,623		$	109,626
Cost of sales		27,491			28,768			82,973			83,161
Gross profit		8,193			8,452			27,650			26,465
Selling, general & administrative expenses		5,693			6,027			18,070			18,402
Restructuring costs		-			25			63			203
Material overcharge settlement		-			(1,681	)		(121	)		(2,114	)
Loss (Gain) on sale of fixed assets		-			-			3			(4	)
Operating income		2,500			4,081			9,635			9,978
Interest income		63			42			147			104
Interest expense		(12	)		(17	)		(39	)		(53	)
Income before income tax expense		2,551			4,106			9,743			10,029
Income tax expense		856			1,437			3,248			3,550
Net income	$	1,695		$	2,669		$	6,495		$	6,479

Net income per share:
Basic	$	0.23		$	0.37		$	0.90		$	0.90
Diluted	$	0.23		$	0.37		$	0.89		$	0.89
Weighted average common shares outstanding:
Basic		7,264			7,195			7,240			7,183
Diluted		7,353			7,282			7,326			7,265

The accompanying notes are an integral part of these condensed consolidated financial statements.

UFP Technologies, Inc.

Condensed Consolidated Statements of Cash Flows

(In thousands)

(Unaudited)

	Nine Months Ended September 30
	2017			2016
Cash flows from operating activities:
Net income	$	6,495		$	6,479
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		4,171			4,109
Loss (Gain) on sale of fixed assets		3			(4	)
Share-based compensation		842			871
Excess tax benefit on share-based compensation		-			(126	)
Deferred income taxes		254			224
Changes in operating assets and liabilities:
Receivables, net		(795	)		(4,826	)
Inventories		1,015			(366	)
Prepaid expenses		47			(1,231	)
Refundable income taxes		(172	)		1,146
Other assets		(138	)		(93	)
Accounts payable		429			197
Accrued expenses		658			(317	)
Non-qualified deferred compensation plan and other liabilities		201			205
Net cash provided by operating activities		13,010			6,268
Cash flows from investing activities:
Additions to property, plant and equipment		(6,880	)		(5,766	)
Proceeds from sale of fixed assets		6			4
Net cash used in investing activities		(6,874	)		(5,762	)
Cash flows from financing activities:
Principal repayments of long-term debt		(772	)		(758	)
Proceeds from exercise of stock options, net of attestation		630			529
Excess tax benefit on share-based compensation		-			126
Payment of statutory withholdings for stock options exercised and restricted stock units vested		(107	)		(89	)
Net cash used in financing activities		(249	)		(192	)
Net increase in cash and cash equivalents		5,887			314
Cash and cash equivalents at beginning of period		31,359			29,804
Cash and cash equivalents at end of period	$	37,246		$	30,118

The accompanying notes are an integral part of these condensed consolidated financial statements.

Notes to Interim Condensed Consolidated Financial Statements

(1)

Basis of Presentation

The interim condensed consolidated financial statements of UFP Technologies, Inc. (the “Company”) presented herein, have been prepared pursuant to the rules of the Securities and Exchange Commission for quarterly reports on Form 10-Q and do not include all the information and note disclosures required by accounting principles generally accepted in the United States of America. These statements should be read in conjunction with the consolidated financial statements and notes thereto for the year ended December 31, 2016, included in the Company's 2016 Annual Report on Form 10-K, as filed with the Securities and Exchange Commission.

The condensed consolidated balance sheet as of September 30, 2017, the condensed consolidated statements of income for the three- and nine-month periods ended September 30, 2017 and 2016, and the condensed consolidated statements of cash flows for the nine-month periods ended September 30, 2017 and 2016 are unaudited but, in the opinion of management, include all adjustments (consisting of normal, recurring adjustments) necessary for a fair presentation of results for these interim periods. The condensed consolidated balance sheet as of December 31, 2016 has been derived from the Company’s annual financial statements that were audited by an independent registered public accounting firm, but does not include all of the information and footnotes required for complete annual financial statements.

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.

The results of operations for the three- and nine-months periods ended September 30, 2017, are not necessarily indicative of the results to be expected for the entire fiscal year ending December 31, 2017.

Recent Accounting Pronouncements

In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2014-09, Revenue from Contracts with Customers, which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. This standard will replace most existing revenue recognition guidance when it becomes effective. The standard permits the use of either the full retrospective or modified retrospective transition methods. The Company expects to adopt the standard in the first quarter of 2018 using the modified retrospective transition method. The Company has identified its primary revenue streams, completed a preliminary review of a representative sample of contracts with its customers and is in the process of evaluating the impact of this ASU on its revenue streams and accounting policies. Based on the procedures completed to date, the Company expects that for a significant portion of its business, the recognition of revenue under the updated standard will occur at a point in time, which is consistent with current practice. The Company has identified certain revenue streams for which the recognition of revenue may occur over time, which is a change from current practice. These revenue streams include certain customer stocking commitments. Additionally, the Company has identified certain revenue streams for which the recognition of revenue may be deferred, which is also a change from current practice. These revenue streams include certain tooling sales. The Company does not expect that the impact of these changes in the timing of revenue recognition for these items to be significant to the financial statements. The Company is also in the process of updating its internal controls and drafting the expanded disclosures as required by this ASU. The Company does not expect significant changes to its systems or internal controls. As the Company continues through the adoption process, it is possible that these preliminary conclusions may change.

In February 2016, the FASB issued ASU No. 2016-02, Leases. The guidance in this ASU supersedes the leasing guidance in Topic 840, Leases. Under the new guidance, lessees are required to recognize lease assets and lease liabilities on the balance sheet for those leases previously classified as operating leases. The amendments in ASU No. 2016-02 are effective for annual reporting periods beginning after December 15, 2018, including interim periods within that reporting period with early adoption permitted. The Company is evaluating the impact of adopting this ASU on its consolidated financial position and results of operations.

In March 2016, the FASB issued ASU No. 2016-09, Improvements to Employee Share Based Payment Accounting. This ASU simplifies several aspects of the accounting for share-based payment transactions, including income tax consequences, classification of awards, forfeitures and classification on the statement of cash flows. The Company adopted this ASU on January 1, 2017. As the Company has not had a significant amount of forfeitures historically, under the provisions of this ASU the Company has elected to account for forfeitures as they occur, rather than estimate expected forfeitures. The impact of adopting this update to the Company’s Consolidated Financial Statements will depend on market factors and the timing and intrinsic value of future share-based compensation award vests and exercises. Subsequent to adoption, the Company notes the potential for volatility in its effective tax rate as any windfall or shortfall tax benefits related to its share-based compensation plans will be recorded directly to income tax expense in the Condensed Consolidated Statement of Income.

Revisions

Certain revisions have been made to the 2016 Condensed Consolidated Statement of Cash Flows to conform to the current year presentation relating to a reserve for uncertain tax positions and to cash paid for capital expenditures. The reclassification of a reserve for uncertain tax positions resulted in an increase to the change in refundable income taxes of $315,000 and a decrease to the change in accrued expenses of $315,000. A change in presentation of cash paid for capital expenditures resulted in a decrease of $311,000 in both the change in accounts payable and in additions to property, plant and equipment, net. These revisions had no impact on previously reported net income and are deemed immaterial to the previously issued financial statements.

(2)

Supplemental Cash Flow Information

	Nine Months Ended September 30
	2017		2016
	(in thousands)
Cash paid for:
Interest	$	37	$	51
Income taxes, net of refunds		3,167		2,178

Non-cash investing and financing activities:
Capital additions accrued but not yet paid	$	527	$	311

(3)

Fair Value of Financial Instruments

The Company has financial instruments, such as accounts receivable, accounts payable, and accrued expenses, which are stated at carrying amounts that approximate fair value because of the short maturity of those instruments. The carrying amount of the Company’s long-term debt approximates fair value as the interest rate on the debt approximates the estimated borrowing rate currently available to the Company.

(4)

Share-Based Compensation

Share-based compensation is measured at the grant date based on the fair value of the award and is recognized as an expense over the requisite service period (generally the vesting period of the equity grant).

The Company issues share-based awards through several plans that are described in detail in the notes to the consolidated financial statements for the year ended December 31, 2016. The compensation cost charged against income for those plans is included in selling, general & administrative expenses as follows (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
Share-based compensation related to:	2017		2016		2017		2016
Common stock granted to the Board of Directors	$	-	$	-	$	105	$	105
Common stock granted to the Chief Executive Officer		100		100		300		300
Stock options granted to directors		-		-		105		105
Stock options granted to employees		4		34		25		107
Restricted Stock Unit awards to employees		102		95		307		254
Total share-based compensation	$	206	$	229	$	842	$	871

The total income tax benefit recognized in the condensed consolidated statements of income for share-based compensation arrangements was approximately $106,000 and $67,000, respectively, for the three-month periods ended September 30, 2017 and 2016, and approximately $441,000 and $264,000, respectively, for the nine-month periods ended September 30, 2017 and 2016.

The following is a summary of stock option activity under all plans for the three-month period ended September 30, 2017:

	Shares Under Options			Weighted Average Exercise Price (per share)		Weighted Average Remaining Contractual Life (in years)		Aggregate Intrinsic Value (in thousands)
Outstanding at December 31, 2016		232,578		$	16.53
Granted		12,336			27.05
Exercised		(51,285	)		26.88
Expired		(3,750	)		18.85
Outstanding at September 30, 2017		189,879		$	17.41		3.55	$	2,029
Exercisable at September 30, 2017		184,879		$	17.23		3.60	$	2,011
Vested and expected to vest at September 30, 2017		189,879		$	17.41		3.55	$	2,029

On June 6, 2017, the Company granted options to its directors for the purchase of 12,336 shares of common stock at that day’s closing price of $27.05. The compensation expense related to these grants was determined as the fair value of the options using the Black Scholes option pricing model based on the following assumptions:

Expected volatility			29.1%
Expected dividends			None
Risk-free interest rate			1.84%
Exercise price			$27.05
Expected term (in years)			5.8
Weighted-average grant date fair value			$8.51

The stock volatility for each grant is determined based on a review of the experience of the weighted average of historical daily price changes of the Company’s common stock over the expected option term, and the risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods corresponding with the expected term of the option. The expected term is estimated based on historical option exercise activity.

During the nine-month periods ended September 30, 2017 and 2016, the total intrinsic value of all options exercised (i.e., the difference between the market price on the exercise date and the price paid by the employees to exercise the options) was approximately $577,000 and $564,000, respectively, and the total amount of consideration received by the Company from the exercised options was approximately $802,000 and $529,000, respectively. At its discretion, the Company allows option holders to surrender previously owned common stock in lieu of paying the exercise price and withholding taxes. During the nine-month period ended September 30, 2017 there were 6,511 shares surrendered at an average market price of $26.45. During the nine-month period ended September 30, 2016 there were no shares surrendered for this purpose.

On February 21, 2017, the Company’s Compensation Committee approved the award of $400,000, payable in shares of common stock to the Company’s Chairman, Chief Executive Officer, and President under the 2003 Incentive Plan. The shares will be issued in December, 2017.

The following table summarizes information about Restricted Stock Units (“RSUs”) activity during the nine-month period ended September 30, 2017:

	Restricted Stock Units			Weighted Average Award Date Fair Value
Unvested at December 31, 2016		46,558		$	20.05
Awarded		22,770			24.70
Shares vested		(13,419	)		23.54
Unvested at September 30, 2017		55,909		$	20.96

At the Company’s discretion, RSU holders are given the option to net-share settle to cover the required minimum withholding tax, and the remaining amount is converted into the equivalent number of common shares. During the nine-month periods ended September 30, 2017 and 2016, 4,377 and 3,889 shares were surrendered at an average market price of $24.50 and $22.82, respectively.

As of September 30, 2017, the Company had approximately $754,000 of unrecognized compensation expense, which is expected to be recognized over a period of 3.5 years.

(5)

Inventories

Inventories are stated at the lower of cost (first-in, first-out) or net realizable value, and consist of the following at the stated dates (in thousands):

	September 30, 2017		December 31, 2016
Raw materials	$	6,660	$	7,111
Work in process		1,161		1,354
Finished goods		5,315		5,686
Total inventory	$	13,136	$	14,151

(6)

Preferred Stock

On March 18, 2009, the Company declared a dividend of one preferred share purchase right (a “Right”) for each outstanding share of common stock, par value $0.01 per share, to the stockholders of record on March 20, 2009. Each Right entitles the registered holder to purchase from the Company one one-thousandth of a share of Series A Junior Participating Preferred Stock, par value $0.01 per share (the “Preferred Share”) of the Company, at a price of $25 per one one-thousandth of a Preferred Share subject to adjustment and the terms of the Rights Agreement. The Rights expire on March 19, 2019.

(7)

Income Per Share

Basic income per share is based on the weighted average number of shares of common stock outstanding. Diluted income per share is based upon the weighted average number of common shares outstanding and dilutive common stock equivalent shares outstanding during each period.

The weighted average number of shares used to compute basic and diluted net income per share consisted of the following (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2017		2016		2017		2016
Weighted average common shares outstanding, basic		7,264		7,195		7,240		7,183
Weighted average common equivalent shares due to stock options and RSUs		89		87		86		82
Weighted average common shares outstanding, diluted		7,353		7,282		7,326		7,265

The computation of diluted earnings per share excludes the effect of the potential exercise of stock awards, including stock options, when the average market price of the common stock is lower than the exercise price of the related options during the period. These outstanding stock awards are not included in the computation of diluted income per share because the effect would be antidilutive. For the three- and nine-month periods ended September 30, 2017, the number of stock awards excluded from the computation of diluted earnings per share for this reason was zero and 27,336, respectively. For the three- and nine-month periods ended September 30, 2016, the number of stock awards excluded from the computation of diluted earnings per share for this reason was 35,193 and 52,377, respectively.

(8)

Segment Reporting

The Company consists of a single operating and reportable segment.

Revenues from customers outside of the United States are not material. No customer comprised more than 10% of the Company’s consolidated revenues for the three- and nine-month periods ended September 30, 2017. All of the Company’s assets are located in the United States.

The Company’s products are primarily sold to customers within the Medical, Consumer, Automotive, Aerospace and Defense, Industrial and Electronics markets. Net sales by market for the three- and nine-month periods ended September 30, 2017 and 2016, respectively, are as follows (in thousands):

	Three Months Ended September 30,										Nine Months Ended September 30,
	2017					2016					2017					2016
Market	Net Sales		%			Net Sales		%			Net Sales		%			Net Sales		%

Medical	$	16,712		46.8	%	$	16,548		44.5	%	$	52,822		47.7	%	$	48,953		44.7	%
Consumer		6,006		16.8	%		5,648		15.2	%		15,713		14.2	%		15,303		14.0	%
Automotive		5,174		14.5	%		6,942		18.7	%		18,018		16.3	%		20,485		18.7	%
Aerospace & Defense		2,682		7.5	%		2,516		6.8	%		8,290		7.5	%		7,929		7.2	%
Industrial		2,591		7.3	%		2,792		7.5	%		7,629		6.9	%		8,441		7.7	%
Electronics		2,519		7.1	%		2,774		7.5	%		8,151		7.4	%		8,515		7.8	%
Net Sales	$	35,684		100.0	%	$	37,220		100.0	%	$	110,623		100.0	%	$	109,626		100.0	%

Certain amounts for the three- and nine-month periods ended September 30, 2016 were reclassified between markets to conform to the current period presentation.

(9)

Other Intangible Assets

The carrying values of the Company’s definite lived intangible assets as of September 30, 2017 and December 31, 2016, are as follows (in thousands):

	Patents			Non- Compete			Customer List			Total
Estimated useful life (in years)		14			5			5
Gross amount at September 30, 2017	$	429		$	512		$	2,046		$	2,987
Accumulated amortization at September 30, 2017		(429	)		(496	)		(1,983	)	$	(2,908	)
Net balance at September 30, 2017	$	-		$	16		$	63		$	79

Estimated useful life (in years)		14			5			5
Gross amount at December 31, 2016	$	429		$	512		$	2,046		$	2,987
Accumulated amortization at December 31, 2016		(429	)		(449	)		(1,791	)	$	(2,669	)
Net balance at December 31, 2016	$	-		$	63		$	255		$	318

Amortization expense related to intangible assets was approximately $79,000 for each of the three-month periods ended September 30, 2017 and 2016, and was approximately $239,000 for each of the nine-month periods ended September 30, 2017 and 2016. As of September 30, 2017, the estimated remaining amortization expense for 2017 is $79,000.

(10)

Income Taxes

The income tax expense included in the accompanying unaudited condensed consolidated statements of income principally relates to the Company’s proportionate share of the pre-tax income of its wholly-owned subsidiaries. The determination of income tax expense for interim reporting purposes is based upon the estimated effective tax rate for the year, adjusted for the impact of any discrete items which are accounted for in the period in which they occur.

(11)

Plant Consolidations

Restructuring Costs

On March 18, 2015, the Company committed to move forward with a plan to cease operations at its Raritan, New Jersey, plant and consolidate operations into its Newburyport, Massachusetts, facility and other UFP facilities. The Company’s decision was in response to a continued decline in business at the Raritan facility and the Company’s purchase of the 137,000-square-foot facility in Newburyport. The activities related to this consolidation are complete.

The Company also relocated all operations in its Haverhill, Massachusetts, and Byfield, Massachusetts, facilities and relocated certain operations in its Georgetown, Massachusetts, facility to Newburyport. The Haverhill and Byfield relocations were complete at December 31, 2015, and the partial Georgetown relocation was complete at June 30, 2017.

The Company incurred approximately $2.1 million in one-time expenses in connection with the Massachusetts consolidations. Included in this amount are approximately $180,000 relating to employee severance payments and relocation costs, approximately $1.6 million in moving expenses and expenses associated with vacating the Raritan, Haverhill, and Byfield properties, and approximately $360,000 in lease termination costs. Total cash charges were approximately $2.0 million.

The Company recorded the following restructuring costs associated with the Massachusetts consolidations for the three- and nine-month periods ended September 30, 2017 and 2016 (in thousands):

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
Restructuring Costs	2017		2016		2017		2016
Relocation	$	-	$	25	$	63	$	203
Total	$	-	$	25	$	63	$	203

Costs for the three- and nine- month periods ended September 30, 2017 and 2016 were reclassified in the Condensed Consolidated Statement of Income as “Restructuring Costs” from Cost of Sales.

(12)

Related Party Transactions

Daniel Croteau, who has been a member of the Company’s board of directors since December 16, 2015, was the Chief Executive Officer (through March 2017) of Vention Medical, Inc. (“Vention”), a customer of the Company. Sales to Vention for the three-months ended March 31, 2017 were approximately $148,000. As a result of the sale of Vention, Mr. Croteau’s employment ended in March 2017 and sales to Vention are no longer considered related party transactions.

(13)

Material Overcharge Settlement

The Company was a participant in a class action lawsuit against a number of polyurethane foam suppliers (“Defendants”) that was settled during the second quarter of 2016. The suit was filed to recover damages and obtain injunctive relief for Defendants’ alleged violations of the federal antitrust laws with respect to the fixing of prices of polyurethane foam sold from January 1, 1999 through August 2010. During the three- and nine-month periods ended September 30, 2017, the Company received settlement amounts of $0 and approximately $121,000, respectively. During the three- and nine-month periods ended September 30, 2016, the Company received settlement amounts of approximately $1.7 million and $2.1 million, respectively. The settlement amounts for the three- and nine-month periods ended September 30, 2017 and 2016 are recorded as “Material overcharge settlement” in the operating income section of the Condensed Consolidated Statements of Income.

ITEM 2:

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Forward-looking Statements

Some of the statements contained in this Report are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (“Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (“Exchange Act”). These statements are subject to known and unknown risks, uncertainties, and other factors, which may cause our or our industry’s actual results, performance, or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Forward-looking statements include, but are not limited to, statements about the Company’s prospects, anticipated trends in the different markets in which the Company competes, including the medical, automotive, consumer, electronics, industrial and aerospace and defense markets, anticipated new customer and vendor contracts, statements regarding anticipated advantages relating to the Company’s decisions to consolidate or expand certain facilities, including the ongoing expansion of its Newburyport facility, and the expected cost savings and efficiencies associated therewith, anticipated advantages and the timing associated with requalification of parts, anticipated advantages of maintaining fewer, larger plants, anticipated advantages the Company expects to realize from its investments and capital expenditures, including the development of and investments in its molded fiber product lines, expectations regarding the manufacturing capacity and efficiencies of the Company and the expected timing associated therewith, statements regarding the end of the Company’s automotive door panel program with Mercedes Benz, and the resulting impact to revenues, statements about the Company’s acquisition opportunities and strategies, its participation and growth in multiple markets, its business opportunities, the Company’s growth potential and strategies for growth, anticipated revenues and the timing of such revenues, and any indication that the Company may be able to sustain or increase its sales and earnings or sales and earnings growth rates. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including without limitation risks and uncertainties associated with the identification of suitable acquisition candidates and the successful, efficient execution of acquisition transactions and integration of any such acquisition candidates, risks and uncertainties associated with plant closures and consolidations and expected efficiencies from consolidating manufacturing, risks and uncertainties associated with the requalification of parts, the risk that we may not be able to finalize anticipated new customer contracts, risks associated with the implementation of new production equipment and requalification or recertification of transferred equipment in a timely, cost-efficient manner, and risks that any benefits from such new equipment may be delayed or not fully realized, or that the Company may be unable to fully utilize its expected production capacity. Accordingly, actual results may differ materially.

In some cases, you can identify forward-looking statements by terms such as “may,” “will,” “should,” “could,” “would,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “projects,” “predicts,” “potential,” and similar expressions intended to identify forward-looking statements. Our actual results could be different from the results described in or anticipated by our forward-looking statements due to the inherent uncertainty of estimates, forecasts, and projections, and may be materially better or worse than anticipated. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Forward-looking statements represent our estimates and assumptions only as of the date of this Report. We expressly disclaim any duty to provide updates to forward-looking statements, and the estimates and assumptions associated with them, after the date of this Report, in order to reflect changes in circumstances or expectations, or the occurrence of unanticipated events, except to the extent required by applicable securities laws. All of the forward-looking statements are qualified in their entirety by reference to the factors discussed above and under “Risk Factors” set forth in Part I Item 1A of the Company’s Annual Report on Form 10-K for the year ended December 31, 2016, as well as the risks and uncertainties discussed elsewhere in this Report. We qualify all of our forward-looking statements by these cautionary statements. We caution you that these risks are not exhaustive. We operate in a continually changing business environment and new risks emerge from time to time.

Unless the context requires otherwise, the terms “we”, “us”, “our”, or “the Company” refer to UFP Technologies, Inc. and its consolidated subsidiaries.

Overview

UFP Technologies is an innovative designer and custom converter of foams, plastics, and natural fiber materials, principally serving the Medical, Consumer, Automotive, Aerospace and Defense, Industrial and Electronics markets. The Company consists of a single operating and reportable segment.

The Company had a slight increase in sales through the first nine months of 2017, largely fueled by continued growth in sales to customers in the medical market, partially offset by declined sales to customer in the automotive market. The Company improved gross margins for the nine-month period ended September 30, 2017 to 25.0% from 24.1% in the first nine months of 2016 as the Company has become much more efficient in manufacturing particularly in those plants impacted by recent consolidations. Absent non-recurring restructuring and material overcharge items, operating income increased by 19% in the first nine months of 2017.

The Company’s previously announced consolidation and relocation efforts were complete as of June 30, 2017. The Company is in the process of further expanding its Newburyport, Massachusetts, manufacturing plant. The Company constantly evaluates ways to enhance operating efficiencies and will consider additional expansions, consolidations, or relocations of operations from time to time.

The Company’s current strategy includes further organic growth and growth through strategic acquisitions.

Results of Operations

Sales

Sales for the three-month period ended September 30, 2017 decreased approximately 4.1% to $35.7 million compared to $37.2 million in the same period in 2016. The decrease in sales during the three-month period ended September 30, 2017 was primarily due to decreases in sales to customers in the automotive and electronics markets of approximately 25.5% and 9.2%, respectively. These decreases were partially offset by increases in sales to customers in the aerospace and defense and consumer markets of approximately 6.6% and 6.3%, respectively. The decline in sales to customers in the automotive market was primarily due to soft demand for interior trim components in certain legacy programs. The Company has been notified that the remaining portion of its southeast automotive door panel program for Mercedes Benz, which began in 2004, will end with modest sales anticipated into the first quarter of 2018. The Company estimates sales for the program will total approximately $3.0 million in 2017 and will be modest in 2018. The decline in sales to customers in the electronics market was primarily due to reduced demand for protective packaging. The increase in sales to customers in the aerospace and defense market was primarily due to increased demand for components from our government contractor customers. The increase in sales to customers in the consumer market was primarily due to higher demand for molded fiber protective packaging. Sales to customers in the medical market grew at 1% for the quarter—a rate slower than recent historical levels—as two large customers in this market added second suppliers to meet their internal risk mitigation requirements and certain customers ordered less due to storm related disruptions to their business.

Sales for the nine-month period ended September 30, 2017 increased approximately 0.9% to $110.6 million from sales of $109.6 million for the same period in 2016. The increase in sales for the nine-month period ended September 30, 2017 was primarily due to increases in sales to customers in the medical market of approximately 7.9% partially offset by decreases in sales to customers in the automotive and industrial markets of approximately 12.0% and 9.6% respectively. The increase in sales to customers in the medical market was primarily due to strong demand for our customers’ products as well as selective price increases. The decline in sales to customers in the automotive market was primarily due to soft demand for interior trim components in certain legacy programs. The decline in sales to customers in the industrial market was primarily due to a credit issue at one of our customers within this market.

Gross Profit

Gross profit as a percentage of sales (“gross margin”) increased to 23.0% for the three-month period ended September 30, 2017, from 22.7% for the same period in 2016. As a percentage of sales, material and labor costs collectively decreased 0.8%, while overhead increased 0.5%. The decrease in collective material and labor costs as a percentage of sales is primarily due to gains in manufacturing efficiencies resulting from continuous improvement initiatives. The increase in overhead as a percentage of sales is primarily due to fixed overhead costs measured against reduced sales.

Gross margin increased to 25.0% for the nine-month period ended September 30, 2017, from 24.1% for the same period in 2016. As a percentage of sales, material and labor costs collectively decreased 1.6%, while overhead increased 0.7%. The decrease in collective material and labor costs as a percentage of sales is primarily due to gains in manufacturing efficiencies resulting from continuous improvement initiatives, strategic price increases and an improvement in the overall book of business. The increase in overhead is primarily due to an increase in indirect labor costs of approximately $700,000 due largely to hires made in the second half of 2016 to support growth.

Selling, General and Administrative Expenses

Selling, general, and administrative expenses (“SG&A”) decreased approximately 5.5% to $5.7 million for the three-month period ended September 30, 2017 from $6.0 million for the same period in 2016. As a percentage of sales, SG&A decreased to 16.0% for the three-month period ended September 30, 2017 from 16.2% for the same three-month period in 2016. The decrease in SG&A for the three-month period ended September 30, 2017 is primarily due to reductions in general and administrative payroll and recruiting costs.

SG&A decreased approximately 1.8% to $18.1 million for the nine-month period ended September 30, 2017 from $18.4 million for the same period in 2016. As a percentage of sales, SG&A decreased to 16.3% for the nine-month period ended September 30, 2017 from 16.8% for the same nine-month period in 2016. The decrease in SG&A for the nine-month period ended September 30, 2017 is primarily due to reductions in consulting and recruiting expenses. The decrease in SG&A as a percentage of sales is primarily due to reductions in general and administrative payroll, consulting and recruiting expenses measured against higher sales.

Restructuring Costs

For the three-month period ended September 30, 2017 the Company did not incur any restructuring costs compared to approximately $25,000 for the same period in 2016.

Additional information regarding restructuring costs can be found in Note 11 of the Notes to Interim Condensed Consolidated Financial Statements.

Material Overcharge Settlement

Interest Income and Expense

The Company had net interest income of approximately $51,000 and $25,000 for the three-month periods ended September 30, 2017 and 2016, respectively. The Company had net interest income of approximately $108,000 and $51,000 for the nine-month periods ended September 30, 2017 and 2016, respectively. The increase in net interest income is primarily due to an increase in interest earned on money market accounts and certificates of deposit and decreasing interest costs on the Company’s term loans.

Income Taxes

The Company recorded tax expense of approximately 33.6% and 35.0% of income before income tax expense, respectively, for each of the three-month periods ended September 30, 2017 and 2016. The decrease in the effective tax rate for the current period is due to a tax benefit of approximately $37,000 recorded in the three-month period ended September 30, 2017 as a result of the adoption of ASU No. 2016-09 on January 1, 2017 (See Note 1). The Company recorded a tax expense of approximately 33.3% and 35.4% of income before income tax expense for each of the nine-month periods ended September 30, 2017 and 2016. The decrease in the effective tax rate for the current period is due to a tax benefit of approximately $162,000 recorded in the nine-month period ended September 30, 2017 as a result of the adoption of ASU No. 2016-09 on January 1, 2017 (See Note 1); and a tax assessment of approximately $40,000 from one jurisdiction recorded in the first quarter of 2016. The Company notes the potential for volatility in its effective tax rate, as any windfall or shortfall tax benefits related to its share-based compensation plans will be recorded directly into income tax expense. The Company has deferred tax assets on its books associated with net operating losses generated in previous years. The Company has considered both positive and negative available evidence in its determination that the deferred tax assets are more likely than not to be realized, and has not recorded a tax valuation allowance at September 30, 2017. The Company will continue to assess whether the deferred tax assets will be realizable and, when appropriate, will record a valuation allowance against these assets. The amount of the net deferred tax asset considered realizable, however, could be reduced in the near term if estimates of future taxable income during the carry-forward period are reduced.

Liquidity and Capital Resources

The Company generally funds its operating expenses, capital requirements, and growth plan through internally generated cash and bank credit facilities.

Cash Flows

Net cash provided by operations for the nine-month period ended September 30, 2017 was approximately $13.0 million and was primarily a result of net income generated of $6.5 million, depreciation and amortization of approximately $4.2 million, share-based compensation of $0.8 million, an increase in deferred taxes of $0.3 million, a decrease in inventory of approximately $1.0 million due primarily to management initiatives, an increase in accounts payable of approximately $0.4 million due to the timing of vendor payments in the ordinary course of business, an increase in accrued expenses of approximately $0.7 million due to compensation accruals and an increase in other long-term liabilities of $0.2 million. These cash inflows and adjustments to income were partially offset by an increase in accounts receivable of approximately $0.8 million due to the timing of customer collections, an increase in refundable income taxes of approximately $0.2 million and an increase in other assets of approximately $0.1 million.

Net cash used in investing activities during the nine-month period ended September 30, 2017 was approximately $6.9 million and was primarily the result of additions of manufacturing machinery and equipment and the expansion of the Newburyport, Massachusetts plant.

Net cash used in financing activities was approximately $0.2 million during the nine-month period ended September 30, 2017, representing cash used to service term debt of approximately $0.7 million and to pay statutory withholding for stock options exercised and restricted stock units vested of approximately $0.1 million, partially offset by net proceeds received upon stock options exercises of approximately $0.6 million.

Outstanding and Available Debt

The Company maintains an unsecured $40 million revolving credit facility with Bank of America, N.A. The credit facility calls for interest of LIBOR plus a margin that ranges from 1.0% to 1.5% or, at the discretion of the Company, the bank’s prime rate less a margin that ranges from 0.25% to zero. In both cases the applicable margin is dependent upon Company performance. Under the credit facility, the Company is subject to a minimum fixed-charge coverage financial covenant as well as a maximum total funded debt to EBITDA financial covenant. The Company’s $40 million credit facility matures on November 30, 2018.

As of September 30, 2017, the Company had no borrowings outstanding under the credit facility. Included in the credit facility were approximately $300,000 in standby letters of credit drawable as a financial guarantee on worker’s compensation insurance policies. As of September 30, 2017, the Company was in compliance with all covenants under the credit facility.

In 2012, the Company financed the purchase of two molded fiber machines through five-year term loans that mature in October 2017. The annual interest rate is fixed at 1.83% and the loans are secured by the related molded fiber machines. As of September 30, 2017, the outstanding balance of the term loan facility was approximately $84,000.

Future Liquidity

The Company requires cash to pay its operating expenses, purchase capital equipment, and service its contractual obligations. The Company’s principal sources of funds are its operations and its revolving credit facility. The Company generated cash of approximately $13.0 million from operations during the nine-month period ended September 30, 2017; however, the Company cannot guarantee that its operations will generate cash in future periods. The Company’s longer-term liquidity is contingent upon future operating performance.

Throughout fiscal 2017, the Company plans to continue to add capacity to enhance operating efficiencies in its manufacturing plants. The Company is in the process of further expanding its Newburyport, Massachusetts, manufacturing plant. The Company may consider additional acquisitions of companies, technologies, or products that are complementary to its business. The Company believes that its existing resources, including its revolving credit facility, together with cash expected to be generated from operations and funds expected to be available to it through any necessary equipment financings and additional bank borrowings, will be sufficient to fund its cash flow requirements, including capital asset acquisitions, through the next twelve months.

Stock Repurchase Program

On June 16, 2015, the Company announced that its Board of Directors authorized the repurchase of up to $10.0 million of the Company’s outstanding common stock. Under the program, the Company is authorized to repurchase shares through Rule 10b5-1 plans, open market purchases, privately negotiated transactions, block purchases or otherwise in accordance with applicable federal securities laws, including Rule 10b-18 of the Securities Exchange Act of 1934. The stock repurchase program will end upon the earlier of the date on which the plan is terminated by the Board or when all authorized repurchases are completed. The timing and amount of stock repurchases, if any, will be determined based upon our evaluation of market conditions and other factors. The stock repurchase program may be suspended, modified, or discontinued at any time, and the Company has no obligation to repurchase any amount of its common stock under the program. The Company did not repurchase any shares of its common stock under this program in the first nine months of 2017. Through September 30, 2017, the Company had repurchased a total of 29,559 shares of its common stock under this program at a cost of approximately $587,000. At September 30, 2017, approximately $9.4 million was available for future repurchases of the Company’s common stock under this authorization.

Commitments and Contractual Obligations

There have been no material changes outside the ordinary course of business to our contractual obligations and commitments, as disclosed in our Annual Report on Form 10-K for the year ended December 31, 2016.

Off-Balance-Sheet Arrangements

In addition to operating leases, the Company’s off-balance-sheet arrangements include standby letters of credit which are included in the Company’s revolving credit facility. As of September 30, 2017, there was approximately $300,000 in standby letters of credit drawable as a financial guarantee on worker’s compensation insurance policies.

ITEM 3:

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

There have been no material changes in our market risks as previously disclosed in Item 7A of our Annual Report on Form 10-K for the year ended December 31, 2016.

ITEM 4:

CONTROLS AND PROCEDURES

As of the end of the period covered by this report (the “Evaluation Date”), the Company’s management, under the supervision and with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, performed an evaluation of the effectiveness of the design and operation of the Company’s “disclosure controls and procedures” (as defined in SEC Rule 13a-15(e) or 15d-15(e)). Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that, as of the Evaluation Date, the Company’s disclosure controls and procedures were effective to ensure that information required to be disclosed by the Company in the reports that it files or submits under the Securities Exchange Act of 1934, as amended, is (i) recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and (ii) accumulated and communicated to the Company’s management, including the Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

There has been no change in the Company’s internal control over financial reporting during the most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

PART II:

OTHER INFORMATION

ITEM 1A:

RISK FACTORS

There have been no material changes from the risk factors previously disclosed in Part 1 - Item 1A of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2016.

ITEM 2:

UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Issuer’s Purchases of Equity Securities

On June 16, 2015, the Company issued a press release announcing that its Board of Directors authorized the repurchase of up to $10.0 million of the Company’s outstanding common stock. The Company did not repurchase any shares of its common stock under this program in the first nine months of 2017. Through September 30, 2017, the Company had repurchased a total of 29,559 shares of its common stock under this program at a cost of approximately $587,000. At September 30, 2017, approximately $9.4 million was available for future repurchases of the Company’s common stock under this authorization.

ITEM 6:

EXHIBITS

Exhibit No.	Description

31.1	Rule 13a-14(a)/15d-14(a) Certification of the Chief Executive Officer.*
31.2	Rule 13a-14(a)/15d-14(a) Certification of the Chief Financial Officer.*
32.1	Certifications pursuant to 18 U.S.C., Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.**
101.INS	XBRL Instance Document.*
101.SCH	XBRL Taxonomy Extension Schema Document.*
101.CAL	XBRL Taxonomy Calculation Linkbase Document.*
101.LAB	XBRL Taxonomy Label Linkbase Document.*
101.PRE	XBRL Taxonomy Presentation Linkbase Document.*
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document.*

__________________

Filed herewith.

Furnished herewith.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

UFP TECHNOLOGIES, INC.

	Date: November 9, 2017		By: /s/ R. Jeffrey Bailly
			R. Jeffrey Bailly
			Chairman, Chief Executive Officer, President, and Director
			(Principal Executive Officer)

	Date: November 9, 2017		By: /s/ Ronald J. Lataille
			Ronald J. Lataille
			Chief Financial Officer
			(Principal Financial Officer)

EXHIBIT INDEX

Exhibit No.	Description

31.1	Rule 13a-14(a)/15d-14(a) Certification of the Chief Executive Officer.*
31.2	Rule 13a-14(a)/15d-14(a) Certification of the Chief Financial Officer.*
32.1	Certifications pursuant to 18 U.S.C., Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.**
101.INS	XBRL Instance Document.*
101.SCH	XBRL Taxonomy Extension Schema Document.*
101.CAL	XBRL Taxonomy Calculation Linkbase Document.*
101.LAB	XBRL Taxonomy Label Linkbase Document.*
101.PRE	XBRL Taxonomy Presentation Linkbase Document.*
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document.*

__________________

Filed herewith.

Furnished herewith.

EX-31.1 2 exh_311.htm EXHIBIT 31.1

EXHIBIT 31.1

EXHIBITS

Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, R. Jeffrey Bailly, President and Chief Executive Officer of UFP Technologies, Inc. certify that:

I have reviewed this quarterly report on Form 10-Q of UFP Technologies, Inc.;

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 9, 2017	/s/ R. Jeffrey Bailly
	R. Jeffrey Bailly
	Chairman, Chief Executive Officer, President and Director
	(Principal Executive Officer)

EX-31.2 3 exh_312.htm EXHIBIT 31.2

EXHIBIT 31.2

Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Ronald J. Lataille, Chief Financial Officer of UFP Technologies, Inc., certify that:

I have reviewed this quarterly report on Form 10-Q of UFP Technologies, Inc.;

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 9, 2017	/s/ Ronald J. Lataille
	Ronald J. Lataille
	Chief Financial Officer
	(Principal Financial Officer)

EX-32.1 4 exh_321.htm EXHIBIT 32.1

EXHIBIT 32.1

Certification

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), the undersigned officers of UFP Technologies, Inc., a Delaware corporation (the “Company”) do hereby certify that, to the best of such officers’ knowledge and belief, that:

(1)

The Quarterly Report on Form 10-Q for the quarter ended September 30, 2017 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)

The information contained in the Form 10-Q fairly presents, in all materials respects, the financial condition and results of operations of the Company.

Date: November 9, 2017	/s/ R. Jeffrey Bailly
	R. Jeffrey Bailly
	Chairman, Chief Executive Officer, President, and Director
	(Principal Executive Officer)

Date: November 9, 2017	/s/ Ronald J. Lataille
	Ronald J. Lataille
	Chief Financial Officer
	(Principal Financial Officer)

A signed original of these written statements required by Section 906 has been provided to UFP Technologies, Inc. and will be retained by UFP Technologies, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

EX-101.INS 5 ufpt-20170930.xml XBRL INSTANCE FILE false --12-31 Q3 2017 2017-09-30 10-Q 0000914156 7267662 Yes Accelerated Filer UFP TECHNOLOGIES INC No No ufpt <div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" style="; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; min-width: 700px;"> <tr style="vertical-align: top"> <td style="width: 27pt"><div style="display: inline; font-weight: bold;">(<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11</div>)</div></td> <td><div style="display: inline; font-weight: bold;">Plant Consolidations</div></td> </tr> </table> <div style=" margin: 0pt 0 0pt 27.35pt; font-size: 10pt"> </div> <div style=" margin: 0pt 0 0pt 27.35pt; font-size: 10pt"></div> <div style=" margin: 0pt 0 0pt 27pt; font-size: 10pt"><div style="display: inline; font-style: italic;">Restructuring Costs</div></div> <div style=" margin: 0pt 0 0pt 27pt; font-size: 10pt"> </div> <div style=" margin: 0pt 0 0pt 27pt; font-size: 10pt">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 18, 2015, </div>the Company committed to move forward with a plan to cease operations at its Raritan, New Jersey, plant and consolidate operations into its Newburyport, Massachusetts, facility and other UFP facilities. The Company’s decision was in response to a continued decline in business at the Raritan facility and the Company’s purchase of the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">137,000</div>-square-foot facility in Newburyport. The activities related to this consolidation are complete.</div> <div style=" margin: 0pt 0 0pt 27pt; font-size: 10pt"> </div> <div style=" margin: 0pt 0 0pt 27pt; font-size: 10pt">The Company also relocated all operations in its Haverhill, Massachusetts, and Byfield, Massachusetts, facilities and relocated certain operations in its Georgetown, Massachusetts, facility to Newburyport. The Haverhill and Byfield relocations were complete at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2015, </div>and the partial Georgetown relocation was complete at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2017.</div></div> <div style=" margin: 0pt 0; font-size: 10pt"> </div> <div style=" margin: 0pt 0 0pt 27pt; font-size: 10pt">The Company incurred approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2.1</div> million in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div>-time expenses in connection with the Massachusetts consolidations. Included in this amount are approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$180,000</div> relating to employee severance payments and relocation costs, approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.6</div> million in moving expenses and expenses associated with vacating the Raritan, Haverhill, and Byfield properties, and approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$360,000</div> in lease termination costs. Total cash charges were approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2.0</div> million.</div> <div style=" margin: 0pt 0 0pt 27pt; font-size: 10pt"></div>  <div style=" margin: 0pt 0 0pt 27pt; font-size: 10pt"></div> <div style=" margin: 0pt 0; font-size: 10pt"> </div> <div style=" margin: 0pt 0 0pt 27pt; font-size: 10pt">The Company recorded the following restructuring costs associated with the Massachusetts consolidations for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div>- and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div>-month periods ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> (in thousands):</div> <div style=" margin: 0pt 0 0pt 27pt; font-size: 10pt"> </div> <div style=" margin: 0pt 0 0pt 27pt; font-size: 10pt"></div> <div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; margin: 0pt 0pt 0pt 27pt; min-width: 700px;"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; text-align: center"> </td> <td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center">Three Months Ended</td> <td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center">Nine Months Ended</td> </tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; text-align: center"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">September 30,</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">September 30,</td> </tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1pt solid">Restructuring Costs</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2017</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2016</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2017</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2016</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; font-size: 10pt; padding-bottom: 1pt">Relocation</td> <td style="width: 1%; font-size: 10pt; padding-bottom: 1pt"> </td> <td style="width: 1%; border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</td> <td style="width: 12%; border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt; padding-bottom: 1pt"> </td> <td style="width: 1%; border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</td> <td style="width: 12%; border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">25</div></td> <td style="width: 1%; border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt; padding-bottom: 1pt"> </td> <td style="width: 1%; border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</td> <td style="width: 12%; border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">63</div></td> <td style="width: 1%; border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt; padding-bottom: 1pt"> </td> <td style="width: 1%; border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</td> <td style="width: 12%; border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">203</div></td> <td style="width: 1%; border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 2.25pt">Total</td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">25</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">63</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">203</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> </tr> </table> </div> <div style=" margin: 0pt 0 0pt 27pt; font-size: 10pt"></div> <div style=" margin: 0pt 0 0pt 27pt; font-size: 10pt"> </div> <div style=" margin: 0pt 0 0pt 27pt; font-size: 10pt"></div> <div style=" margin: 0pt 0 0pt 27pt; font-size: 10pt">Costs for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div>- and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div>- month periods ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> were reclassified in the Condensed Consolidated Statement of Income as “Restructuring Costs” from Cost of Sales.</div></div> 1 630000 529000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"> <div style=" margin: 0pt 0 0pt 27.35pt; font-size: 10pt"></div><div style=" margin: 0pt 0 0pt 27.35pt; font-size: 10pt"><div style="display: inline; font-style: italic;">Revisions</div></div> <div style=" margin: 0pt 0 0pt 27.35pt; font-size: 10pt"> </div> <div style=" margin: 0pt 0 0pt 27.35pt; font-size: 10pt">Certain revisions have been made to the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> Condensed Consolidated Statement of Cash Flows to conform to the current year presentation relating to a reserve for uncertain tax positions and to cash paid for capital expenditures. The reclassification of a reserve for uncertain tax positions resulted in an increase to the change in refundable income taxes of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$315,000</div> and a decrease to the change in accrued expenses of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$315,000.</div> A change in presentation of cash paid for capital expenditures resulted in a decrease of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$311,000</div> in both the change in accounts payable and in additions to property, plant and equipment, net. These revisions had <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> impact on previously reported net income and are deemed immaterial to the previously issued financial statements.</div></div></div> 6511 0 26.45 24.50 22.82

4958000

4002000

5356000

4698000

51815000

48290000

26580000

25216000

105000

100000

300000

105000

4000

34000

25000

107000

102000

95000

307000

254000

206000

229000

842000

871000

602000

567000

79000

239000

79000

239000

27336

35193

52377

137000

137091000

127934000

75639000

69847000

25000

63000

203000

527000

311000

37246000

31359000

29804000

30118000

5887000

314000

0.001

0.01

20000000

7299721

7242023

7270162

7212464

73000

72000

0.468

0.445

0.477

0.447

0.168

0.152

0.142

0.14

0.145

0.187

0.163

0.187

0.075

0.068

0.075

0.072

0.073

0.075

0.069

0.077

0.071

0.075

0.074

0.078

27491000

28768000

82973000

83161000

1949000

1682000

254000

224000

3713000

3459000

4171000

4109000

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; min-width: 700px;"> <tr style="vertical-align: top"> <td style="width: 0"></td> <td style="width: 27pt"><div style="display: inline; font-weight: bold;">(<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4</div>)</div></td> <td><div style="display: inline; font-weight: bold;">Share-Based Compensation</div></td> </tr> </table> <div style=" margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"> </div> <div style=" margin: 0pt 0 0pt 27pt; font-size: 10pt">Share-based compensation is measured at the grant date based on the fair value of the award and is recognized as an expense over the requisite service period (generally the vesting period of the equity grant).</div> <div style=" margin: 0pt 0 0pt 27pt; font-size: 10pt"> </div> <div style=" margin: 0pt 0 0pt 27pt; font-size: 10pt">The Company issues share-based awards through several plans that are described in detail in the notes to the consolidated financial statements for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016. </div>The compensation cost charged against income for those plans is included in selling, general & administrative expenses as follows (in thousands):</div> <div style=" margin: 0pt 0 0pt 27.35pt; font-size: 10pt"> </div> <div style=" margin: 0pt 0 0pt 27.35pt; font-size: 10pt"></div>   <div style=" margin: 0pt 0 0pt 27.35pt; font-size: 10pt"></div> <div style=" margin: 0pt 0 0pt 27pt; font-size: 10pt"> </div> <div style=" margin: 0pt 27.9pt 0pt 27pt; font-size: 10pt"></div> <div style=" margin: 0pt 27.9pt 0pt 27pt; font-size: 10pt"></div> <div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; margin: 0pt 0pt 0pt 27pt; min-width: 700px;"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; color: #8497B0; text-align: center"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Three Months Ended<br /> September 30,</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Nine Months Ended<br /> September 30,</td> </tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1pt solid">Share-based compensation related to:</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2017</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2016</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2017</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2016</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; font-size: 10pt; text-align: left">Common stock granted to the Board of Directors</td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 12%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 12%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 12%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">105</div></td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 12%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">105</div></td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Common stock granted to the Chief Executive Officer</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100</div></td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100</div></td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">300</div></td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">300</div></td> <td style="font-size: 10pt; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Stock options granted to directors</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">105</div></td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">105</div></td> <td style="font-size: 10pt; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Stock options granted to employees</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4</div></td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">34</div></td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">25</div></td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">107</div></td> <td style="font-size: 10pt; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Restricted Stock Unit awards to employees</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">102</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">95</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">307</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">254</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.25pt">Total share-based compensation</td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">206</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">229</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">842</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">871</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> </tr> </table> </div> <div style=" margin: 0pt 27.9pt 0pt 27pt; font-size: 10pt"></div> <div style=" margin: 0pt 0 0pt 27pt; font-size: 10pt; text-align: center"></div> <div style=" margin: 0pt 0 0pt 27pt; font-size: 10pt"> </div> <div style=" margin: 0pt 0 0pt 27pt; font-size: 10pt">The total income tax benefit recognized in the condensed consolidated statements of income for share-based compensation arrangements was approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$106,000</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$67,000,</div> respectively, for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div>-month periods ended <div style="display: inline; color: windowtext"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> and approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$441,000</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$264,000,</div> respectively, for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div>-month periods ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div></div>.</div> <div style=" margin: 0pt 0 0pt 27pt; font-size: 10pt"> </div> <div style=" margin: 0pt 0 0pt 27pt; font-size: 10pt">The following is a summary of stock option activity under all plans for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div>-month period ended <div style="display: inline; color: windowtext"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017</div></div>:</div> <div style=" margin: 0pt 0 0pt 27pt; font-size: 10pt"> </div> <div style=" margin: 0pt 0 0pt 27pt; font-size: 10pt"></div> <div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; margin: 0pt 0pt 0pt 27pt; min-width: 700px;"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; text-align: center"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><div style="display: inline; font-weight: bold;"> </div></td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><div style=" margin-top: 0; margin-bottom: 0"><div style="display: inline; font-weight: bold;">Shares Under</div></div> <div style=" margin-top: 0; margin-bottom: 0"><div style="display: inline; font-weight: bold;">Options</div></div></td> <td style="font-size: 10pt; font-weight: normal; font-style: normal; padding-bottom: 1pt"><div style="display: inline; font-weight: bold;"> </div></td> <td colspan="3" style="font-size: 10pt; font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid"><div style=" margin-top: 0; margin-bottom: 0"><div style="display: inline; font-weight: bold;">Weighted Average Exercise Price</div></div> <div style=" margin-top: 0; margin-bottom: 0"><div style="display: inline; font-weight: bold;">(per share)</div></div></td> <td style="font-size: 10pt; font-weight: normal; font-style: normal; padding-bottom: 1pt"><div style="display: inline; font-weight: bold;"> </div></td> <td colspan="3" style="font-size: 10pt; font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid"><div style=" margin-top: 0; margin-bottom: 0"><div style="display: inline; font-weight: bold;">Weighted Average Remaining</div></div> <div style=" margin-top: 0; margin-bottom: 0"><div style="display: inline; font-weight: bold;">Contractual Life</div></div> <div style=" margin-top: 0; margin-bottom: 0"><div style="display: inline; font-weight: bold;">(in years)</div></div></td> <td style="font-size: 10pt; font-weight: normal; font-style: normal; padding-bottom: 1pt"><div style="display: inline; font-weight: bold;"> </div></td> <td colspan="3" style="font-size: 10pt; font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid"><div style=" margin-top: 0; margin-bottom: 0"><div style="display: inline; font-weight: bold;">Aggregate Intrinsic Value</div></div> <div style=" margin-top: 0; margin-bottom: 0"><div style="display: inline; font-weight: bold;">(in thousands)</div></div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; font-size: 10pt">Outstanding at December 31, 2016</td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 12%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">232,578</div></td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 12%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">16.53</div></td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 12%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt; text-decoration: line-through"> </td> <td style="width: 1%; font-size: 10pt; text-decoration: line-through; text-align: left"> </td> <td style="width: 12%; font-size: 10pt; text-decoration: line-through; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="width: 1%; font-size: 10pt; text-decoration: line-through; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Granted</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12,336</div></td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">27.05</div></td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-size: 10pt; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Exercised</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(51,285</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">26.88</div></td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-size: 10pt; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Expired</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left; border-bottom: Black 1pt solid"> </td> <td style="padding-bottom: 1pt; font-size: 10pt; text-align: right; border-bottom: Black 1pt solid"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(3,750</div></td> <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left; border-bottom: Black 1pt solid">)</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td> <td style="padding-bottom: 1pt; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18.85</div></td> <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td> <td style="padding-bottom: 1pt; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td> <td style="padding-bottom: 1pt; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 2.25pt">Outstanding at September 30, 2017</td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">189,879</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17.41</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.55</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,029</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 2.25pt">Exercisable at September 30, 2017</td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">184,879</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17.23</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.60</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,011</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.25pt">Vested and expected to vest at September 30, 2017</td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">189,879</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17.41</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.55</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,029</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> </tr> </table> </div> <div style=" margin: 0pt 0 0pt 27pt; font-size: 10pt"></div> <div style=" margin: 0pt 0 0pt 27pt; font-size: 10pt"> </div> <div style=" margin: 0pt 0 0pt 27pt; font-size: 10pt">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 6, 2017, </div>the Company granted options to its directors for the purchase of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12,336</div> shares of common stock at that day’s closing price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$27.05.</div> The compensation expense related to these grants was determined as the fair value of the options using the Black Scholes option pricing model based on the following assumptions:</div> <div style=" margin: 0pt 0 0pt 27pt; font-size: 10pt"> </div> <div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; margin: 0pt 0pt 0pt 27pt; min-width: 700px;"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 74%; font-size: 10pt; text-align: left">Expected volatility</td> <td style="width: 2%; font-size: 10pt"> </td> <td style="width: 2%; font-size: 10pt; text-align: left"> </td> <td style="width: 21%; font-size: 10pt; text-align: left"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">29.1%</div></td> <td style="width: 1%; font-size: 10pt; text-align: left"></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Expected dividends</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">None</div></td> <td style="font-size: 10pt; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Risk-free interest rate</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.84%</div></td> <td style="font-size: 10pt; text-align: left"></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Exercise price</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$27.05</div></td> <td style="font-size: 10pt; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Expected term (in years)</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5.8 </div></td> <td style="font-size: 10pt; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Weighted-average grant date fair value</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$8.51</div></td> <td style="font-size: 10pt; text-align: left"> </td> </tr> </table> </div> <div style=" margin: 0pt 0 0pt 27pt; font-size: 10pt"> </div> <div style=" margin: 0pt 0 0pt 27pt; font-size: 10pt">The stock volatility for each grant is determined based on a review of the experience of the weighted average of historical daily price changes of the Company’s common stock over the expected option term, and the risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods corresponding with the expected term of the option. The expected term is estimated based on historical option exercise activity.</div> <div style=" margin: 0pt 0 0pt 27pt; font-size: 10pt"> </div> <div style=" margin: 0pt 0 0pt 27pt; font-size: 10pt">During the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div>-month periods ended <div style="display: inline; color: windowtext"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div></div>, the total intrinsic value of all options exercised (i.e., the difference between the market price on the exercise date and the price paid by the employees to exercise the options) was approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$577,000</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$564,000,</div> respectively, and the total amount of consideration received by the Company from the exercised options was approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$802,000</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$529,000,</div> respectively. At its discretion, the Company allows option holders to surrender previously owned common stock in lieu of paying the exercise price and withholding taxes. During the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div>-month period ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017 </div>there were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,511</div> shares <div style="display: inline; color: windowtext">surrendered at an average market price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$26.45.</div></div> During the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div>-month period ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2016 </div>there were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> shares surrendered for this purpose.</div> <div style=" margin: 0pt 0 0pt 27pt; font-size: 10pt"></div>  <div style=" margin: 0pt 0 0pt 27pt; font-size: 10pt"> </div> <div style=" margin: 0pt 0 0pt 27pt; font-size: 10pt">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February 2</div><div style="display: inline; color: black"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> the Company’s Compensation Committee approved the award of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$400,000,</div> payable in shares of common stock to the Company’s Chairman, Chief Executive Officer, and President under the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2003</div> </div><div style="display: inline; color: windowtext">Incentive Plan. The shares will be issued in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December, 2017. </div></div></div> <div style=" margin: 0pt 0 0pt 27pt; font-size: 10pt"> </div> <div style=" margin: 0pt 0 0pt 27pt; font-size: 10pt">The following table summarizes information about Restricted Stock Units (“RSUs”) activity during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div>-month period ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017:</div></div> <div style=" margin: 0pt 0 0pt 27pt; font-size: 10pt"> </div> <div style=" margin: 0pt 0 0pt 27pt; font-size: 10pt"></div> <div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; margin: 0pt 0pt 0pt 27pt; min-width: 700px;"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; text-align: center"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Restricted<br /> Stock Units</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; padding-bottom: 1pt; border-bottom: Black 1pt solid">Weighted Average<br /> Award Date<br /> Fair Value</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 70%; font-size: 10pt">Unvested at December 31, 2016</td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 12%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">46,558</div></td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 12%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20.05</div></td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Awarded</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">22,770</div></td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">24.70</div></td> <td style="font-size: 10pt; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Shares vested</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(13,419</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td> <td style="padding-bottom: 1pt; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">23.54</div></td> <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 2.25pt">Unvested at September 30, 2017</td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">55,909</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="padding-bottom: 2.25pt; font-size: 10pt; text-align: left">$</td> <td style="padding-bottom: 2.25pt; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20.96</div></td> <td style="padding-bottom: 2.25pt; font-size: 10pt; text-align: left"> </td> </tr> </table> </div> <div style=" margin: 0pt 0 0pt 27pt; font-size: 10pt"></div> <div style=" margin: 0pt 0 0pt 27pt; font-size: 10pt"> </div> <div style=" margin: 0pt 0 0pt 27pt; font-size: 10pt">At the Company’s discretion, RSU holders are given the option to net-share settle to cover the required minimum withholding tax, and the remaining amount is converted into the equivalent number of common shares. During the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div>-month periods ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,377</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,889</div> shares were surrendered at an average market price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$24.50</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$22.82,</div> respectively.</div> <div style=" margin: 0pt 0 0pt 27pt; font-size: 10pt"> </div> <div style=" margin: 0pt 0 0pt 27pt; font-size: 10pt"><div style="display: inline; color: windowtext">As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017, </div>the Company had approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$754,000</div> of unrecognized compensation expense, which is expected to be recognized over a period of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.5</div> years</div>.</div></div>

0.23

0.37

0.90

0.23

0.37

0.89

0.336

0.35

0.333

0.354

754000

P3Y182D

106000

67000

441000

264000

126000

P14Y

P5Y

P14Y

P5Y

429000

496000

1983000

2908000

429000

449000

1791000

2669000

79000

429000

512000

2046000

2987000

429000

512000

2046000

2987000

-3000

4000

-3000

4000

1681000

121000

2114000

7322000

8193000

8452000

27650000

26465000

2551000

4106000

9743000

10029000

-37000

-162000

856000

1437000

3248000

3550000

3167000

2178000

979000

807000

429000

197000

-315000

658000

-317000

315000

172000

-1146000

-1015000

366000

138000

93000

201000

205000

-47000

1231000

795000

4826000

89000

87000

86000

82000

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" style="; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; min-width: 700px;"> <tr style="vertical-align: top"> <td style="width: 0"></td> <td style="width: 27pt"><div style="display: inline; font-weight: bold;">(<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9</div>)</div></td> <td><div style="display: inline; font-weight: bold;">Other Intangible Assets</div></td> </tr> </table> <div style=" margin: 0pt 0 0pt 27pt; font-size: 10pt"> </div> <div style=" margin: 0pt 0 0pt 27.35pt; font-size: 10pt">The carrying values of the Company’s definite lived intangible assets as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> are as follows (in thousands):</div> <div style=" margin: 0pt 0 0pt 27.35pt; font-size: 10pt"> </div> <div style=" margin: 0pt 0 0pt 27.35pt; font-size: 10pt"></div> <div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; margin: 0pt 0pt 0pt 27pt; min-width: 700px;"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Patents</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Non-<br /> Compete</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Customer<br /> List</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Total</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt">Estimated useful life (in years)</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14</div></td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5</div></td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5</div></td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-size: 10pt; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 40%; font-size: 10pt">Gross amount at September 30, 2017</td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 12%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">429</div></td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 12%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">512</div></td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 12%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,046</div></td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 12%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,987</div></td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 1pt">Accumulated amortization at September 30, 2017</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(429</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(496</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,983</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(2,908</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 2.25pt">Net balance at September 30, 2017</td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">16</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">63</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">79</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Estimated useful life (in years)</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14</div></td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5</div></td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5 </div></td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-size: 10pt; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt">Gross amount at December 31, 2016</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">429</div></td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">512</div></td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,046</div></td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,987</div></td> <td style="font-size: 10pt; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 1pt">Accumulated amortization at December 31, 2016</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(429</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(449</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,791</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(2,669</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 2.25pt">Net balance at December 31, 2016</td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">63</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">255</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">318</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> </tr> </table> </div> <div style=" margin: 0pt 0 0pt 27.35pt; font-size: 10pt"></div> <div style=" margin: 0pt 0 0pt 27.35pt; font-size: 10pt"> </div> <div style=" margin: 0pt 0 0pt 27.35pt; font-size: 10pt">Amortization expense related to intangible assets was approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$79,000</div></div> for each of the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div>-month periods ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> and was approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$239,000</div></div> for each of the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div>-month periods ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016.</div> As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017, </div>the estimated remaining amortization expense for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$79,000.</div></div></div>

16000

63000

79000

63000

255000

318000

12000

17000

39000

53000

37000

51000

5315000

5686000

13136000

14151000

6660000

7111000

1161000

1354000

63000

42000

147000

104000

16178000

14881000

137091000

127934000

10398000

9556000

121000

1700000

2100000

84000

856000

-249000

-192000

-6874000

-5762000

13010000

6268000

1695000

2669000

6495000

6479000

<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt 0 0pt 27pt; font-size: 10pt"><div style="display: inline; font-style: italic;">Recent Accounting Pronouncements</div></div> <div style=" margin: 0pt 0 0pt 27pt; font-size: 10pt"><div style="display: inline; font-style: italic;"> </div></div> <div style=" margin: 0pt 0 0pt 27.35pt; font-size: 10pt">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 2014, </div>the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09,</div> <div style="display: inline; font-style: italic;">Revenue from Contracts with Customers</div>, which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. This standard will replace most existing revenue recognition guidance when it becomes effective. The standard permits the use of either the full retrospective or modified retrospective transition methods. The Company expects to adopt the standard in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div> using the modified retrospective transition method. The Company has identified its primary revenue streams, completed a preliminary review of a representative sample of contracts with its customers and is in the process of evaluating the impact of this ASU on its revenue streams and accounting policies. Based on the procedures completed to date, the Company expects that for a significant portion of its business, the recognition of revenue under the updated standard will occur at a point in time, which is consistent with current practice. The Company has identified certain revenue streams for which the recognition of revenue <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>occur over time, which is a change from current practice. These revenue streams include certain customer stocking commitments. Additionally, the Company has identified certain revenue streams for which the recognition of revenue <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be deferred, which is also a change from current practice. These revenue streams include certain tooling sales. The Company does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> expect that the impact of these changes in the timing of revenue recognition for these items to be significant to the financial statements. The Company is also in the process of updating its internal controls and drafting the expanded disclosures as required by this ASU. <div style="display: inline; color: windowtext">The Company does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> expect significant changes to its systems or internal controls. As the Company continues thr</div>ough the adoption process, it is possible that these preliminary conclusions <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>change.</div> <div style=" margin: 0pt 0 0pt 27.35pt; font-size: 10pt"> </div> <div style=" margin: 0pt 0 0pt 27.35pt; font-size: 10pt">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February 2016, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02,</div> <div style="display: inline; font-style: italic;">Leases.</div> The guidance in this ASU supersedes the leasing guidance in Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">840,</div> <div style="display: inline; font-style: italic;">Leases</div>. Under the new guidance, lessees are required to recognize lease assets and lease liabilities on the balance sheet for those leases previously classified as operating leases. The amendments in ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02</div> are effective for annual reporting periods beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018,</div> including interim periods within that reporting period with early adoption permitted. The Company is evaluating the impact of adopting this ASU on its consolidated financial position and results of operations.</div> <div style=" margin: 0pt 0 0pt 27.35pt; font-size: 10pt"> </div> <div style=" margin: 0pt 0 0pt 27.35pt; font-size: 10pt">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 2016, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09,</div> <div style="display: inline; font-style: italic;">Improvements to Employee Share Based Payment Accounting</div>. This ASU simplifies several aspects of the accounting for share-based payment transactions, including income tax consequences, classification of awards, forfeitures and classification on the statement of cash flows. The Company adopted this ASU on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 1, 2017. </div>As the Company has <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> had a significant amount of forfeitures historically, under the provisions of this ASU the Company has elected to account for forfeitures as they occur, rather than estimate expected forfeitures. The impact of adopting this update to the Company’s Consolidated Financial Statements will depend on market factors and the timing and intrinsic value of future share-based compensation award vests and exercises. Subsequent to adoption, the Company notes the potential for volatility in its effective tax rate as any windfall or shortfall tax benefits related to its share-based compensation plans will be recorded directly to income tax expense in the Condensed Consolidated Statement of Income.</div></div></div>

2500000

4081000

9635000

9978000

2069000

1931000

118000

184000

2000000

107000

89000

-311000

6880000

5766000

0.01

1000000

2234000

2281000

6000

4000

802000

529000

103797000

96806000

51982000

48516000

22044000

21249000

772000

758000

180000

1600000

360000

2100000

25000

63000

203000

25000

63000

203000

94847000

88352000

148000

35684000

37220000

110623000

109626000

16712000

16548000

52822000

48953000

6006000

5648000

15713000

15303000

5174000

6942000

18018000

20485000

2682000

2516000

8290000

7929000

2591000

2792000

7629000

8441000

2519000

2774000

8151000

8515000

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; margin: 0pt 0pt 0pt 27pt; min-; min-width: 700px;"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="15" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Three Months Ended September 30,</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="15" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Nine Months Ended September 30,</td> </tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2017</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2016</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2017</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2016</td> </tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Market</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Net Sales</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt; border-bottom: Black 1pt solid"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">%</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Net Sales</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt; border-bottom: Black 1pt solid"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">%</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Net Sales</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt; border-bottom: Black 1pt solid"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">%</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Net Sales</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt; border-bottom: Black 1pt solid"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">%</td> </tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt"> </td> <td colspan="3" style="font-size: 10pt"> </td> <td style="font-size: 10pt"> </td> <td colspan="3" style="font-size: 10pt"> </td> <td style="font-size: 10pt"> </td> <td colspan="3" style="font-size: 10pt"> </td> <td style="font-size: 10pt"> </td> <td colspan="3" style="font-size: 10pt"> </td> <td style="font-size: 10pt"> </td> <td colspan="3" style="font-size: 10pt"> </td> <td style="font-size: 10pt"> </td> <td colspan="3" style="font-size: 10pt"> </td> <td style="font-size: 10pt"> </td> <td colspan="3" style="font-size: 10pt"> </td> <td style="font-size: 10pt"> </td> <td colspan="3" style="font-size: 10pt"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 20%; font-size: 10pt">Medical</td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 7%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">16,712</div></td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 7%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">46.8</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">%</td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 7%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">16,548</div></td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 7%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">44.5</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">%</td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 7%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">52,822</div></td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 7%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">47.7</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">%</td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 7%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">48,953</div></td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 7%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">44.7</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">%</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">Consumer</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,006</div></td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">16.8</div></td> <td style="font-size: 10pt; text-align: left">%</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,648</div></td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15.2</div></td> <td style="font-size: 10pt; text-align: left">%</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,713</div></td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14.2</div></td> <td style="font-size: 10pt; text-align: left">%</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,303</div></td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14.0</div></td> <td style="font-size: 10pt; text-align: left">%</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt">Automotive</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,174</div></td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14.5</div></td> <td style="font-size: 10pt; text-align: left">%</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,942</div></td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18.7</div></td> <td style="font-size: 10pt; text-align: left">%</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18,018</div></td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">16.3</div></td> <td style="font-size: 10pt; text-align: left">%</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,485</div></td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18.7</div></td> <td style="font-size: 10pt; text-align: left">%</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Aerospace & Defense</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,682</div></td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7.5</div></td> <td style="font-size: 10pt; text-align: left">%</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,516</div></td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6.8</div></td> <td style="font-size: 10pt; text-align: left">%</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,290</div></td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7.5</div></td> <td style="font-size: 10pt; text-align: left">%</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7,929</div></td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7.2</div></td> <td style="font-size: 10pt; text-align: left">%</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt">Industrial</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,591</div></td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7.3</div></td> <td style="font-size: 10pt; text-align: left">%</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,792</div></td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7.5</div></td> <td style="font-size: 10pt; text-align: left">%</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7,629</div></td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6.9</div></td> <td style="font-size: 10pt; text-align: left">%</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,441</div></td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7.7</div></td> <td style="font-size: 10pt; text-align: left">%</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 1pt">Electronics</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,519</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt; border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7.1</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">%</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,774</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt; border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7.5</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">%</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,151</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt; border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7.4</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">%</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,515</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt; border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7.8</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">%</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.25pt; padding-left: 10pt">Net Sales</td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">35,684</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.25pt; border-bottom: Black 2.5pt double"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100.0</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">%</td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">37,220</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.25pt; border-bottom: Black 2.5pt double"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100.0</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">%</td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">110,623</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.25pt; border-bottom: Black 2.5pt double"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100.0</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">%</td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">109,626</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.25pt; border-bottom: Black 2.5pt double"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100.0</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">%</td> </tr> </table></div>

5693000

6027000

18070000

18402000

842000

871000

22770

24.70

46558

55909

20.05

20.96

13419

23.54

27.05

0.291

0.0184

184879

17.23

577000

564000

3750

12336

8.51

2029000

232578

189879

16.53

17.41

2029000

189879

26.88

18.85

27.05

P5Y292D

2011000

P3Y219D

P3Y200D

4377

3889

51285

400000

120913000

113053000

40000

29559

587000

7353000

7282000

7326000

7265000

7264000

7195000

7240000

7183000

xbrli:shares xbrli:pure utr:sqft iso4217:USD iso4217:USD xbrli:shares 0000914156 2009-03-18 2009-03-18 0000914156 ufpt:NewburyportMassachusettsFacilityMember 2015-03-18 2015-03-18 0000914156 2016-01-01 2016-03-31 0000914156 2016-01-01 2016-09-30 0000914156 ufpt:CommonStockIssuedUnderTheEquityIncentivePlanMember us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:ChiefExecutiveOfficerMember 2016-01-01 2016-09-30 0000914156 ufpt:CommonStockIssuedUnderTheEquityIncentivePlanMember us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:DirectorMember 2016-01-01 2016-09-30 0000914156 us-gaap:EmployeeStockOptionMember us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:DirectorMember 2016-01-01 2016-09-30 0000914156 us-gaap:EmployeeStockOptionMember us-gaap:SellingGeneralAndAdministrativeExpensesMember ufpt:EmployeesMember 2016-01-01 2016-09-30 0000914156 us-gaap:RestrictedStockUnitsRSUMember 2016-01-01 2016-09-30 0000914156 us-gaap:RestrictedStockUnitsRSUMember us-gaap:SellingGeneralAndAdministrativeExpensesMember ufpt:EmployeesMember 2016-01-01 2016-09-30 0000914156 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2016-01-01 2016-09-30 0000914156 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember ufpt:AerospaceDefenseMember 2016-01-01 2016-09-30 0000914156 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember ufpt:AutomotiveMember 2016-01-01 2016-09-30 0000914156 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember ufpt:ConsumerMember 2016-01-01 2016-09-30 0000914156 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember ufpt:ElectronicsMember 2016-01-01 2016-09-30 0000914156 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember ufpt:IndustrialMember 2016-01-01 2016-09-30 0000914156 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember ufpt:MedicalMember 2016-01-01 2016-09-30 0000914156 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2016-01-01 2016-09-30 0000914156 ufpt:PolyurethaneFoamAntitrustLawsuitMember 2016-01-01 2016-09-30 0000914156 ufpt:AerospaceDefenseMember 2016-01-01 2016-09-30 0000914156 ufpt:AutomotiveMember 2016-01-01 2016-09-30 0000914156 ufpt:ConsumerMember 2016-01-01 2016-09-30 0000914156 ufpt:ElectronicsMember 2016-01-01 2016-09-30 0000914156 ufpt:IndustrialMember 2016-01-01 2016-09-30 0000914156 ufpt:MedicalMember 2016-01-01 2016-09-30 0000914156 ufpt:NewburyportMassachusettsFacilityMember 2016-01-01 2016-09-30 0000914156 us-gaap:RestatementAdjustmentMember 2016-01-01 2016-09-30 0000914156 2016-01-01 2016-12-31 0000914156 us-gaap:CustomerListsMember 2016-01-01 2016-12-31 0000914156 us-gaap:NoncompeteAgreementsMember 2016-01-01 2016-12-31 0000914156 us-gaap:PatentsMember 2016-01-01 2016-12-31 0000914156 2016-07-01 2016-09-30 0000914156 ufpt:CommonStockIssuedUnderTheEquityIncentivePlanMember us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:ChiefExecutiveOfficerMember 2016-07-01 2016-09-30 0000914156 ufpt:CommonStockIssuedUnderTheEquityIncentivePlanMember us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:DirectorMember 2016-07-01 2016-09-30 0000914156 us-gaap:EmployeeStockOptionMember us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:DirectorMember 2016-07-01 2016-09-30 0000914156 us-gaap:EmployeeStockOptionMember us-gaap:SellingGeneralAndAdministrativeExpensesMember ufpt:EmployeesMember 2016-07-01 2016-09-30 0000914156 us-gaap:RestrictedStockUnitsRSUMember us-gaap:SellingGeneralAndAdministrativeExpensesMember ufpt:EmployeesMember 2016-07-01 2016-09-30 0000914156 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2016-07-01 2016-09-30 0000914156 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember ufpt:AerospaceDefenseMember 2016-07-01 2016-09-30 0000914156 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember ufpt:AutomotiveMember 2016-07-01 2016-09-30 0000914156 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember ufpt:ConsumerMember 2016-07-01 2016-09-30 0000914156 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember ufpt:ElectronicsMember 2016-07-01 2016-09-30 0000914156 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember ufpt:IndustrialMember 2016-07-01 2016-09-30 0000914156 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember ufpt:MedicalMember 2016-07-01 2016-09-30 0000914156 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2016-07-01 2016-09-30 0000914156 ufpt:PolyurethaneFoamAntitrustLawsuitMember 2016-07-01 2016-09-30 0000914156 ufpt:AerospaceDefenseMember 2016-07-01 2016-09-30 0000914156 ufpt:AutomotiveMember 2016-07-01 2016-09-30 0000914156 ufpt:ConsumerMember 2016-07-01 2016-09-30 0000914156 ufpt:ElectronicsMember 2016-07-01 2016-09-30 0000914156 ufpt:IndustrialMember 2016-07-01 2016-09-30 0000914156 ufpt:MedicalMember 2016-07-01 2016-09-30 0000914156 ufpt:NewburyportMassachusettsFacilityMember 2016-07-01 2016-09-30 0000914156 ufpt:VentionMedicalIncMember ufpt:NonemployeeMembersOfBoardOfDirectorsMember 2017-01-01 2017-03-31 0000914156 2017-01-01 2017-09-30 0000914156 us-gaap:AccountingStandardsUpdate201609Member 2017-01-01 2017-09-30 0000914156 ufpt:CommonStockIssuedUnderTheEquityIncentivePlanMember us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:ChiefExecutiveOfficerMember 2017-01-01 2017-09-30 0000914156 ufpt:CommonStockIssuedUnderTheEquityIncentivePlanMember us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:DirectorMember 2017-01-01 2017-09-30 0000914156 us-gaap:EmployeeStockOptionMember 2017-01-01 2017-09-30 0000914156 us-gaap:EmployeeStockOptionMember us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:DirectorMember 2017-01-01 2017-09-30 0000914156 us-gaap:EmployeeStockOptionMember us-gaap:SellingGeneralAndAdministrativeExpensesMember ufpt:EmployeesMember 2017-01-01 2017-09-30 0000914156 us-gaap:RestrictedStockUnitsRSUMember 2017-01-01 2017-09-30 0000914156 us-gaap:RestrictedStockUnitsRSUMember us-gaap:SellingGeneralAndAdministrativeExpensesMember ufpt:EmployeesMember 2017-01-01 2017-09-30 0000914156 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2017-01-01 2017-09-30 0000914156 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember ufpt:AerospaceDefenseMember 2017-01-01 2017-09-30 0000914156 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember ufpt:AutomotiveMember 2017-01-01 2017-09-30 0000914156 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember ufpt:ConsumerMember 2017-01-01 2017-09-30 0000914156 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember ufpt:ElectronicsMember 2017-01-01 2017-09-30 0000914156 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember ufpt:IndustrialMember 2017-01-01 2017-09-30 0000914156 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember ufpt:MedicalMember 2017-01-01 2017-09-30 0000914156 us-gaap:CustomerListsMember 2017-01-01 2017-09-30 0000914156 us-gaap:NoncompeteAgreementsMember 2017-01-01 2017-09-30 0000914156 us-gaap:PatentsMember 2017-01-01 2017-09-30 0000914156 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2017-01-01 2017-09-30 0000914156 ufpt:PolyurethaneFoamAntitrustLawsuitMember 2017-01-01 2017-09-30 0000914156 ufpt:AerospaceDefenseMember 2017-01-01 2017-09-30 0000914156 ufpt:AutomotiveMember 2017-01-01 2017-09-30 0000914156 ufpt:ConsumerMember 2017-01-01 2017-09-30 0000914156 ufpt:ElectronicsMember 2017-01-01 2017-09-30 0000914156 ufpt:IndustrialMember 2017-01-01 2017-09-30 0000914156 ufpt:MedicalMember 2017-01-01 2017-09-30 0000914156 ufpt:NewburyportMassachusettsFacilityMember 2017-01-01 2017-09-30 0000914156 us-gaap:CommonStockMember ufpt:The2003IncentivePlanMember ufpt:ChairmanChiefExecutiveOfficerAndPresidentMember 2017-02-21 2017-02-21 0000914156 2017-06-06 2017-06-06 0000914156 2017-07-01 2017-09-30 0000914156 us-gaap:AccountingStandardsUpdate201609Member 2017-07-01 2017-09-30 0000914156 ufpt:CommonStockIssuedUnderTheEquityIncentivePlanMember us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:ChiefExecutiveOfficerMember 2017-07-01 2017-09-30 0000914156 ufpt:CommonStockIssuedUnderTheEquityIncentivePlanMember us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:DirectorMember 2017-07-01 2017-09-30 0000914156 us-gaap:EmployeeStockOptionMember us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:DirectorMember 2017-07-01 2017-09-30 0000914156 us-gaap:EmployeeStockOptionMember us-gaap:SellingGeneralAndAdministrativeExpensesMember ufpt:EmployeesMember 2017-07-01 2017-09-30 0000914156 us-gaap:RestrictedStockUnitsRSUMember us-gaap:SellingGeneralAndAdministrativeExpensesMember ufpt:EmployeesMember 2017-07-01 2017-09-30 0000914156 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2017-07-01 2017-09-30 0000914156 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember ufpt:AerospaceDefenseMember 2017-07-01 2017-09-30 0000914156 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember ufpt:AutomotiveMember 2017-07-01 2017-09-30 0000914156 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember ufpt:ConsumerMember 2017-07-01 2017-09-30 0000914156 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember ufpt:ElectronicsMember 2017-07-01 2017-09-30 0000914156 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember ufpt:IndustrialMember 2017-07-01 2017-09-30 0000914156 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember ufpt:MedicalMember 2017-07-01 2017-09-30 0000914156 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2017-07-01 2017-09-30 0000914156 ufpt:PolyurethaneFoamAntitrustLawsuitMember 2017-07-01 2017-09-30 0000914156 ufpt:AerospaceDefenseMember 2017-07-01 2017-09-30 0000914156 ufpt:AutomotiveMember 2017-07-01 2017-09-30 0000914156 ufpt:ConsumerMember 2017-07-01 2017-09-30 0000914156 ufpt:ElectronicsMember 2017-07-01 2017-09-30 0000914156 ufpt:IndustrialMember 2017-07-01 2017-09-30 0000914156 ufpt:MedicalMember 2017-07-01 2017-09-30 0000914156 ufpt:NewburyportMassachusettsFacilityMember 2017-07-01 2017-09-30 0000914156 2009-03-18 0000914156 ufpt:PreferredSharePurchaseRightMember 2009-03-18 0000914156 ufpt:SeriesAJuniorParticipatingPreferredStockMember 2009-03-18 0000914156 ufpt:EmployeeSeverancePaymentsAndRelocationCostsMember ufpt:NewburyportMassachusettsFacilityMember 2015-03-18 0000914156 ufpt:LeaseTerminationMember ufpt:NewburyportMassachusettsFacilityMember 2015-03-18 0000914156 ufpt:MovingAndVacatingExpenseMember ufpt:NewburyportMassachusettsFacilityMember 2015-03-18 0000914156 ufpt:NewburyportMassachusettsFacilityMember 2015-03-18 0000914156 2015-12-31 0000914156 2016-09-30 0000914156 2016-12-31 0000914156 us-gaap:RestrictedStockUnitsRSUMember 2016-12-31 0000914156 us-gaap:CustomerListsMember 2016-12-31 0000914156 us-gaap:NoncompeteAgreementsMember 2016-12-31 0000914156 us-gaap:PatentsMember 2016-12-31 0000914156 2017-09-30 0000914156 us-gaap:EmployeeStockOptionMember 2017-09-30 0000914156 us-gaap:RestrictedStockUnitsRSUMember 2017-09-30 0000914156 us-gaap:CustomerListsMember 2017-09-30 0000914156 us-gaap:NoncompeteAgreementsMember 2017-09-30 0000914156 us-gaap:PatentsMember 2017-09-30 0000914156 2017-11-06

EX-101.SCH 6 ufpt-20170930.xsd XBRL SCHEMA FILE 000 - Document - Document And Entity Information link:calculationLink link:definitionLink link:presentationLink 001 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) link:calculationLink link:definitionLink link:presentationLink 002 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) link:calculationLink link:definitionLink link:presentationLink 003 - Statement - Condensed Consolidated Statements of Income (Unaudited) link:calculationLink link:definitionLink link:presentationLink 004 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:calculationLink link:definitionLink link:presentationLink 005 - Disclosure - Note 1 - Basis of Presentation link:calculationLink link:definitionLink link:presentationLink 006 - Disclosure - Note 2 - Supplemental Cash Flow Information link:calculationLink link:definitionLink link:presentationLink 007 - Disclosure - Note 3 - Fair Value of Financial Instruments link:calculationLink link:definitionLink link:presentationLink 008 - Disclosure - Note 4 - Share-based Compensation link:calculationLink link:definitionLink link:presentationLink 009 - Disclosure - Note 5 - Inventories link:calculationLink link:definitionLink link:presentationLink 010 - Disclosure - Note 6 - Preferred Stock link:calculationLink link:definitionLink link:presentationLink 012 - Document - Note 8 - Segment Reporting link:calculationLink link:definitionLink link:presentationLink 013 - Disclosure - Note 9 - Other Intangible Assets link:calculationLink link:definitionLink link:presentationLink 014 - Disclosure - Note 10 - Income Taxes link:calculationLink link:definitionLink link:presentationLink 015 - Disclosure - Note 11 - Plant Consolidations link:calculationLink link:definitionLink link:presentationLink 017 - Disclosure - Note 13 - Material Overcharge Settlement link:calculationLink link:definitionLink link:presentationLink 018 - Disclosure - Significant Accounting Policies (Policies) link:calculationLink link:definitionLink link:presentationLink 019 - Disclosure - Note 2 - Supplemental Cash Flow Information (Tables) link:calculationLink link:definitionLink link:presentationLink 020 - Disclosure - Note 4 - Share-based Compensation (Tables) link:calculationLink link:definitionLink link:presentationLink 021 - Disclosure - Note 5 - Inventories (Tables) link:calculationLink link:definitionLink link:presentationLink 023 - Disclosure - Note 8 - Segment Reporting (Tables) link:calculationLink link:definitionLink link:presentationLink 024 - Disclosure - Note 9 - Other Intangible Assets (Tables) link:calculationLink link:definitionLink link:presentationLink 025 - Disclosure - Note 11 - Plant Consolidations (Tables) link:calculationLink link:definitionLink link:presentationLink 026 - Disclosure - Note 1 - Basis of Presentation (Details Textual) link:calculationLink link:definitionLink link:presentationLink 027 - Disclosure - Note 2 - Supplemental Cash Flow Information - Schedule of Supplemental Cash Flow Information (Details) link:calculationLink link:definitionLink link:presentationLink 028 - Disclosure - Note 4 - Share-based Compensation (Details Textual) link:calculationLink link:definitionLink link:presentationLink 029 - Disclosure - Note 4 - Share-based Compensation - Allocation of Share-based Compensation (Details) link:calculationLink link:definitionLink link:presentationLink 030 - Disclosure - Note 4 - Share-based Compensation - Stock Option Activity (Details) link:calculationLink link:definitionLink link:presentationLink 031 - Disclosure - Note 4 - Share-based Compensation - Option Pricing Assumptions (Details) link:calculationLink link:definitionLink link:presentationLink 032 - Disclosure - Note 4 - Share-based Compensation - Restricted Stock Unit Activity (Details) link:calculationLink link:definitionLink link:presentationLink 033 - Disclosure - Note 5 - Inventories - Summary of Inventory (Details) link:calculationLink link:definitionLink link:presentationLink 034 - Disclosure - Note 6 - Preferred Stock (Details Textual) link:calculationLink link:definitionLink link:presentationLink 037 - Disclosure - Note 8 - Segment Reporting - Net Sales by Market (Details) link:calculationLink link:definitionLink link:presentationLink 038 - Disclosure - Note 9 - Other Intangible Assets (Details Textual) link:calculationLink link:definitionLink link:presentationLink 039 - Disclosure - Note 9 - Other Intangible Assets - Definite Lived Intangible Assets (Details) link:calculationLink link:definitionLink link:presentationLink 040 - Disclosure - Note 10 - Income Taxes (Details Textual) link:calculationLink link:definitionLink link:presentationLink 041 - Disclosure - Note 11 - Plant Consolidations (Details Textual) link:calculationLink link:definitionLink link:presentationLink 042 - Disclosure - Note 11 - Plant Consolidations - Restructuring Costs (Details) link:calculationLink link:definitionLink link:presentationLink 044 - Disclosure - Note 13 - Material Overcharge Settlement (Details Textual) link:calculationLink link:definitionLink link:presentationLink EX-101.CAL 7 ufpt-20170930_cal.xml XBRL CALCULATION FILE EX-101.DEF 8 ufpt-20170930_def.xml XBRL DEFINITION FILE EX-101.LAB 9 ufpt-20170930_lab.xml XBRL LABEL FILE Document And Entity Information Note To Financial Statement Details Textual statementsignificantaccountingpoliciespolicies statementnote2supplementalcashflowinformationtables statementnote4sharebasedcompensationtables Excess tax benefit on share-based compensation statementnote5inventoriestables Type of Adoption [Domain] statementnote7incomepersharetables Adjustments for New Accounting Pronouncements [Axis] statementnote8segmentreportingtables us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment of statutory withholdings for stock options exercised and restricted stock units vested statementnote9otherintangibleassetstables statementnote11plantconsolidationstables statementnote2supplementalcashflowinformationscheduleofsupplementalcashflowinformationdetails statementnote4sharebasedcompensationallocationofsharebasedcompensationdetails statementnote4sharebasedcompensationstockoptionactivitydetails statementnote4sharebasedcompensationoptionpricingassumptionsdetails statementnote4sharebasedcompensationrestrictedstockunitactivitydetails statementnote5inventoriessummaryofinventorydetails statementnote7incomepershareweightedaveragenumberofsharesusedtocomputenetepsdetails statementnote8segmentreportingnetsalesbymarketdetails statementnote9otherintangibleassetsdefinitelivedintangibleassetsdetails statementnote11plantconsolidationsrestructuringcostsdetails Notes To Financial Statements Notes To Financial Statements [Abstract] us-gaap_ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised Cash flows from investing activities: Equity Component [Domain] Common Stock [Member] Non-qualified deferred compensation plan and other liabilities Equity Components [Axis] Accrued expenses us-gaap_IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities Preferred stock, shares outstanding (in shares) Common stock, shares outstanding (in shares) New Accounting Pronouncements, Policy [Policy Text Block] Diluted (in shares) Weighted average common shares outstanding, diluted (in shares) us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Accounts payable us-gaap_IncreaseDecreaseInAccountsPayable Legal Matters and Contingencies [Text Block] Director [Member] Related Party [Axis] us-gaap_RevenueFromRelatedParties Revenue from Related Parties Diluted (in dollars per share) Related Party [Domain] Net sales Cash and cash equivalents Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period us-gaap_RepaymentsOfLongTermDebt Principal repayments of long-term debt Restatement Adjustment [Member] Weighted average common shares outstanding, basic (in shares) Basic (in shares) us-gaap_AreaOfRealEstateProperty Area of Real Estate Property Basic (in dollars per share) Scenario, Unspecified [Domain] us-gaap_RestructuringAndRelatedCostExpectedCost1 Restructuring and Related Cost, Expected Cost Selling, General and Administrative Expenses [Member] Scenario [Axis] Common Stock Issued Under the Equity Incentive Plan [Member] Stock that is subordinate to all other stock issued under the equity incentive plan. Percentage of concentration risk Restructuring Type [Axis] Income Statement Location [Domain] Income Statement Location [Axis] Type of Restructuring [Domain] Customer Concentration Risk [Member] Restructuring and Related Costs [Table Text Block] us-gaap_TreasuryStockValue Treasury stock at cost, 29,559 shares at September 30, 2017 and December 31, 2016 Customer [Axis] us-gaap_IncreaseDecreaseInOtherOperatingAssets Other assets Concentration Risk Type [Domain] Customer [Domain] Accounting Policies [Abstract] us-gaap_LitigationSettlementAmountAwardedFromOtherParty Litigation Settlement, Amount Awarded from Other Party Statement of Financial Position [Abstract] Relationship to Entity [Domain] Concentration Risk Type [Axis] Title of Individual [Axis] us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation Shares Paid for Tax Withholding for Share Based Compensation Stockholders' Equity Note Disclosure [Text Block] us-gaap_IncreaseDecreaseInPrepaidExpense Prepaid expenses Sales Revenue, Net [Member] Statement of Cash Flows [Abstract] Share-based compensation us-gaap_AllocatedShareBasedCompensationExpense Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Axis] Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] us-gaap_IncreaseDecreaseInReceivables Receivables, net us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised Exercised (in shares) us-gaap_IncreaseDecreaseInIncomeTaxesReceivable Increase (Decrease) in Income Taxes Receivable Refundable income taxes Schedule of Cash Flow, Supplemental Disclosures [Table Text Block] us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures Granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Geographical [Domain] Cash Flow, Supplemental Disclosures [Text Block] Geographical [Axis] Other liabilities Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block] Deferred income taxes us-gaap_LiabilitiesAndStockholdersEquity Total liabilities and stockholders' equity Income tax expense Income Tax Expense (Benefit) Retained earnings us-gaap_PolicyTextBlockAbstract Accounting Policies us-gaap_IncreaseDecreaseInInventories Inventories Proceeds from exercise of stock options, net of attestation The cash inflow associated with the amount received from holders exercising their stock options, net of attestation. The 2003 Incentive Plan [Member] Represents the reporting entity's "2003 Incentive Plan." Statement [Table] ufpt_SharesPaidForExercisePriceAndTaxWithholdingForShareBasedCompensation Shares Paid for Exercise Price and Tax Withholding for Share Based Compensation Represents the number of shares the employees use to repay the employer for the exercise price and income tax withholding obligations. ufpt_SharesPaidForTaxWithholdingForShareBasedCompensationMarketPrice Shares Paid for Tax Withholding for Share Based Compensation Market Price For net-share settlement of share-based awards when the employer settles employees' income tax withholding obligations, this element represents the market price per share of shares used by the employees to repay the employer. Noncompete Agreements [Member] Plant Consolidation Disclosure [Text Block] The entire disclosure for plant consolidation consisting of restructuring and consolidation of plant facilities of the entity. ufpt_PreferredStockDividendsNumberOfPreferredSharePurchaseRightsDistributedForEachShareOfCommonStockOutstanding Preferred Stock Dividends Number of Preferred Share Purchase Rights Distributed for each Share of Common Stock Outstanding Represents the number of preferred share purchase rights declared as dividend for each outstanding share of common stock on March, 2009. Income Statement [Abstract] Non-qualified deferred compensation plan Cash flows from financing activities: Medical [Member] Information pertaining to the Medical group of major customers. Series A Junior Participating Preferred Stock [Member] Represents the "Series A Junior Participating Preferred Stock," which is a classification of auction market preferred securities. Consumer [Member] Information pertaining to the Consumer group of major customers. Automotive [Member] Information pertaining to the Automotive group of major customers. Industrial [Member] Information pertaining to the Industrial group of major customers. Electronics [Member] Information pertaining to the Electronics group of major customers. Class of Stock [Domain] Patents [Member] Class of Stock [Axis] Aerospace & Defense [Member] Information pertaining to the Aerospace & Defense group of major customers. Award Type [Axis] Schedule of Weighted Average Number of Shares [Table Text Block] Equity Award [Domain] Employee Severance Payments and Relocation Costs [Member] Represents restructuring costs related to employee severance payments and relocation costs. Newburyport, Massachusetts Facility [Member] Represents the facility located in Newburyport, Massachusetts. Lease Termination [Member] Represents restructuring costs related to the lease termination. Moving and Vacating Expense [Member] Represents the restructuring costs related to moving and vacating expenses. Customer Lists [Member] Finite-Lived Intangible Assets, Major Class Name [Domain] Segment Reporting Disclosure [Text Block] Vention Medical, Inc. [Member] Represents the information pertaining to the transaction with Vention Medical Inc. Non-employee Members of Board of Directors [Member] Person serving on the board of directors (who collectively have responsibility for governing the entity). Polyurethane Foam Antitrust Lawsuit [Member] Represents the defendant in a class action lawsuit against a number of polyurethane foam suppliers. Finite-Lived Intangible Assets by Major Class [Axis] us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent us-gaap_DisclosureTextBlockAbstract Notes to Financial Statements us-gaap_LiabilitiesCurrent Total current liabilities Raw materials Chairman Chief Executive Officer and President [Member] Represents the entity's Chairman, the highest ranking executive officer, who has an ultimate managerial responsibility for the entity and who reports to the board of directors and the first or second ranking officer who may be appointed by the board of directors. Finished goods ufpt_SharesPaidForExercisePriceAndTaxWithholdingForShareBasedCompensationAverageMarketPrice Shares Paid for Exercise Price and Tax Withholding for Share-based Compensation, Average Market Price Represents the average price per share used by the employees to repay the employer for the exercise price and income tax withholding obligations. Work in process Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Changes in operating assets and liabilities: Share-based Compensation, Stock Options, Activity [Table Text Block] Exercise price (in dollars per share) Schedule of Share-based Compensation, Restricted Stock Units Award Activity [Table Text Block] Interest income Expected dividends Risk-free interest rate Expected volatility us-gaap_OperatingIncomeLoss Operating income Preferred Share Purchase Right [Member] Represents the preferred share purchase right (the "Right"). Each Right entitles the registered holders to purchase from the Company one one-thousandth of a share of Series A Junior Participating Preferred Stock of the Company. Schedule of Inventory, Current [Table Text Block] Inventory Disclosure [Text Block] Deferred income taxes us-gaap_DeferredIncomeTaxExpenseBenefit Expected term (Year) us-gaap_GrossProfit Gross profit Litigation Case [Domain] Treasury stock, shares (in shares) Amendment Flag Litigation Case [Axis] Short-term debt Common stock, $.01 par value, 20,000,000 shares authorized; 7,299,721 and 7,270,162 shares issued and outstanding, respectively at September 30, 2017; and 7,242,023 and 7,212,464 shares issued and outstanding, respectively at December 31, 2016 us-gaap_PaymentsForRestructuring Payments for Restructuring us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear Finite-Lived Intangible Assets, Amortization Expense, Remainder of Fiscal Year us-gaap_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities Excess tax benefit on share-based compensation Common stock, shares authorized (in shares) Shares vested (in dollars per share) Common stock, shares issued (in shares) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Unvested, weighted average award date fair value (in dollars per share) Unvested, weighted average award date fair value (in dollars per share) Other assets us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Unvested (in shares) Unvested (in shares) Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Income Tax Disclosure [Text Block] Awarded, weighted average award date fair value (in dollars per share) us-gaap_GainLossOnSaleOfPropertyPlantEquipment Loss (Gain) on sale of fixed assets Share-based compensation Awarded (in shares) Current Fiscal Year End Date us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Shares vested (in shares) Vested and expected to vest, weighted average exercise price (in dollars per share) Vested and expected to vest (in shares) us-gaap_GainLossRelatedToLitigationSettlement Material overcharge settlement Document Fiscal Period Focus Vested and expected to vest, weighted average remaining contractual life (Year) Document Fiscal Year Focus Vested and expected to vest, aggregate intrinsic value Exercisable, aggregate intrinsic value EX-101.PRE 10 ufpt-20170930_pre.xml XBRL PRESENTATION FILE XML 11 R1.htm IDEA: XBRL DOCUMENT

Document And Entity Information - shares	9 Months Ended
Document And Entity Information - shares	Sep. 30, 2017	Nov. 06, 2017
Document Information [Line Items]
Entity Registrant Name	UFP TECHNOLOGIES INC
Entity Central Index Key	0000914156
Trading Symbol	ufpt
Current Fiscal Year End Date	--12-31
Entity Filer Category	Accelerated Filer
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Entity Common Stock, Shares Outstanding (in shares)		7,267,662
Document Type	10-Q
Document Period End Date	Sep. 30, 2017
Document Fiscal Year Focus	2017
Document Fiscal Period Focus	Q3
Amendment Flag	false

XML 12 R2.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016
Cash and cash equivalents	$ 37,246	$ 31,359
Receivables, less allowance for doubtful accounts of $602 at September 30, 2017 and $567 at December 31, 2016	22,044	21,249
Inventories	13,136	14,151
Prepaid expenses	2,234	2,281
Refundable income taxes	979	807
Total current assets	75,639	69,847
Property, plant and equipment	103,797	96,806
Less accumulated depreciation and amortization	(51,815)	(48,290)
Net property, plant and equipment	51,982	48,516
Goodwill	7,322	7,322
Intangible assets, net	79	318
Other assets	2,069	1,931
Total assets	137,091	127,934
Current liabilities:
Accounts payable	4,958	4,002
Accrued expenses	5,356	4,698
Short-term debt	84	856
Total current liabilities	10,398	9,556
Deferred income taxes	3,713	3,459
Non-qualified deferred compensation plan	1,949	1,682
Other liabilities	118	184
Total liabilities	16,178	14,881
Commitments and contingencies
Stockholders’ equity:
Preferred stock, $.01 par value, 1,000,000 shares authorized; zero shares issued or outstanding	0	0
Common stock, $.01 par value, 20,000,000 shares authorized; 7,299,721 and 7,270,162 shares issued and outstanding, respectively at September 30, 2017; and 7,242,023 and 7,212,464 shares issued and outstanding, respectively at December 31, 2016	73	72
Additional paid-in capital	26,580	25,216
Retained earnings	94,847	88,352
Treasury stock at cost, 29,559 shares at September 30, 2017 and December 31, 2016	(587)	(587)
Total stockholders’ equity	120,913	113,053
Total liabilities and stockholders' equity	$ 137,091	$ 127,934

XML 13 R3.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016
Receivables, allowance for doubtful accounts	$ 602	$ 567
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized (in shares)	1,000,000	1,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	20,000,000	20,000,000
Common stock, shares issued (in shares)	7,299,721	7,242,023
Common stock, shares outstanding (in shares)	7,270,162	7,212,464
Treasury stock, shares (in shares)	29,559	29,559

XML 14 R4.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Income (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Net sales	$ 35,684	$ 37,220	$ 110,623	$ 109,626
Cost of sales	27,491	28,768	82,973	83,161
Gross profit	8,193	8,452	27,650	26,465
Selling, general & administrative expenses	5,693	6,027	18,070	18,402
Restructuring costs		25	63	203
Material overcharge settlement		(1,681)	(121)	(2,114)
Loss (Gain) on sale of fixed assets			3	(4)
Operating income	2,500	4,081	9,635	9,978
Interest income	63	42	147	104
Interest expense	(12)	(17)	(39)	(53)
Income before income tax expense	2,551	4,106	9,743	10,029
Income tax expense	856	1,437	3,248	3,550
Net income	$ 1,695	$ 2,669	$ 6,495	$ 6,479
Net income per share:
Basic (in dollars per share)	$ 0.23	$ 0.37	$ 0.90	$ 0.90
Diluted (in dollars per share)	$ 0.23	$ 0.37	$ 0.89	$ 0.89
Weighted average common shares outstanding:
Basic (in shares)	7,264	7,195	7,240	7,183
Diluted (in shares)	7,353	7,282	7,326	7,265

XML 15 R5.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Net income	$ 6,495	$ 6,479
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	4,171	4,109
Loss (Gain) on sale of fixed assets	3	(4)
Share-based compensation	842	871
Excess tax benefit on share-based compensation		(126)
Deferred income taxes	254	224
Changes in operating assets and liabilities:
Receivables, net	(795)	(4,826)
Inventories	1,015	(366)
Prepaid expenses	47	(1,231)
Refundable income taxes	(172)	1,146
Other assets	(138)	(93)
Accounts payable	429	197
Accrued expenses	658	(317)
Non-qualified deferred compensation plan and other liabilities	201	205
Net cash provided by operating activities	13,010	6,268
Cash flows from investing activities:
Additions to property, plant and equipment	(6,880)	(5,766)
Proceeds from sale of fixed assets	6	4
Net cash used in investing activities	(6,874)	(5,762)
Cash flows from financing activities:
Principal repayments of long-term debt	(772)	(758)
Proceeds from exercise of stock options, net of attestation	630	529
Excess tax benefit on share-based compensation		126
Payment of statutory withholdings for stock options exercised and restricted stock units vested	(107)	(89)
Net cash used in financing activities	(249)	(192)
Net increase in cash and cash equivalents	5,887	314
Cash and cash equivalents at beginning of period	31,359	29,804
Cash and cash equivalents at end of period	$ 37,246	$ 30,118

XML 16 R6.htm IDEA: XBRL DOCUMENT

Note 1 - Basis of Presentation

9 Months Ended

Sep. 30, 2017

Notes to Financial Statements

Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]

(

)

Basis of Presentation

-Q and do

not

include all the information and note disclosures required by accounting principles generally accepted in the United States of America. These statements should be read in conjunction with the consolidated financial statements and notes thereto for the year ended

December 31, 2016,

included in the Company's

2016

Annual Report on Form

-K, as filed with the Securities and Exchange Commission.

The condensed consolidated balance sheet as of

September 30, 2017,

the condensed consolidated statements of income for the

three

- and

nine

-month periods ended

September 30, 2017

and

2016,

and the condensed consolidated statements of cash flows for the

nine

-month periods ended

September 30, 2017

and

2016

are unaudited but, in the opinion of management, include all adjustments (consisting of normal, recurring adjustments) necessary for a fair presentation of results for these interim periods. The condensed consolidated balance sheet as of

December 31, 2016

has been derived from the Company’s annual financial statements that were audited by an independent registered public accounting firm, but does

not

include all of the information and footnotes required for complete annual financial statements.

The results of operations for the

three

- and

nine

-months periods ended

September 30, 2017,

are

not

necessarily indicative of the results to be expected for the entire fiscal year ending

December 31, 2017.

Recent Accounting Pronouncements

May 2014,

the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU)

No.

2014

09,

Revenue from Contracts with Customers

, which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. This standard will replace most existing revenue recognition guidance when it becomes effective. The standard permits the use of either the full retrospective or modified retrospective transition methods. The Company expects to adopt the standard in the

first

quarter of

2018

using the modified retrospective transition method. The Company has identified its primary revenue streams, completed a preliminary review of a representative sample of contracts with its customers and is in the process of evaluating the impact of this ASU on its revenue streams and accounting policies. Based on the procedures completed to date, the Company expects that for a significant portion of its business, the recognition of revenue under the updated standard will occur at a point in time, which is consistent with current practice. The Company has identified certain revenue streams for which the recognition of revenue

may

occur over time, which is a change from current practice. These revenue streams include certain customer stocking commitments. Additionally, the Company has identified certain revenue streams for which the recognition of revenue

may

be deferred, which is also a change from current practice. These revenue streams include certain tooling sales. The Company does

not

expect that the impact of these changes in the timing of revenue recognition for these items to be significant to the financial statements. The Company is also in the process of updating its internal controls and drafting the expanded disclosures as required by this ASU.

The Company does

not

expect significant changes to its systems or internal controls. As the Company continues thr

ough the adoption process, it is possible that these preliminary conclusions

may

change.

February 2016,

the FASB issued ASU

No.

2016

02,

Leases.

The guidance in this ASU supersedes the leasing guidance in Topic

840,

Leases

. Under the new guidance, lessees are required to recognize lease assets and lease liabilities on the balance sheet for those leases previously classified as operating leases. The amendments in ASU

No.

2016

are effective for annual reporting periods beginning after

December

15,

2018,

including interim periods within that reporting period with early adoption permitted. The Company is evaluating the impact of adopting this ASU on its consolidated financial position and results of operations.

March 2016,

the FASB issued ASU

No.

2016

09,

Improvements to Employee Share Based Payment Accounting

. This ASU simplifies several aspects of the accounting for share-based payment transactions, including income tax consequences, classification of awards, forfeitures and classification on the statement of cash flows. The Company adopted this ASU on

January 1, 2017.

As the Company has

not

had a significant amount of forfeitures historically, under the provisions of this ASU the Company has elected to account for forfeitures as they occur, rather than estimate expected forfeitures. The impact of adopting this update to the Company’s Consolidated Financial Statements will depend on market factors and the timing and intrinsic value of future share-based compensation award vests and exercises. Subsequent to adoption, the Company notes the potential for volatility in its effective tax rate as any windfall or shortfall tax benefits related to its share-based compensation plans will be recorded directly to income tax expense in the Condensed Consolidated Statement of Income.

Revisions

Certain revisions have been made to the

2016

Condensed Consolidated Statement of Cash Flows to conform to the current year presentation relating to a reserve for uncertain tax positions and to cash paid for capital expenditures. The reclassification of a reserve for uncertain tax positions resulted in an increase to the change in refundable income taxes of

$315,000

and a decrease to the change in accrued expenses of

$315,000.

A change in presentation of cash paid for capital expenditures resulted in a decrease of

$311,000

in both the change in accounts payable and in additions to property, plant and equipment, net. These revisions had

impact on previously reported net income and are deemed immaterial to the previously issued financial statements.

XML 17 R7.htm IDEA: XBRL DOCUMENT

Note 2 - Supplemental Cash Flow Information

9 Months Ended

Sep. 30, 2017

Notes to Financial Statements

Cash Flow, Supplemental Disclosures [Text Block]

(

)

Supplemental Cash Flow Information

	Nine Months Ended September 30
	2017		2016
	(in thousands)
Cash paid for:
Interest	$	37	$	51
Income taxes, net of refunds		3,167		2,178

Non-cash investing and financing activities:
Capital additions accrued but not yet paid	$	527	$	311

XML 18 R8.htm IDEA: XBRL DOCUMENT

Note 3 - Fair Value of Financial Instruments

9 Months Ended

Sep. 30, 2017

Notes to Financial Statements

Fair Value Disclosures [Text Block]

(

)

Fair Value of Financial Instruments

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

XML 19 R9.htm IDEA: XBRL DOCUMENT

Note 4 - Share-based Compensation

9 Months Ended

Sep. 30, 2017

Notes to Financial Statements

Disclosure of Compensation Related Costs, Share-based Payments [Text Block]

(

)

Share-Based Compensation

The Company issues share-based awards through several plans that are described in detail in the notes to the consolidated financial statements for the year ended

December 31, 2016.

The compensation cost charged against income for those plans is included in selling, general & administrative expenses as follows (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
Share-based compensation related to:	2017		2016		2017		2016
Common stock granted to the Board of Directors	$	-	$	-	$	105	$	105
Common stock granted to the Chief Executive Officer		100		100		300		300
Stock options granted to directors		-		-		105		105
Stock options granted to employees		4		34		25		107
Restricted Stock Unit awards to employees		102		95		307		254
Total share-based compensation	$	206	$	229	$	842	$	871

The total income tax benefit recognized in the condensed consolidated statements of income for share-based compensation arrangements was approximately

$106,000

and

$67,000,

respectively, for the

three

-month periods ended

September 30, 2017

and

2016,

and approximately

$441,000

and

$264,000,

respectively, for the

nine

-month periods ended

September 30, 2017

and

2016

The following is a summary of stock option activity under all plans for the

three

-month period ended

September 30, 2017

	Shares Under Options			Weighted Average Exercise Price (per share)		Weighted Average Remaining Contractual Life (in years)		Aggregate Intrinsic Value (in thousands)
Outstanding at December 31, 2016		232,578		$	16.53
Granted		12,336			27.05
Exercised		(51,285	)		26.88
Expired		(3,750	)		18.85
Outstanding at September 30, 2017		189,879		$	17.41		3.55	$	2,029
Exercisable at September 30, 2017		184,879		$	17.23		3.60	$	2,011
Vested and expected to vest at September 30, 2017		189,879		$	17.41		3.55	$	2,029

June 6, 2017,

the Company granted options to its directors for the purchase of

12,336

shares of common stock at that day’s closing price of

$27.05.

The compensation expense related to these grants was determined as the fair value of the options using the Black Scholes option pricing model based on the following assumptions:

Expected volatility			29.1%
Expected dividends			None
Risk-free interest rate			1.84%
Exercise price			$27.05
Expected term (in years)			5.8
Weighted-average grant date fair value			$8.51

During the

nine

-month periods ended

September 30, 2017

and

2016

, the total intrinsic value of all options exercised (i.e., the difference between the market price on the exercise date and the price paid by the employees to exercise the options) was approximately

$577,000

and

$564,000,

respectively, and the total amount of consideration received by the Company from the exercised options was approximately

$802,000

and

$529,000,

respectively. At its discretion, the Company allows option holders to surrender previously owned common stock in lieu of paying the exercise price and withholding taxes. During the

nine

-month period ended

September 30, 2017

there were

6,511

surrendered at an average market price of

$26.45.

During the

nine

-month period ended

September 30, 2016

there were

shares surrendered for this purpose.

February 2

2017,

the Company’s Compensation Committee approved the award of

$400,000,

payable in shares of common stock to the Company’s Chairman, Chief Executive Officer, and President under the

2003

Incentive Plan. The shares will be issued in

December, 2017.

The following table summarizes information about Restricted Stock Units (“RSUs”) activity during the

nine

-month period ended

September 30, 2017:

	Restricted Stock Units			Weighted Average Award Date Fair Value
Unvested at December 31, 2016		46,558		$	20.05
Awarded		22,770			24.70
Shares vested		(13,419	)		23.54
Unvested at September 30, 2017		55,909		$	20.96

nine

-month periods ended

September 30, 2017

and

2016,

4,377

and

3,889

shares were surrendered at an average market price of

$24.50

and

$22.82,

respectively.

As of

September 30, 2017,

the Company had approximately

$754,000

of unrecognized compensation expense, which is expected to be recognized over a period of

3.5

years

XML 20 R10.htm IDEA: XBRL DOCUMENT

Note 5 - Inventories

9 Months Ended

Sep. 30, 2017

Notes to Financial Statements

Inventory Disclosure [Text Block]

(

)

Inventories

Inventories are stated at the lower of cost (

first

-in,

first

-out) or net realizable value, and consist of the following at the stated dates (in thousands):

	September 30, 2017		December 31, 2016
Raw materials	$	6,660	$	7,111
Work in process		1,161		1,354
Finished goods		5,315		5,686
Total inventory	$	13,136	$	14,151

XML 21 R11.htm IDEA: XBRL DOCUMENT

Note 6 - Preferred Stock

9 Months Ended

Sep. 30, 2017

Notes to Financial Statements

Stockholders' Equity Note Disclosure [Text Block]

(

)

Preferred Stock

March 18, 2009,

the Company declared a dividend of

one

preferred share purchase right (a “Right”) for each outstanding share of common stock, par value

$0.01

per share, to the stockholders of record on

March

20,

2009.

Each Right entitles the registered holder to purchase from the Company

one one

-thousandth of a share of Series A Junior Participating Preferred Stock, par value

$0.01

per share (the “Preferred Share”) of the Company, at a price of

$25

per

one one

-thousandth of a Preferred Share subject to adjustment and the terms of the Rights Agreement. The Rights expire on

March 19, 2019.

XML 22 R12.htm IDEA: XBRL DOCUMENT

Note 7 - Income Per Share

9 Months Ended

Sep. 30, 2017

Notes to Financial Statements

Earnings Per Share [Text Block]

(

)

Income Per Share

The weighted average number of shares used to compute basic and diluted net income per share consisted of the following (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2017		2016		2017		2016
Weighted average common shares outstanding, basic		7,264		7,195		7,240		7,183
Weighted average common equivalent shares due to stock options and RSUs		89		87		86		82
Weighted average common shares outstanding, diluted		7,353		7,282		7,326		7,265

not

included in the computation of diluted income per share because the effect would be antidilutive. For the

three

- and

nine

-month periods ended

September 30, 2017

, the number of stock awards excluded from the computation of diluted earnings per share for this reason was

zero

and

27,336,

respectively. For the

three

- and

nine

-month periods ended

September 30, 2016

, the number of stock awards excluded from the computation of diluted earnings per share for this reason was

35,193

and

52,377,

respectively.

XML 23 R13.htm IDEA: XBRL DOCUMENT

Note 8 - Segment Reporting

9 Months Ended

Sep. 30, 2017

Notes to Financial Statements

Segment Reporting Disclosure [Text Block]

(

)

Segment Reporting

The Company consists of a single operating and reportable segment.

Revenues from customers outside of the United States are

not

material.

customer comprised more than

10%

of the Company’s consolidated revenues for the

three

- and

nine

-month periods ended

September 30, 2017.

All of the Company’s assets are located in the United States.

The Company’s products are primarily sold to customers within the Medical, Consumer, Automotive, Aerospace and Defense, Industrial and Electronics markets. Net sales by market for the

three

- and

nine

-month periods ended

September 30, 2017

and

2016,

respectively, are as follows (in thousands)

	Three Months Ended September 30,										Nine Months Ended September 30,
	2017					2016					2017					2016
Market	Net Sales		%			Net Sales		%			Net Sales		%			Net Sales		%

Medical	$	16,712		46.8	%	$	16,548		44.5	%	$	52,822		47.7	%	$	48,953		44.7	%
Consumer		6,006		16.8	%		5,648		15.2	%		15,713		14.2	%		15,303		14.0	%
Automotive		5,174		14.5	%		6,942		18.7	%		18,018		16.3	%		20,485		18.7	%
Aerospace & Defense		2,682		7.5	%		2,516		6.8	%		8,290		7.5	%		7,929		7.2	%
Industrial		2,591		7.3	%		2,792		7.5	%		7,629		6.9	%		8,441		7.7	%
Electronics		2,519		7.1	%		2,774		7.5	%		8,151		7.4	%		8,515		7.8	%
Net Sales	$	35,684		100.0	%	$	37,220		100.0	%	$	110,623		100.0	%	$	109,626		100.0	%

Certain amounts for the

three

- and

nine

-month periods ended

September 30, 2016

were reclassified between markets to conform to the current period presentation.

XML 24 R14.htm IDEA: XBRL DOCUMENT

Note 9 - Other Intangible Assets

9 Months Ended

Sep. 30, 2017

Notes to Financial Statements

Intangible Assets Disclosure [Text Block]

(

)

Other Intangible Assets

The carrying values of the Company’s definite lived intangible assets as of

September 30, 2017

and

December

31,

2016,

are as follows (in thousands):

	Patents			Non- Compete			Customer List			Total
Estimated useful life (in years)		14			5			5
Gross amount at September 30, 2017	$	429		$	512		$	2,046		$	2,987
Accumulated amortization at September 30, 2017		(429	)		(496	)		(1,983	)	$	(2,908	)
Net balance at September 30, 2017	$	-		$	16		$	63		$	79

Estimated useful life (in years)		14			5			5
Gross amount at December 31, 2016	$	429		$	512		$	2,046		$	2,987
Accumulated amortization at December 31, 2016		(429	)		(449	)		(1,791	)	$	(2,669	)
Net balance at December 31, 2016	$	-		$	63		$	255		$	318

Amortization expense related to intangible assets was approximately

$79,000

for each of the

three

-month periods ended

September 30, 2017

and

2016,

and was approximately

$239,000

for each of the

nine

-month periods ended

September 30, 2017

and

2016.

As of

September 30, 2017,

the estimated remaining amortization expense for

2017

$79,000.

XML 25 R15.htm IDEA: XBRL DOCUMENT

Note 10 - Income Taxes

9 Months Ended

Sep. 30, 2017

Notes to Financial Statements

Income Tax Disclosure [Text Block]

(

)

Income Taxes

The Company recorded tax expense of approximately

33.6%

and

35.0%

of income before income tax expense, respectively, for each of the

three

-month periods ended

September 30, 2017

and

2016.

The decrease in the effective tax rate for the current period is due to a tax benefit of approximately

$37,000

recorded in the

three

-month period ended

September 30, 2017

as a result of the adoption of ASU

No.

2016

January 1, 2017 (

See Note

). The Company recorded a tax expense of approximately

33.3%

and

35.4%

of income before income tax expense for each of the

nine

-month periods ended

September 30, 2017

and

2016.

The decrease in the effective tax rate for the current period is due to a tax benefit of approximately

$162,000

recorded in the

nine

-month period ended

September 30, 2017

as a result of the adoption of ASU

No.

2016

January 1, 2017 (

See Note

); and a tax assessment of approximately

$40,000

from

one

jurisdiction recorded in the

first

quarter of

2016.

The Company notes the potential for volatility in its effective tax rate, as any windfall or shortfall tax benefits related to its share-based compensation plans will be recorded directly into income tax expense.

XML 26 R16.htm IDEA: XBRL DOCUMENT

Note 11 - Plant Consolidations

9 Months Ended

Sep. 30, 2017

Notes to Financial Statements

Plant Consolidation Disclosure [Text Block]

(

)

Plant Consolidations

Restructuring Costs

March 18, 2015,

the Company committed to move forward with a plan to cease operations at its Raritan, New Jersey, plant and consolidate operations into its Newburyport, Massachusetts, facility and other UFP facilities. The Company’s decision was in response to a continued decline in business at the Raritan facility and the Company’s purchase of the

137,000

-square-foot facility in Newburyport. The activities related to this consolidation are complete.

December 31, 2015,

and the partial Georgetown relocation was complete at

June 30, 2017.

The Company incurred approximately

$2.1

million in

one

-time expenses in connection with the Massachusetts consolidations. Included in this amount are approximately

$180,000

relating to employee severance payments and relocation costs, approximately

$1.6

million in moving expenses and expenses associated with vacating the Raritan, Haverhill, and Byfield properties, and approximately

$360,000

in lease termination costs. Total cash charges were approximately

$2.0

million.

The Company recorded the following restructuring costs associated with the Massachusetts consolidations for the

three

- and

nine

-month periods ended

September 30, 2017

and

2016

(in thousands):

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
Restructuring Costs	2017		2016		2017		2016
Relocation	$	-	$	25	$	63	$	203
Total	$	-	$	25	$	63	$	203

Costs for the

three

- and

nine

- month periods ended

September 30, 2017

and

2016

were reclassified in the Condensed Consolidated Statement of Income as “Restructuring Costs” from Cost of Sales.

XML 27 R17.htm IDEA: XBRL DOCUMENT

Note 12 - Related Party Transactions

9 Months Ended

Sep. 30, 2017

Notes to Financial Statements

(

)

Related Party Transactions

Daniel Croteau, who has been a member of the Company’s board of directors since

December 16, 2015,

was the Chief Executive Officer (through

March 2017)

of Vention Medical, Inc. (“Vention”), a customer of the Company. Sales to Vention for the

three

-months ended

March 31, 2017

were approximately

$148,000.

As a result of the sale of Vention, Mr. Croteau’s employment ended in

March 2017

and sales to Vention are

longer considered related party transactions.

XML 28 R18.htm IDEA: XBRL DOCUMENT

Note 13 - Material Overcharge Settlement

9 Months Ended

Sep. 30, 2017

Notes to Financial Statements

Legal Matters and Contingencies [Text Block]

(

)

Material Overcharge Settlement

The Company was a participant in a class action lawsuit against a number of polyurethane foam suppliers (“Defendants”) that was settled during the

second

quarter of

2016.

The suit was filed to recover damages and obtain injunctive relief for Defendants’ alleged violations of the federal antitrust laws with respect to the fixing of prices of polyurethane foam sold from

January 1, 1999

through

August 2010.

During the

three

- and

nine

-month periods ended

September 30, 2017,

the Company received settlement amounts of

and approximately

$121,000,

respectively. During the

three

- and

nine

-month periods ended

September 30, 2016,

the Company received settlement amounts of approximately

$1.7

million and

$2.1

million, respectively. The settlement amounts for the

three

- and

nine

-month periods ended

September 30, 2017

and

2016

are recorded as “Material overcharge settlement” in the operating income section of the Condensed Consolidated Statements of Income.

XML 29 R19.htm IDEA: XBRL DOCUMENT

Significant Accounting Policies (Policies)	9 Months Ended
Significant Accounting Policies (Policies)	Sep. 30, 2017
Accounting Policies [Abstract]
New Accounting Pronouncements, Policy [Policy Text Block]	Recent Accounting Pronouncements In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2014 - 09, Revenue from Contracts with Customers , which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. This standard will replace most existing revenue recognition guidance when it becomes effective. The standard permits the use of either the full retrospective or modified retrospective transition methods. The Company expects to adopt the standard in the first quarter of 2018 using the modified retrospective transition method. The Company has identified its primary revenue streams, completed a preliminary review of a representative sample of contracts with its customers and is in the process of evaluating the impact of this ASU on its revenue streams and accounting policies. Based on the procedures completed to date, the Company expects that for a significant portion of its business, the recognition of revenue under the updated standard will occur at a point in time, which is consistent with current practice. The Company has identified certain revenue streams for which the recognition of revenue may occur over time, which is a change from current practice. These revenue streams include certain customer stocking commitments. Additionally, the Company has identified certain revenue streams for which the recognition of revenue may be deferred, which is also a change from current practice. These revenue streams include certain tooling sales. The Company does not expect that the impact of these changes in the timing of revenue recognition for these items to be significant to the financial statements. The Company is also in the process of updating its internal controls and drafting the expanded disclosures as required by this ASU. The Company does not expect significant changes to its systems or internal controls. As the Company continues thr ough the adoption process, it is possible that these preliminary conclusions may change. In February 2016, the FASB issued ASU No. 2016 - 02, Leases. The guidance in this ASU supersedes the leasing guidance in Topic 840, Leases . Under the new guidance, lessees are required to recognize lease assets and lease liabilities on the balance sheet for those leases previously classified as operating leases. The amendments in ASU No. 2016 - 02 are effective for annual reporting periods beginning after December 15, 2018, including interim periods within that reporting period with early adoption permitted. The Company is evaluating the impact of adopting this ASU on its consolidated financial position and results of operations. In March 2016, the FASB issued ASU No. 2016 - 09, Improvements to Employee Share Based Payment Accounting . This ASU simplifies several aspects of the accounting for share-based payment transactions, including income tax consequences, classification of awards, forfeitures and classification on the statement of cash flows. The Company adopted this ASU on January 1, 2017. As the Company has not had a significant amount of forfeitures historically, under the provisions of this ASU the Company has elected to account for forfeitures as they occur, rather than estimate expected forfeitures. The impact of adopting this update to the Company’s Consolidated Financial Statements will depend on market factors and the timing and intrinsic value of future share-based compensation award vests and exercises. Subsequent to adoption, the Company notes the potential for volatility in its effective tax rate as any windfall or shortfall tax benefits related to its share-based compensation plans will be recorded directly to income tax expense in the Condensed Consolidated Statement of Income.
Revisions Policy [Policy Text Block]	Revisions Certain revisions have been made to the 2016 Condensed Consolidated Statement of Cash Flows to conform to the current year presentation relating to a reserve for uncertain tax positions and to cash paid for capital expenditures. The reclassification of a reserve for uncertain tax positions resulted in an increase to the change in refundable income taxes of $315,000 and a decrease to the change in accrued expenses of $315,000. A change in presentation of cash paid for capital expenditures resulted in a decrease of $311,000 in both the change in accounts payable and in additions to property, plant and equipment, net. These revisions had no impact on previously reported net income and are deemed immaterial to the previously issued financial statements.

XML 30 R20.htm IDEA: XBRL DOCUMENT

Note 2 - Supplemental Cash Flow Information (Tables)

9 Months Ended

Sep. 30, 2017

Notes Tables

Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]

	Nine Months Ended September 30
	2017		2016
	(in thousands)
Cash paid for:
Interest	$	37	$	51
Income taxes, net of refunds		3,167		2,178

Non-cash investing and financing activities:
Capital additions accrued but not yet paid	$	527	$	311

XML 31 R21.htm IDEA: XBRL DOCUMENT

Note 4 - Share-based Compensation (Tables)

9 Months Ended

Sep. 30, 2017

Notes Tables

Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]

	Three Months Ended September 30,				Nine Months Ended September 30,
Share-based compensation related to:	2017		2016		2017		2016
Common stock granted to the Board of Directors	$	-	$	-	$	105	$	105
Common stock granted to the Chief Executive Officer		100		100		300		300
Stock options granted to directors		-		-		105		105
Stock options granted to employees		4		34		25		107
Restricted Stock Unit awards to employees		102		95		307		254
Total share-based compensation	$	206	$	229	$	842	$	871

Share-based Compensation, Stock Options, Activity [Table Text Block]

	Shares Under Options			Weighted Average Exercise Price (per share)		Weighted Average Remaining Contractual Life (in years)		Aggregate Intrinsic Value (in thousands)
Outstanding at December 31, 2016		232,578		$	16.53
Granted		12,336			27.05
Exercised		(51,285	)		26.88
Expired		(3,750	)		18.85
Outstanding at September 30, 2017		189,879		$	17.41		3.55	$	2,029
Exercisable at September 30, 2017		184,879		$	17.23		3.60	$	2,011
Vested and expected to vest at September 30, 2017		189,879		$	17.41		3.55	$	2,029

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

Expected volatility			29.1%
Expected dividends			None
Risk-free interest rate			1.84%
Exercise price			$27.05
Expected term (in years)			5.8
Weighted-average grant date fair value			$8.51

Schedule of Share-based Compensation, Restricted Stock Units Award Activity [Table Text Block]

	Restricted Stock Units			Weighted Average Award Date Fair Value
Unvested at December 31, 2016		46,558		$	20.05
Awarded		22,770			24.70
Shares vested		(13,419	)		23.54
Unvested at September 30, 2017		55,909		$	20.96

XML 32 R22.htm IDEA: XBRL DOCUMENT

Note 5 - Inventories (Tables)

9 Months Ended

Sep. 30, 2017

Notes Tables

Schedule of Inventory, Current [Table Text Block]

	September 30, 2017		December 31, 2016
Raw materials	$	6,660	$	7,111
Work in process		1,161		1,354
Finished goods		5,315		5,686
Total inventory	$	13,136	$	14,151

XML 33 R23.htm IDEA: XBRL DOCUMENT

Note 7 - Income Per Share (Tables)

9 Months Ended

Sep. 30, 2017

Notes Tables

Schedule of Weighted Average Number of Shares [Table Text Block]

	Three Months Ended September 30,				Nine Months Ended September 30,
	2017		2016		2017		2016
Weighted average common shares outstanding, basic		7,264		7,195		7,240		7,183
Weighted average common equivalent shares due to stock options and RSUs		89		87		86		82
Weighted average common shares outstanding, diluted		7,353		7,282		7,326		7,265

XML 34 R24.htm IDEA: XBRL DOCUMENT

Note 8 - Segment Reporting (Tables)

9 Months Ended

Sep. 30, 2017

Notes Tables

Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block]

	Three Months Ended September 30,										Nine Months Ended September 30,
	2017					2016					2017					2016
Market	Net Sales		%			Net Sales		%			Net Sales		%			Net Sales		%

Medical	$	16,712		46.8	%	$	16,548		44.5	%	$	52,822		47.7	%	$	48,953		44.7	%
Consumer		6,006		16.8	%		5,648		15.2	%		15,713		14.2	%		15,303		14.0	%
Automotive		5,174		14.5	%		6,942		18.7	%		18,018		16.3	%		20,485		18.7	%
Aerospace & Defense		2,682		7.5	%		2,516		6.8	%		8,290		7.5	%		7,929		7.2	%
Industrial		2,591		7.3	%		2,792		7.5	%		7,629		6.9	%		8,441		7.7	%
Electronics		2,519		7.1	%		2,774		7.5	%		8,151		7.4	%		8,515		7.8	%
Net Sales	$	35,684		100.0	%	$	37,220		100.0	%	$	110,623		100.0	%	$	109,626		100.0	%

XML 35 R25.htm IDEA: XBRL DOCUMENT

Note 9 - Other Intangible Assets (Tables)

9 Months Ended

Sep. 30, 2017

Notes Tables

Schedule of Finite-Lived Intangible Assets [Table Text Block]

	Patents			Non- Compete			Customer List			Total
Estimated useful life (in years)		14			5			5
Gross amount at September 30, 2017	$	429		$	512		$	2,046		$	2,987
Accumulated amortization at September 30, 2017		(429	)		(496	)		(1,983	)	$	(2,908	)
Net balance at September 30, 2017	$	-		$	16		$	63		$	79

Estimated useful life (in years)		14			5			5
Gross amount at December 31, 2016	$	429		$	512		$	2,046		$	2,987
Accumulated amortization at December 31, 2016		(429	)		(449	)		(1,791	)	$	(2,669	)
Net balance at December 31, 2016	$	-		$	63		$	255		$	318

XML 36 R26.htm IDEA: XBRL DOCUMENT

Note 11 - Plant Consolidations (Tables)

9 Months Ended

Sep. 30, 2017

Notes Tables

Restructuring and Related Costs [Table Text Block]

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
Restructuring Costs	2017		2016		2017		2016
Relocation	$	-	$	25	$	63	$	203
Total	$	-	$	25	$	63	$	203

XML 37 R27.htm IDEA: XBRL DOCUMENT

Note 1 - Basis of Presentation (Details Textual) - USD ($)	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Increase (Decrease) in Income Taxes Receivable	$ 172,000	$ (1,146,000)
Increase (Decrease) in Accrued Liabilities	658,000	(317,000)
Payments to Acquire Property, Plant, and Equipment	$ 6,880,000	5,766,000
Restatement Adjustment [Member]
Increase (Decrease) in Income Taxes Receivable		315,000
Increase (Decrease) in Accrued Liabilities		(315,000)
Payments to Acquire Property, Plant, and Equipment		$ (311,000)

XML 38 R28.htm IDEA: XBRL DOCUMENT

Note 2 - Supplemental Cash Flow Information - Schedule of Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Cash paid for:
Interest	$ 37	$ 51
Income taxes, net of refunds	3,167	2,178
Non-cash investing and financing activities:
Capital additions accrued but not yet paid	$ 527	$ 311

XML 39 R29.htm IDEA: XBRL DOCUMENT

Note 4 - Share-based Compensation (Details Textual) - USD ($)			3 Months Ended		9 Months Ended
	Jun. 06, 2017	Feb. 21, 2017	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Employee Service Share-based Compensation, Tax Benefit from Compensation Expense			$ 106,000	$ 67,000	$ 441,000	$ 264,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	12,336				12,336
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price	$ 27.05				$ 27.05
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value					$ 577,000	564,000
Proceeds from Stock Options Exercised					$ 802,000	$ 529,000
Shares Paid for Exercise Price and Tax Withholding for Share Based Compensation					6,511	0
Shares Paid for Exercise Price and Tax Withholding for Share-based Compensation, Average Market Price					$ 26.45
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized			$ 754,000		$ 754,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition					3 years 182 days
Restricted Stock Units (RSUs) [Member]
Shares Paid for Tax Withholding for Share Based Compensation					4,377	3,889
Shares Paid for Tax Withholding for Share Based Compensation Market Price					$ 24.50	$ 22.82
The 2003 Incentive Plan [Member] \| Chairman Chief Executive Officer and President [Member] \| Common Stock [Member]
Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures		$ 400,000

XML 40 R30.htm IDEA: XBRL DOCUMENT

Note 4 - Share-based Compensation - Allocation of Share-based Compensation (Details) - Selling, General and Administrative Expenses [Member] - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Share-based compensation	$ 206	$ 229	$ 842	$ 871
Director [Member] \| Common Stock Issued Under the Equity Incentive Plan [Member]
Share-based compensation			105	105
Director [Member] \| Employee Stock Option [Member]
Share-based compensation			105	105
Chief Executive Officer [Member] \| Common Stock Issued Under the Equity Incentive Plan [Member]
Share-based compensation	100	100	300	300
Employees [Member] \| Employee Stock Option [Member]
Share-based compensation	4	34	25	107
Employees [Member] \| Restricted Stock Units (RSUs) [Member]
Share-based compensation	$ 102	$ 95	$ 307	$ 254

XML 41 R31.htm IDEA: XBRL DOCUMENT

Note 4 - Share-based Compensation - Stock Option Activity (Details) - USD ($) $ / shares in Units, $ in Thousands		9 Months Ended
	Jun. 06, 2017	Sep. 30, 2017
Outstanding (in shares)		232,578
Outstanding, weighted average exercise price (in dollars per share)		$ 16.53
Granted (in shares)	12,336	12,336
Granted, weighted average exercise price (in dollars per share)	$ 27.05	$ 27.05
Exercised (in shares)		(51,285)
Exercised, weighted average exercise price (in dollars per share)		$ 26.88
Expired (in shares)		(3,750)
Expired, weighted average exercise price (in dollars per share)		$ 18.85
Outstanding (in shares)		189,879
Outstanding, weighted average exercise price (in dollars per share)		$ 17.41
Outstanding, weighted average remaining contractual life (Year)		3 years 200 days
Outstanding, aggregate intrinsic value		$ 2,029
Exercisable (in shares)		184,879
Exercisable, weighted average exercise price (in dollars per share)		$ 17.23
Exercisable, weighted average remaining contractual life (Year)		3 years 219 days
Exercisable, aggregate intrinsic value		$ 2,011
Vested and expected to vest (in shares)		189,879
Vested and expected to vest, weighted average exercise price (in dollars per share)		$ 17.41
Vested and expected to vest, weighted average remaining contractual life (Year)		3 years 200 days
Vested and expected to vest, aggregate intrinsic value		$ 2,029

XML 42 R32.htm IDEA: XBRL DOCUMENT

Note 4 - Share-based Compensation - Option Pricing Assumptions (Details)	9 Months Ended
	Sep. 30, 2017 $ / shares
Weighted-average grant date fair value (in dollars per share)	$ 8.51
Employee Stock Option [Member]
Expected volatility	29.10%
Expected dividends
Risk-free interest rate	1.84%
Exercise price (in dollars per share)	$ 27.05
Expected term (Year)	5 years 292 days

XML 43 R33.htm IDEA: XBRL DOCUMENT

Note 4 - Share-based Compensation - Restricted Stock Unit Activity (Details) - Restricted Stock Units (RSUs) [Member]	9 Months Ended
	Sep. 30, 2017 $ / shares shares
Unvested (in shares) \| shares	46,558
Unvested, weighted average award date fair value (in dollars per share) \| $ / shares	$ 20.05
Awarded (in shares) \| shares	22,770
Awarded, weighted average award date fair value (in dollars per share) \| $ / shares	$ 24.70
Shares vested (in shares) \| shares	(13,419)
Shares vested (in dollars per share) \| $ / shares	$ 23.54
Unvested (in shares) \| shares	55,909
Unvested, weighted average award date fair value (in dollars per share) \| $ / shares	$ 20.96

XML 44 R34.htm IDEA: XBRL DOCUMENT

Note 5 - Inventories - Summary of Inventory (Details) - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016
Raw materials	$ 6,660	$ 7,111
Work in process	1,161	1,354
Finished goods	5,315	5,686
Total inventory	$ 13,136	$ 14,151

XML 45 R35.htm IDEA: XBRL DOCUMENT

Note 6 - Preferred Stock (Details Textual)	Mar. 18, 2009 $ / shares shares	Sep. 30, 2017 $ / shares	Dec. 31, 2016 $ / shares
Preferred Stock Dividends Number of Preferred Share Purchase Rights Distributed for each Share of Common Stock Outstanding	1
Common Stock, Par or Stated Value Per Share	$ 0.01	$ 0.01	$ 0.01
Preferred Stock, Par or Stated Value Per Share		$ 0.01	$ 0.01
Preferred Share Purchase Right [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 25
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right \| shares	0.001
Series A Junior Participating Preferred Stock [Member]
Preferred Stock, Par or Stated Value Per Share	$ 0.01

XML 46 R36.htm IDEA: XBRL DOCUMENT

Note 7 - Income Per Share (Details Textual) - shares	3 Months Ended		9 Months Ended
Note 7 - Income Per Share (Details Textual) - shares	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	0	35,193	27,336	52,377

XML 47 R37.htm IDEA: XBRL DOCUMENT

Note 7 - Income Per Share - Weighted Average Number of Shares Used to Compute Net EPS (Details) - shares shares in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Weighted average common shares outstanding, basic (in shares)	7,264	7,195	7,240	7,183
Weighted average common equivalent shares due to stock options and RSUs (in shares)	89	87	86	82
Weighted average common shares outstanding, diluted (in shares)	7,353	7,282	7,326	7,265

XML 48 R38.htm IDEA: XBRL DOCUMENT

Note 8 - Segment Reporting - Net Sales by Market (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Net sales	$ 35,684	$ 37,220	$ 110,623	$ 109,626
Sales Revenue, Net [Member] \| Customer Concentration Risk [Member]
Percentage of concentration risk	100.00%	100.00%	100.00%	100.00%
Medical [Member]
Net sales	$ 16,712	$ 16,548	$ 52,822	$ 48,953
Medical [Member] \| Sales Revenue, Net [Member] \| Customer Concentration Risk [Member]
Percentage of concentration risk	46.80%	44.50%	47.70%	44.70%
Consumer [Member]
Net sales	$ 6,006	$ 5,648	$ 15,713	$ 15,303
Consumer [Member] \| Sales Revenue, Net [Member] \| Customer Concentration Risk [Member]
Percentage of concentration risk	16.80%	15.20%	14.20%	14.00%
Automotive [Member]
Net sales	$ 5,174	$ 6,942	$ 18,018	$ 20,485
Automotive [Member] \| Sales Revenue, Net [Member] \| Customer Concentration Risk [Member]
Percentage of concentration risk	14.50%	18.70%	16.30%	18.70%
Aerospace & Defense [Member]
Net sales	$ 2,682	$ 2,516	$ 8,290	$ 7,929
Aerospace & Defense [Member] \| Sales Revenue, Net [Member] \| Customer Concentration Risk [Member]
Percentage of concentration risk	7.50%	6.80%	7.50%	7.20%
Industrial [Member]
Net sales	$ 2,591	$ 2,792	$ 7,629	$ 8,441
Industrial [Member] \| Sales Revenue, Net [Member] \| Customer Concentration Risk [Member]
Percentage of concentration risk	7.30%	7.50%	6.90%	7.70%
Electronics [Member]
Net sales	$ 2,519	$ 2,774	$ 8,151	$ 8,515
Electronics [Member] \| Sales Revenue, Net [Member] \| Customer Concentration Risk [Member]
Percentage of concentration risk	7.10%	7.50%	7.40%	7.80%

XML 49 R39.htm IDEA: XBRL DOCUMENT

Note 9 - Other Intangible Assets (Details Textual) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Amortization of Intangible Assets	$ 79,000	$ 79,000	$ 239,000	$ 239,000
Finite-Lived Intangible Assets, Amortization Expense, Remainder of Fiscal Year	$ 79,000		$ 79,000

XML 50 R40.htm IDEA: XBRL DOCUMENT

Note 9 - Other Intangible Assets - Definite Lived Intangible Assets (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2017	Dec. 31, 2016
Estimated useful life (Year)
Gross amount	$ 2,987	$ 2,987
Accumulated amortization	(2,908)	(2,669)
Net balance	$ 79	$ 318
Patents [Member]
Estimated useful life (Year)	14 years	14 years
Gross amount	$ 429	$ 429
Accumulated amortization	(429)	(429)
Net balance
Noncompete Agreements [Member]
Estimated useful life (Year)	5 years	5 years
Gross amount	$ 512	$ 512
Accumulated amortization	(496)	(449)
Net balance	$ 16	$ 63
Customer Lists [Member]
Estimated useful life (Year)	5 years	5 years
Gross amount	$ 2,046	$ 2,046
Accumulated amortization	(1,983)	(1,791)
Net balance	$ 63	$ 255

XML 51 R41.htm IDEA: XBRL DOCUMENT

Note 10 - Income Taxes (Details Textual) - USD ($)	3 Months Ended			9 Months Ended
Note 10 - Income Taxes (Details Textual) - USD ($)	Sep. 30, 2017	Sep. 30, 2016	Mar. 31, 2016	Sep. 30, 2017	Sep. 30, 2016
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	33.60%	35.00%		33.30%	35.40%
Income Tax Expense (Benefit)	$ 856,000	$ 1,437,000		$ 3,248,000	$ 3,550,000
Tax Adjustments, Settlements, and Unusual Provisions			$ 40,000
Accounting Standards Update 2016-09 [Member]
Income Tax Expense (Benefit)	$ (37,000)			$ (162,000)

XML 52 R42.htm IDEA: XBRL DOCUMENT

Note 11 - Plant Consolidations (Details Textual)		3 Months Ended		9 Months Ended
Note 11 - Plant Consolidations (Details Textual)	Mar. 18, 2015 USD ($) ft²	Sep. 30, 2017 USD ($)	Sep. 30, 2016 USD ($)	Sep. 30, 2017 USD ($)	Sep. 30, 2016 USD ($)
Restructuring Charges			$ 25,000	$ 63,000	$ 203,000
Newburyport, Massachusetts Facility [Member]
Area of Real Estate Property \| ft²	137,000
Restructuring Charges	$ 2,100,000		$ 25,000	$ 63,000	$ 203,000
Payments for Restructuring	2,000,000
Newburyport, Massachusetts Facility [Member] \| Employee Severance Payments and Relocation Costs [Member]
Restructuring and Related Cost, Expected Cost	180,000
Newburyport, Massachusetts Facility [Member] \| Moving and Vacating Expense [Member]
Restructuring and Related Cost, Expected Cost	1,600,000
Newburyport, Massachusetts Facility [Member] \| Lease Termination [Member]
Restructuring and Related Cost, Expected Cost	$ 360,000

XML 53 R43.htm IDEA: XBRL DOCUMENT

Note 11 - Plant Consolidations - Restructuring Costs (Details) - USD ($)		3 Months Ended		9 Months Ended
	Mar. 18, 2015	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Total			$ 25,000	$ 63,000	$ 203,000
Newburyport, Massachusetts Facility [Member]
Relocation			25,000	63,000	203,000
Total	$ 2,100,000		$ 25,000	$ 63,000	$ 203,000

XML 54 R44.htm IDEA: XBRL DOCUMENT

Note 12 - Related Party Transactions (Details Textual)	3 Months Ended
Note 12 - Related Party Transactions (Details Textual)	Mar. 31, 2017 USD ($)
Vention Medical, Inc. [Member] \| Non-employee Members of Board of Directors [Member]
Revenue from Related Parties	$ 148,000

XML 55 R45.htm IDEA: XBRL DOCUMENT

Note 13 - Material Overcharge Settlement (Details Textual) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Polyurethane Foam Antitrust Lawsuit [Member]
Litigation Settlement, Amount Awarded from Other Party	$ 0	$ 1,700,000	$ 121,000	$ 2,100,000

EXCEL 56 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( 'I*:4L?(\\#P !," + 7W)E;',O+G)E;'.MDD^+ MPD ,Q;]*F?L:5\'#8CUYZ6U9_ )Q)OU#.Y,A$[%^>X>];+=44/ 87O+>CT?V M/S2@=AQ2V\54C'X(J32M:OP"2+8ECVG%D4)6:A:/FD=I(*+ML2'8K-<[D*F' M.>RGGD7E2B.5^S3%":4A+,*P).B0\5?UX^8 TBTH_0(:+L A#&^NQT:E8(C M-R."?S]PN -02P,$% @ >DII2V;S"V"" L0 ! !D;V-0&UL38Y-"\(P$$3_2NG=;BGB06) L$?!D_>0;FP@R8;-"OGYIH(? MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/ M-(X'P"J8%EQV^3O8:W7..7AKQ%/25V^9"CGIYFHQ*/B76_..7+8\#?NW_+"" MWTG] E!+ P04 " !Z2FE+3$&X;NX K @ $0 &1O8U!R;W!S+V-O M&ULS9+!:L,P#(9?9?B>R&Y@(R;UI66G#08K;.QF;+4UC1-C:R1]^R5> MFS*V!]C1TN]/GT"-"=+T$5]B'S"2PW0W^K9+TH0U.Q(%"9#,$;U.Y93HIN:^ MCU[3](P'"-J<] %AQ?D]>"1M-6F8@458B$PUUD@345,?+WAK%GSXC&V&60/8 MHL>.$HA2 %/SQ' >VP9N@!E&&'WZ+J!=B+GZ)S9W@%V28W)+:AB&MW!=(MT9G'XE)^D<<,VND]^JS7;WR-2*BX="B(+7.UY+44M>?621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS M[BYBZ(:(E/)X8-DOV]:[MR_>X%#BVR]*+41B1%G\@MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C( MWXV(]ZMOFCU7H5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU M+,76>)7 \:V@S&L%&KQMUAVC2/'K^!?F<-0HACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=* MY \FIS_I,C0'HYI9";V$5FJ?JH,@H%\;D>/N5Z> HWEL:\4*Z">P'_ MT=HWPJOX@L Y?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=R MSTS0LS0[=R M2^JVE+ZU)CA*]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZ MG=PZ.)Z8D;D*TU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCR MHB'NH8:8S\-#AWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)2 M56 Q6\8#*Y"B?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYE ML<%5'<]56_*POFH]M!5.S_Y9KF4Q9Z;RWRT,"2Q;B%D2XDU=[=7G MFYRN>B)V^I=WP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5 M' 86%S+D4.Z2D 83 >LX=SFWJXPD6L_UC6'ODR MWSEPVSK> U[F$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\ MU*M:I60K$3]+!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHS MU8NL.8T*;T'50.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\! M4$L#!!0 ( 'I*:4NUF@E8B ( $4) 8 >&PO=V]R:W-H965T&UL?59_KYL@%/TJQ@_P%/S5OEB3MLNR)5O2O&7;W]32:IZ* UK? MOOT ?<[!=?\HX#GW(!\8?Q45I=)[:YM.[/Q*ROXY"$19T9:()];33GVY M,MX2J;K\%HB>4W(QI+8)N*>N+U$S3J/T^O.WZ/G(\HTP2!^ MU'00B[:G4SDS]JH[GR\[/]0SH@TMI0Y!U.M!C[1I="0UCU]34'_6U,1E^SWZ M1Y.\2N9,!#VRYF=]D=7.W_C>A5[)O9$O;/A$IX02WYNR_T(?M%%P/1.E4;)& MF*=7WH5D[11%3:4E;^.[[LQ[&+\D>*+!!#P1\$S Z+^$:")$,P'%)OEQ9B;5 M#T22(N=L\/CXMWJBBP(]1VHQ2SUHULY\4]D*-?HHPCQXZ# 3XC B\ *!9D2@ M8L\"&!(X8(>._Q4XNH@(%HC #")#CQ;T&*;'(#TV]'A!3ZP%"_7?";.LWPRG69KB%2G8QRARI+"S%P&8E1)#L-V1ZV9L%QF$6:DR!'L> MN:;'=ITAU_8X7/T]L.N1:VIL;U\3)EUB5K86!%L?N<;&]AX&83:62K XE%K* M;^;\%E[)[IVY/"Q&YSO"WAR;P5_X>,'X2OBM[H1W9E(=C>8 NS(FJ9I*^*26 MM%)WFKG3T*O4S4RU^7BPCQW)^NG2$LPWI^(/4$L#!!0 ( 'I*:4L67X)( M#00 (P3 8 >&PO=V]R:W-H965T&ULA9A=CYLX%(;_ M2L1]"^?8!C-*(C54U:ZTE49=[?::29Q)5 A98";MOU_S,5%RSO'T)@'RVGYL MS(/CY:5I?W0'Y_K%S[HZ=:OHT/?GASCNM@=7E]W'YNQ._I=]T]9E[T_;Y[@[ MMZ[.Z/)ZB]7*\]MBNE\U+7QU/[K%=="]U7;:_-JYJ+JL(HK<+ MWX[/AWZX$*^7Y_+9_>WZ?\Z/K3^+K[7LCK4[=GZIIYK\2AU^7/Z/I[&[\M<_ULQN0#.!?!: /2[!=1<0)$" M\40V=O5SV9?K9=M<%NUTM\[E,"G@0?G!W X7Q[$;?_.][?S5US7FR_AUJ&>. M;*8(WD;N$P5/J.0:B7W[5P@4(7 LKV_+ X&8(MD8.4V1#'5*0(04*)/++$ID M49R%='YKB$M60@MTQT/*:M@<#H0$"YP'AT0GF SQR%#.T=&J"1%0KJ>1K:FXM9,J:>4X$/TBQDZ=Z0< MJ.3FV;XGDLVIN#E3]D^;_Z$7UU=23EI?Q3?;(L,^U=>R?3Z>NL53T_=-/>Z# M[)NF=[[.Y*/OW\&5N^M)Y?;]<)CYXW;:'YI.^N8\[WW%UPVX]?]02P,$% M @ >DII2Y.,:6=A @ @ @ !@ !X;"]W;W)K;.>U.W;..6G'=KSV/'$C>(K4B'6_'D3&B#N##I MQ6,=Q>BDG)K:@P#$7H.JUBURM;:G14ZNO*Y:O*<.NS8-HG^WN";]QO7=^\)+ M=2FY7/"*O$,7_!/S7]V>"LN;HIRJ!K>L(JU#\7GC?O+7.U\Y*,5KA7LVFSNR ME ,A;]+X=MJX0!+A&A^Y#('$<,,[7-1U$S].\%L= MDH?"7P=B,X]R4>V=>B:J96+U5L1![MUDG%&R'21P)H%+Q"+_! &M M$%#YAW.(4(,8)(F2M(,$Z!BF)HH3.T=@Y0A,CDCC&"3I+ =8 5\#>2):D(16 MDM DB36201+-DOA _328Y[H%3V3EB4R>1..)C#PZR2/%@B&V,L0F0ZHQQ$\9 M'BD6#(F5(3$9,HTA^<@)>2):D*16DM0@2;1:MZE1*P36(_(!X8(HLQ)E)I%6 M]C8S$B4PRQ*H;X]-%T( SN/#^R]#9A$4&]NP)(J 7YL]#B;T(?AK%,MF?[3 M;WV3R6BXOOD^LBC*=*)GLH''FUT%\F[^@>BE:IES(%S<*JKWGPGA6(0$*Q&L M%)\#DU'C,Y?31,SI<"<.!B?=>-][TT='\0]02P,$% @ >DII2Q-Q=5,< M! 0!, !@ !X;"]W;W)K7?6]/EG;>#^*O*Q7_JEI+HL@J'LJ/]9IL_+R]5>Q?VUGEQ[ MG917Y[YW-[_M5S[K(K*YW36=BZS]>K<;F^>=IS:.?T:G_FW.SG!Z_>']EUY\ M*^8UJ^W&Y7^?]\UIY4>^M[>'["UOOKKKKW84I'QO5/^[?;=YBW>1M'/L7%[W MG][NK6Y<,7II0RFR'\/WN>R_KZ/_#S/:0(P&XF;0SOV903@:A#\-Y*<&3NT-6*L!,3U2]DBH= 16=$-01@@&!&&*!8>@U V M!"052*\40\)H!79U2U!::D6KTJ0JC51%8)9$HUF41JHPI)D &9UBB$?,0%44 M)9F@51E2E<&J0'8E&%'PT3)X>>'+"B,:IA[AA86TF(@4$V$Q(%T2C" Q$0KC M"]=P55**$@#:$I#@7-*:8E)3C#6!=4LP@C0]1M(8Q0KW!Q-?9J1P1I<]AL6@ MNL>(7&(@\S<$)1G:(X**=0@R1-?*]LIJ!SK$Q!9?SA([ A& G?> 3# MI8&B"(C-[1;9'SQS@35IJ$E0CP$414'PC4=!80Q5$9":>45PNIW@N)^(8#\Q M,ODKXD[$9)7]&<,KJ."EQ'832)P*7-A KN.D4)V ZFI"^AH3+*%_KW M$$S^_1>V.O9',;6W"YK[]4UC2OZDX6#5A#*JK")5*H[J\-.%F-3Y[;3^NK2V->VZ"[U779_KLUE;VO0P@_'GR]G,[]\"#:K*[ER?QA^C^OKZV[BQZM M'"ZU:;J+;8+6'-?A"SSO- X!H^*OB[EWB^M@2.7-VF_#S:^'=:@&1Z8R^WYH MHG1?[V9GJFIHR?GX9VXT?/0Y!"ZO/UK_,B;ODGDK.[.SU=^70W]>AWD8',RQ MO%7]5WO_Q3>5DP].7!][6W7C9["_=;VMYU:P_:Z6U=RV%0P+-V MQ=P/#\?:C;^Y;#OW]'U3I*OH?6AGEFPG"2XD\%!$KO%'#RCUL$46CC]WL..* M+)5[T&(.>HR/%_%Y07*8)-DH:49)&A<)\2&)LD)V$HM.XK$%O:QF)L35'22\IIJXB1EG1#%CBN>8ME$)IK(>#GHB\U8 M%WE,QY>@R3Q#.!=]Y,P'*$6,<$T2$Q\Y+P>@9Z07HI&"=1+3@A2L$V1&! UZ M7@PH&1N*C710GIJ"ASP@5!4I>X#7+&,35U+%N:^T('+J!9#YT73(SYIE1RYM M9H>KGG3JM+@,R,S$R1HLOG$D8B*+F:B*/&8D;D)')R@V'3B6 2M0%$[ M7)9BFLM^4,8G2OCTI(0R/E'")WW;*( QS7.:DB1+,A^Q4.8G&,O.0,P_HR-RB M@+.,(5A4);[Q*U,/.?4 @-KA1$LU&WI>=W^& M,O50H![0Q0FEC2"=*CM)E?LJ(V,/!>P!93!RGCTAW5;N)!44GGF@9>II)=BA M%)Y%/PV(/*?%$50:/)C0,D"U %"ZE=MJ3D8-.J'5$618Y,IG2 :H%@ *E.BS M:/DG56=(E_F=)%, =)9'BV."VK2G\42E"_;VUO3#/_+%T\>IS;^%Y M-YV]_&AF.@KZO6Q/EZ8+WFS?VWH\:CA:VQOG4GUR!3N;\O"XJ&PO=V]R:W-H965T&UL;5-ACYLP#/TK47[ !=)N=ZL Z7K3 MM$F;5-VT[7,*!J)+,$M"N?W[)8$RKN,+L8W?\[/C9".:%]L"./*J56=SVCK7 M'QBS90M:V#OLH?-_:C1:..^:AMG>@*@B2"O&D^0]TT)VM,AB[&2*# >G9 4?)W/Q7N(#RZ4&)KU&B MLO%+RL$ZU#.+EZ+%ZW3*+I[CS'^%;0/X#. W #85BLH_"B>*S.!(S#3[7H0K M3@_&PO=V]R M:W-H965T&UL;5/;;MP@$/T5Q >$->LVVY5M*9NJ:J5$6J5J M^\S:8QL%/"[@=?+W!>RX;NH78(9SSEP8LA'-LVT!''G1JK,Y;9WKCXS9L@4M M[ WVT/F;&HT6SINF8;8W(*I(THKQW>XCTT)VM,BB[VR*# >G9 =G0^R@M3"O M)U XYC2A;XXGV;0N.%B1]:*![^!^]&?C+;:H5%)#9R5VQ$"=T[OD>$H#/@)^ M2ACMZDQ")1?$YV!\JW*Z"PF!@M(%!>&W*]R#4D'(I_%[UJ1+R$!$>U2]9N3:G!THJJ,6@W!..7V&NYP,E<_$/< 7EX2$3'Z-$9>-*RL$Z MU+.*3T6+EVF77=S'Z2;]--.V"7PF\(5PB''8%"AF_EDX460&1V*FWO&PO=V]R:W-H M965T&UL;5/;;MP@$/T5Q >$->M-5RO;4C95U4JMM$K5]IFU MQS8*&!?P.OW[#MAQW-0OP SGG+DP9*.QSZX%\.1%J\[EM/6^/S'FRA:T<'>F MAPYO:F.U\&C:AKG>@J@B22O&=[M[IH7L:)%%W\46F1F\DAU<+'&#UL+^.8,R M8TX3^NIXDDWK@X,562\:^ [^1W^Q:+%%I9(:.B=-1RS4.7U(3N/1OV2E6]S>J2D@EH,RC^9\3/,]1PHF8O_"C=0" ^98(S2*!=74@[.&SVK M8"I:O$R[[.(^3C?I8:9M$_A,X OA&..P*5#,_*/PHLBL&8F=>M^+\,3)B6-O MRN",K8AWF+Q#[ZU(>)JQ6Q":,><)P]>8!<%0?0G!MT*<^7]TODW?;V:XC_3] M.GIRW!9(-P72*)#^4^+A78E;F/MW0=BJIQIL$Z?)D=(,79SDE7<9V <>W^0- M/DW[-V$;V3ER-1Y?-O:_-L8#IK*[PQ%J\8,MAH+:A^,'/-MIS";#FW[^06SY MQL5?4$L#!!0 ( 'I*:4NSM20CMP$ -(# 8 >&PO=V]R:W-H965T M&UL;5/M;ML@%'T5Q .4F&1-&MF6FD[3)JU2U&G;;V)?VZC@ MZP&.V[=J*&'^!^=F?C+3:KE%)#:R6VQ$"5T?OD>-H%? 3\DC#8Q9F$ M2BZ(S\'X5F9T$Q("!84+"L)O5W@ I8*03^//I$GGD(&X/+^K?XFU^UHNPL(# MJM^R=$U&#Y244(E>N2<]^)\,3)D?O>%,$9 M6Q'O?/+6>Z]YPOEJ!4C95%4JM=(J59MG+PQ@Q1=J MFR7]^]J&$)+R8GO&<\Z<&8^+29MGVP,X]"*%LB7NG1N.A-BZ!\GLC1Y ^9M6 M&\F<-TU'[&" -1$D!:%)A<\A ? WYSF.SFC$(E M%ZV?@_&M*7$2!(& V@4&YK'#@Q*?H];"QA75HW5:+BQ>BF0O M\\Y5W*?Y)LL7V#Z +@"Z @XQ#YD31>5?F&-58?2$S-S[@84G3H_4]Z8.SMB* M>.?%6^^]5FF6%.0:B):8TQQ#MS%K!/'L:PJZE^)$_X/3?7BVJS"+\&R;/3WL M$^2[!'DDR-^5F'XH<2_FHTJRZ:D$T\5ILJC6HXJ3O/&N WM'XYN\A<_3_H.9 MCBN++MKYEXW];[5VX*4D-WZ$>O_!5D- Z\+QLS^;>V$ *[X0VRSI MW]I="V0)WSO5'0FS5@63V3O>@_$VCC63. MFZ8EMC? ZDB2@M#=[IY(QA4N\^@[FS+7@Q-LH"/@)\<1KLZHU#)1>O7 M8#S7!=Z%A$! Y8("\]L5'D&((.33>)LU\1(R$-?GF_J76+NOY<(L/&KQB]>N M*_ !HQH:-@CWHL'+8%LDV! M+ ID_Y28?2AQ"[/_$(2L>BK!M'&:+*KTH.(DK[S+P#[0^"9_X=.T?V.FY552VX)VSO5'QFS5@>+V!GO0_J9!H[CSIFF9 M[0WP.I*49.EN=\<4%YJ6>?2=39GCX*30<#;$#DIQ\^<$$L>")O3-\2S:S@4' M*_.>M_ =W(_^;+S%%I5:*-!6H"8&FH(^),?3/N CX*> T:[.)%1R07P)QI>Z MH+N0$$BH7%#@?KO"(T@9A'P:OV=-NH0,Q/7Y3?TIUNYKN7 +CRA_B=IU!3U0 M4D/#!^F>; M+)UIVX1T)J0+X1#CL"E0S/P3=[S,#8[$3+WO>7CBY)CZWE3!&5L1[WSRUGNO M99+=Y>P:A&;,:<*D:\R"8%Y]"9%NA3BE_]'3;7JVF6$6Z=DZ>G+8%MAO"NRC MP/Z?$N\_E+B%^1B$K7JJP+1QFBRI<-!QDE?>96 ?XB.R=_@T[=^X:86VY(+. MOVSL?X/HP*>RN_$CU/D/MA@2&A>.]_YLIC&;#(?]_(/8\HW+OU!+ P04 M" !Z2FE+MG:^'[4! #2 P &0 'AL+W=O@!/7I34KJ2]]\.),5?WH+B[,P-HO&F-5=RC:3OF!@N\ MB20E698D[YGB0M.JB+Z+K0HS>BDT7"QQHU+<_CF#-%-)4_KJ>!1=[X.#5<7 M._@!_N=PL6BQ5:41"K031A,+;4GOT],Y#_@(>!(PN]&D:\A W)Y?U3_'VK&6*W?P8.0OT?B^I$=*&FCY M*/VCF;[ 4L\[2I;BO\$-),)#)ABC-M+%E=2C\T8M*IB*XB_S+G3LJP-W5PQE;$.TS>H?=6I8>/ M!;L%H05SGC'9%K,B&*JO(;*]$.?L/WJV3S_L9GB(],,V>GK<%\AW!?(HD&\% M\N1-B7N8MT6R34\5V"Y.DR.U&76]N_<=D([7S;V MOS7& Z:2W.$(]?C!5D-"Z\/Q Y[M/&:SX=&JLSEMG>N/C-FR!2WL#?;0^9L:C1;.FZ9AMC<@JDC2 MBO'=[I9I(3M:9-%W-D6&@U.R@[,A=M!:F+\G4#CF-*&OCD?9M"XX6)'UHH&? MX'[U9^,MMJA44D-G)7;$0)W3N^1X2@,^ GY+&.WJ3$(E%\3G8'RKX@O+PD(F/4:*R<27E8!WJ6<6GHL7+M,LN[N-TD_*9MDW@ M,X$OA$.,PZ9 ,?,OPHDB,S@2,_6^%^&)DR/WO2F#,[8BWOGDK?=>BR3E&;L& MH1ESFC!\C5D0S*LO(?A6B!/_C\ZWZ?O-#/>1OE]'3P[; NFF0!H%TGRN_$CU/H/MA@*:A>.G_W93&,V&0[[^0>QY1L7_P!02P,$% @ >DII M2P^)O(NW 0 T@, !D !X;"]W;W)K&UL;5/; M;MP@$/T5Q >$M=>;K%:VI6RJJI5::96J[3-KCVT48%S Z_3O"]AQW=0OP SG MG+DPY".:%]L!./*JI+8%[9SK3XS9J@/%[1WVH/U-@T9QYTW3,ML;X'4D*Z>*2XT+?/HNY@RQ\%)H>%BB!V4XN;W&22.!4WHF^-9M)T+#E;F/6_A&[CO M_<5XBRTJM5"@K4!-##0%?4Q.YRS@(^"'@-&NSB14/X M">9Z#I3,Q7^!&T@/#YGX&!5*&U=2#=:AFE5\*HJ_3KO0<1^GF_UAIFT3TIF0 M+H1CC,.F0#'S#]SQ,C8!<&\^A(BW0IQ3O^CI]OT_6:&^TC?KZ,GQVV!;%,@BP+9/R7>ORMQ M"_/P+@A;]52!:>,T65+AH.,DK[S+P#ZF\4W^PJ=I_\I-*[0E5W3^96/_&T0' M/I7=G1^ASG^PQ9#0N'!\\&7(;.1MYX*#E'G/6O@%[G=_ M,MXBBTK-)2C+M4(&F@+?IH=C%O 1\,1AM*LS"I6ZP$E(" 14+B@P MOUW@#H0(0CZ-EUD3+R$#<7U^4W^(M?M:SLS"G19_>.VZ N\QJJ%A@W"/>OP& M.5;F1H_(3+WO67CB]$!];ZK@C*V(=SYYZ[V7,LWV.;D$H1ES MG#!TC5D0Q*LO(>A6B"/]1*?;]-UFAKM(WZVCI_MM@6Q3((L"V;L2OWXH<0-S MG7P(0E8]E6#:.$T657I0<9)7WF5@;VE\D__P:=I_,M-R9=%9._^RL?^-U@Y\ M*LF5'Z'.?[#%$-"X&PO=V]R:W-H965T)L?3+N CX%<+@UN<2:CD8LQ+,![+C&Y"0B"A\$%! MX':%.Y R"&$:KY,FG4,&XO+\H?X0:\=:+L+!G9&_V](W&3U04D(E>NF?S? - MIGKVE$S%?X?&+-E"UK8.^RA\S.[W3W3 M0G:TR*+O8HH,!Z=D!Q=#[*"U,'_.H'#,:4)?'4^R:5UPL"+K10/?P?WH+\9; M;%&II(;.2NR(@3JG#\GIG 9\!/R4,-K5F81*KHC/P?A2Y707$@(%I0L*PF\W M> 2E@I!/X_>L29>0@;@^OZI_BK7[6J["PB.J7[)R;4Z/E%10BT&Y)QP_PUS/ M@9*Y^*]P ^7A(1,?HT1EXTK*P3K4LXI/18N7:9==W,?I)CW,M&T"GPE\(1QC M'#8%BIE_%$X4F<&1F*GWO0A/G)RX[TT9G+$5\$^TO?KZ,EQ6R#=%$BC0/I/B8=W)6YA[M\% M8:N>:C!-G"9+2ARZ.,DK[S*P#SR^R1M\FO9OPC2RL^2*SK]L['^-Z,"GLKOS M(]3Z#[88"FH7CA_\V4QC-AD.^_D'L>4;%W\!4$L#!!0 ( 'I*:4L@ RG< MQ0$ #<$ 9 >&PO=V]R:W-H965T@"+7@67IL2]M<.1$%/W(*BY4P-(=](J+:AUINZ(&330)@0)3K(DN2>" M,HFK(OC.NBK4:#F3<-;(C$)0_><$7$TE3O&;XYEUO?4.4A4#[> [V!_#63N+ MK"P-$R -4Q)I:$O\F!Y/N<<'P$\&D]GLD:_DHM2+-[XT)4Z\(.!06\] W7*% M)^#<$SD9OQ=.O*;T@=O]&_NG4+NKY4(-/"G^BS6V+_$!HP9:.G+[K*;/L-23 M8[04_Q6NP!W<*W$Y:L5-^*)Z-%:)A<5)$?1U7ID,ZS2?Y(#]1?<7K,7&]J[PRM"&=.O''>:Y7F#P6Y>J(%_=N^-(!V.?70/@R:M6K:IZ;V2+9PL<;W6POX[@C)#1K?TW?$HZ\8' M!\O33M3P!/YW=[)HL9FEE!I:)TU++%09O=L>CDF(CP%_) QN<2:ADK,QS\'X M469T$P2!@L('!H';!>Y!J4"$,EXF3CJG#,#E^9W]>ZP=:SD+!_=&_96E;S)Z M2TD)E>B5?S3# TSU7%,R%?\3+J P/"C!'(51+JZDZ)TW>F)!*5J\CKMLXSZ, M-_N;";8.X!. SX#;F(>-B:+R;\*+/+5F(';L?2?"$V\/''M3!&=L1;Q#\0Z] MEWR[WZ7L$HBFF.,8PY:K!UG"9'"M.W<9(7WGE@[WA\DX_P<=I_"5O+UI&S M\?BRL?^5,1Y0RN8*1ZC!#S8;"BH?CC=XMN.8C88WW?2#V/R-\S=02P,$% M @ >DII2Q\JDGO= 0 04 !D !X;"]W;W)K&UL=51M;]L@$/XKB!]0'.+$761;:EI5F[1)4:=MGXE]?E'!>(#C[M\/L..E M+OMBN..YY[D[P6L]$&"$QI%>R)8V^$\];Z3RE,Y&-YV<%)(#T(P]><(7(X9WN"KXZ6M&^,< M)$][5L-W,#_ZD[(665C*5D"G6]DA!56&'S:'8^+P'O"SA5'?[)&KY"SEJS.^ ME!F.7$+ H3".@=GE H_ N2.R:?R>.?$BZ0)O]U?V9U^[K>7,-#Q*_JLM39/A M>XQ*J-C S8L\DW M^R0E%T&PO=V]R:W-H965TP#=M#ZFPJ-%LZ;IF:V,R#*2-**\*=G"Q1#;:RW,[S,H'#*ZI7?'BZP;%QPL3SM1PS=PW[N+ M\1:;54JIH;426V*@RNC3]G1. CX"?D@8[.),0B57Q-=@?"XSN@D)@8+"!07A MMQL\@U)!R*?Q:]*D<\A 7)[OZA]C[;Z6J[#PC.JG+%V3T2,E)52B5^X%AT\P MU?-(R53\%[B!\O"0B8]1H+)Q)45O'>I)Q:>BQ=NXRS;NPWCS>*>M$_A$X#/A M& EL#!0S_R"Q3=@M"$^8\ M8O@2,R.85Y]#\+409_X?G:_3=ZL9[B)]MXR^3]8%DE6!) HD_Y1X>%?B&N;X M+@A;]%2#J>,T65)@W\9)7GCG@7WB\4W^PL=I_RI,+5M+KNC\R\;^5X@.?"J; M!S]"C?]@LZ&@+!9MYX*#E7G/6_@.[D=_,=YB MBTHM%&@K4!,#34$?=Z=S%O 1\%/ :%=G$BJY(KX$XTM=T"0D!!(J%Q2XWV[P M!%(&(9_&[UF3+B$#<7U^4_\4:_>U7+F%)Y2_1.VZ@AXIJ:'A@W3/.'Z&N9Y[ M2N;BO\(-I(>'3'R,"J6-*ZD&ZU#-*CX5Q5^G7>BXC]/-X7ZF;1/2F9 NA&., MPZ9 ,?./W/$R-S@2,_6^Y^&)=Z?4]Z8*SMB*>.>3M]Y[*W4;EW\!4$L#!!0 ( 'I*:4L7!Z@) ML@$ -(# 9 >&PO=V]R:W-H965T%[F%XNDSSF\B$H' M8]]= ^#)AY+:9;3QOMLSYHH&E' WI@.-?RICE?#HVIJYSH(H(TE)QC>;.Z9$ MJVF>QMC1YJGIO6PU'"UQO5+"?AY FB&C6WH)O+5UXT. Y6DG:O@._D=WM.BQ M6:5L%6C7&DTL5!E]V.X/2P2>CD9,Q[<+Z6&=V$@D!"X8."P.,, MCR!E$,(R?D^:=$X9B$O[HOX<>\=>3L+!HY&_VM(W&;VGI(1*]-*_F>$%IGYN M*9F:_P9GD @/E6".PD@7OZ3HG3=J4L%2E/@8SU;'XZS*4(PCB+^P^(=1L_Y]IZG[!R$)LQAQ/ E9D8P M5)]3\+44!_X?G:_3=ZL5[B)]M\Q^EZP+)*L"211(_FEQ=]7B&N8Z"5O,5(&M MXS8Y4IA>QTU>1.>%?>#Q3O["QVU_%;9NM2,GX_%FX_PK8SQ@*9L;7*$&']CL M2*A\,+^@;<&PO=V]R:W-H965TV M169Z+X6&LR6N5XK;/R>09LCIEGXXGD33^N!@1=;Q!I[!_^S.%BTVJU1"@7;" M:&*ASNG]]GA* SX"?@D8W.),0B478UZ"\:W*Z28D!!)*'Q0X;E=X "F#$*;Q M.FG2.60@+L\?ZE]C[5C+A3MX,/*WJ'R;TP,E%=2\E_[)#(\PU7-+R53\=[B" M1'C(!&.41KJXDK)WWJA)!5-1_&W-_:^-\8"I;&YPA%K\8+,A MH?;A>(=G.X[9:'C333^(S=^X> =02P,$% @ >DII2_CATIRX 0 T@, M !D !X;"]W;W)K&UL;5/;;IPP$/T5RQ\0@Y>D MFQ4@95-5J=1*JU1-GKTP@!5?B&V6].]K&T)HRHOM&9]SYN)Q/FKS8CL A]ZD M4+; G7/]@1!;=2"9O=(]*'_3:".9\Z9IB>T-L#J2I" T26Z(9%SA,H^^DRES M/3C!%9P,LH.4S/PY@M!C@5/\[GCD;>>"@Y1YSUKX!>YW?S+>(HM*S24HR[5" M!IH"WZ6'8Q;P$?#$8;2K,PJ5G+5^"<;WNL!)2 @$5"XH,+]=X!Z$"$(^C==9 M$R\A W%]?E?_%FOWM9R9A7LMGGGMN@+O,:JA88-PCWI\@+F>:XSFXG_ !82' MATQ\C$H+&U=4#=9I.:OX5"1[FW:NXCY.-]?I3-LFT)E %$^QB%3H)CY5^98 MF1L](C/UOF?AB=,#];VI@C.V(M[YY*WW7LITO\_))0C-F..$H6O,@B!>?0E! MMT(27/D1ZOP'6PP! MC0O'+_YLIC&;#*?[^0>1Y1N7?P%02P,$% @ >DII2R;B CH^ @ Q08 M !D !X;"]W;W)K&ULA57;CILP$/T5Q/LNX0X1 M0=JP6K52*T5;M7UVR"2@-9C:3MC^?7UA60).\X(]XS-SSMAFG/6$OK$*@%OO M#6[9QJXX[]:.P\H*&L0>20>M6#D2VB N3'IR6$&XL9_<=9%*O +\JJ%GD[DE*]D3\B:-KX>-O9*" $/)908DA@L4 M@+%,)&3\&7+:(Z4,G,X_LK^HVD4M>\2@(/AW?>#5QDYLZP!'=,;\E?1?8*@G MM*VA^&]P 2S@4HG@* EFZFN59\9),V014AKTKL>Z56.O5$T"#,'>$. -P8( M[O\%^$. _QD0J.*U,E7J,^(HSRCI+:H/JT/R3KAK7VQF*9UJ[]2:J)8)[R5W M4S=S+C+1@-EJC#?%C A'9!\I/!/%UEN$>]<$Q1(11V8&WUB$K^*#JR)F'%N- MB16FU9A87/;53,H2]N"Z030%7@D*C(("@R!_)DACP@E3%"9+04O8@^_&-_6$ M1CVA04\PTQ,N*H\2J6/J$B7E]-WW261,_G[&Z GU2B959)SR^5_-O&. MO?C)D]UCYM^*'JU;ZF<:W>"_(WJJ6V;M"1>]2760(R$4N[6JW=KV_+Z]& MT6'V/%/[6B;Q+=9.D.QC9]$.2#),Z_PM02P,$% @ >DII2P-UC%+= @ 8@L M !D !X;"]W;W)K&ULC5;MDIHP%'T5A@<0$A*" M.^I,U6H[T\[L;*?M[ZQ&918(A:C;MV\":"6YZ/X1$L^Y]]P/KW=REM5;?1!" M>>]Y5M13_Z!4^10$]>8@9/$]]Y%\N7M+]09F+8#8I^5[\$.IG M^5SI4W"ULDUS4=2I++Q*[*;^)_2T1M00&L2O5)SKFW?/A/(JY9LY?-U._= H M$IG8*&."Z\=)+$26&4M:QY_.J'_U:8BW[Q?KJR9X'>[L7V@P 7<$?"4@PNP36$9CE(6BS MVY1KR16?32IY]JJVXTIN&AL],=T0&W/9U+_Y3E>LUK>G&0[Q)#@90QUFWF)P M#Q/U,0L(0_J8)8#I(SZ["!;W(:N'1M9WC00Z&]>48# EN.&37BC4"J7%L 93 M-!@4QF$86O&XL)@YJ)6+(@0YL+4+PS&YA?5BB\#8(B V*\/S%D-O8\-19-?A M$:HGAH!B"""&66):3'(;-!O9Y5@]0O7$4% ,!<0DEAOJ5( RMYYKZJ2&WBE4 M#,J) 3EC2T[LR$E"[,IQ812/!^4P4 YSY2"[C9D3=DP1LL2XH $=":@C 718 M+E:)VPSQB PTPQAT,P;<6&-F.7;2RBAQ?]P/83TY*(2G= @(BNS)"('(@)^! M?P,$F!C('(*G)P+&)W*&.';:@$2,V8/<145),AZ0 P\\!$P\Q&PYD=LR9$1M M.0 *CQ(\H >>>0@8>B@9, %/*@2,*F3-A@5R9Y7I.J?O@IM%P6R?WWFU3XO: M>Y5*[QS-9K"34@EM,QQIFP>]\%X/F=@I\\KT>]5N?>U!R;+;:(/K6CW[!U!+ M P04 " !Z2FE+ N:%Q+@" "G"@ &0 'AL+W=OTDKDK/(XWO)M^W<#W5&M* ;J2F(^ISHBA:%9E)Y_+6D?KNG#NR. M+^Q?C'@EYHT(NF+%GWPK#W-_['M;NB/'0KZR\U=J!26^9]5_IR=:*+C.1.VQ M884PO][F*"0K+8M*I20?S3>OS/=L^2]A< "V ;@-4'O?"XAL0/09$-\-B&U M_.@.B0U(G!V"1KLQ,R.2+&:W(>:Z&N'IHDZKHU>-*=C_E-^"K5Z6F < MSH*3)K*898/!'4R:7$.R/@2UB$ ET&:!H2R6N!>.KS=8]1'IR,EAD&1]E^0J MS0@T*S+Q<2=^,G&\:B"I@51-$J&3Z K 8(/84C60)*.5!0Z=W!]'W.E9@2J&0%V8)@@!0G283OZD)X= MPY L?<".^Y@K-6-0S1BP(X())B#!9-B."9"D4WY6#V"R/B9R,>O[F"L]*(2+ M90A8$M^@N%%OT; I%M/-U+TC "1R+PF P>XE 3 H3&\H FOW,\* *3ICHHYDZPM0HQ/WI(/.(UM2OC<=C_ V[%A)_81T M5MNNZAGK1]I97Z+I"@'KF>["S*/^2=^T<#\(W^>5\-Z85*V!>5-?83@JZDWJ8JC%O6J=F(EEMV\*@[4T7_P%02P,$% @ >DII2SG] M>@K< @ @ L !D !X;"]W;W)K&ULC5;;CILP M$/T5Q'L!7[BMDDC=5%4KM5*T5=MG;^(D: %3XR3;OZ\QA 8SWNQ+P,Z9.6=L MS\&+BY O[9%SY;U69=TN_:-2S4,8MMLCKU@;B(;7^I^]D!53>B@/8=M(SG8F MJ"I#'$5)6+&B]E<+,[>1JX4XJ;*H^49Z[:FJF/S[R$MQ6?K(OTX\%8>CZB;" MU:)A!_Z#JY_-1NI1.&;9%16OVT+4GN3[I?\1/:RQ"3"(7P6_M#?O7E?*LQ O MW>#K;NE'G2)>\JWJ4C#]./,U+\LND];Q9TCJCYQ=X.W[-?MG4[PNYIFU?"W* MW\5.'9=^YGL[OF>G4CV)RQ<^%!3[WE#]-W[FI89W2C3'5I2M^?6VIU:):LBB MI53LM7\6M7E>AOS7,#@ #P%X#$#TS0 R!)#_ :DIOE=F2OW$%%LMI+AXLM^M MAG6' CT0O9C;;M*LG?E/5]OJV?,*XV01GKM$ ^:QQ^!;3$2FF#6 &1&A5C#* MP* ,;,+I1$9J4?28V&#J'D-PG&8P#P%Y","363P])KOA04D0$YB&@C04H,FM M5:6S,TB&)+S#W41$P"BDD ,@@!S(;/%ZT'I[:&+L&OI8'=!@+V0V=(!SI%1]R[!WH$@\\AMJKDO MZ%W"#L=$L#$@P!EH9#-!(-=I@(T! PK [8, =J/UM'$!W>BF\N0IU M=]/O3!Z*NO6>A=*W*G/WV0NAN,X8!7HCCOHZ/ Y*OE?=:ZK?97\G[ =*-,-] M-QPOW:M_4$L#!!0 ( 'I*:4MG&]N3!0( ,\% 9 >&PO=V]R:W-H M965T2?6J*P 3O O>Z%U8&=-N"=%E!8+I MA6RAL3MGJ00S=JDN1+<*V,DG"4YH%*V)8'43%KF/'521RZOA=0,'%>BK$$S] MV0.7W2YNDJ.4KV[Q[;0+(V<(.)3&,3 [W. 1.'=$UL;;P!F.DBYQ.O]@ M?_*UVUJ.3,.CY+_KDZEV818&)SBS*S?/LOL*0SU)& S%?X<;< MW3JQ&*;GV MWZ"\:B/%P&*M"/;>CW7CQZ[?25=#&IY AP0Z)M#8U](+>>=?F&%%KF07J/[L M6^9^\7)+[=F4+NB/PN]9\]I&;P6-TYS<'-& V?<8.L$L1P2Q[*,$Q23V]"Z= MQAE.L$(]KCQ!_!_!9N:QQV0>TWA,MD@^L1FC*O&]2A+A! E*D" $RYE-#$-Q MD34JLD8(5C.1>TP2XQHIJI$B&O%, \,DN$B&BF0(P7HFDMW]5)HNHD]D-JC, M!I&9WV\,,[^@9/*@!*B+;R4Z*.6U\6UL$AV[U0/U#_(?O&]U/YBZU(T.CM+8 M9^T?WUE* ]9*M+ 7I++==5QP.!LW3>U<]3VF7QC9#NV3C#V\^ M02P,$% M @ >DII2R&+O,DM @ :@8 !D !X;"]W;W)K&ULC97;CILP$(9?!7'?&!S,(2)(FZVJ5FJEU59MKQTR"6@-IK83MF]?VQ!* MP2OM37S@G_GF=\R0]UR\R I >:\-:^7>KY3J=@C)LH*&R@WOH-5/SEPT5.FE MN"#9": G&]0PA(,@1@VM6[_([=Z3*')^5:QNX4EX\MHT5/PY ./]W@_]^\9S M?:F4V4!%WM$+? ?UHWL2>H6F+*>Z@5;6O/4$G/?^0[@[A($)L(J?-?1R-O>, ME2/G+V;QY;3W U,1,"B524'U<(-'8,QDTG7\'I/Z$],$SN?W[)^L>6WF2"4\ M^=X(SO3+US/O/,!HBOC>Z_PHW8%IN*M&,DC-I?[WR*A5OQBRZ ME(:^#F/=VK$?\]_#W %X#,!3P-8&H %D*_](%2URP7M/#(??4?,?ASNLSZ8T MF_8H[#-=O-2[MP*3+$.F92L[A&3!&VYTPW*^=<$[[MHH6ERV+%Z0T.Q5;T!<;).3 M7LFOK>VPL]VID3Y@VRK^R8DII2P1/X-+Q 0 - 4 M !D !X;"]W;W)K&UL?93MCIP@%(9OQ7@!B_@Y M.U&3SC2;-FF3R3;=_F;TS&@6Q05FW-Y] 5WC(ND?@P1$E4#'1$/;(!>S5P8[XA40WY%8N! :F/J* J#($4=:7N_S$WL MQ,NSAQ3]RZCO"_!Z!L+'SL?P2>VVLC=0"5^4"N\ OD[^'$U0@M6>JV M@UZTK/[J2,V.O>O"]+OQ P&%2NH,1#5W. *E M.I'">)MS^LN2VKCN?V1_,K6K6LY$P)'1/VTMF\+?^5X-%W*C\IF-WV"N)_&] MN?@?< >JY)I$K5$Q*LS7JVY"LF[.HE Z\CZU;6_:<9K)'F>;VQ#.AG QX/B_ MAF@V1)8!362FU*]$DC+G;/3X]+,&HL\$WD=J,RL=-'MGYE2U0D7O99AF.;KK M1+/F,&G"M>:SXKA51,$B00I@H0B=%*'QQY\H=A;%I,F,IC>:-$T#"V0KRC#& M;I3(B1(Y4!XME$F3K%;!.,46BD,4);$;)7:BQ%N4S"KX$&]622*<6"@.4;I+ MW2B)$R5QH%@%'Y+-WN,(1ZG%XE#%.+%_$5J=7_V>_"3\VO;".S.IKH(YL!?& M)*B,P8-*V:@G;!E0N$C=S52?3Q=Y&D@VS&\46A[*\A]02P,$% @ >DII M2[V7SC@4 @ KP8 !D !X;"]W;W)K&ULC57M MKIHP&+X5P@58/@4,DDS-LB5;8LZR[7>%%R&G4-96.;O[M06)L)ZC?Z0MS]?[ M5MJTI^R55P#">FM(R[=V)42W08CG%328KV@'K7Q34M9@(:?LC'C' !>:U!#D M.6I?0B2-W"D5G\TC28_=T!H?W6=NW;PDM]KH1:0%G:X3/\ M /&S.S(Y0Y-*43?0\IJV%H-R:W]R-X=$X37@5PT]OQM;JI(3I:]J\K78VHX* M! 1RH12P?%QA#X0H(1GCSZAI3Y:*>#^^J7_6MX I%PE41ZY)1P_6OE%RYH,ZK(* U^&YYUJY_]J'^C MF0G>2/ F@O\QP1\)_D3P@@\)P4@(%@0TE*)[<\ "9RFCO<6&W>VP^A.YFT!V M/U>+NMGZG6P/EZO7S(N\%%V5T(C9#1AOAO'GF+T!$\1SS,&D$TP8)'-.83UC M6$\+!#.! 1T>@&9Y V/> MP) W6D0)GHGR #2+$AJCA(8HL5E@;118&P221>\'3'07TPO-'I'1(_K?(W86 M'@,FF;?BO5[$1IO88/..0&(42![OZRYY9LO0W4F@CO+OF)WKEELG*N2AHC_] MDE(!4M!9R2VLY.TQ30B40@TC.6;#&3I,!.W&ZP%-=U3V#U!+ P04 " !Z M2FE+3\>>$ ," !/!0 &0 'AL+W=OHP3UUN*_-4G#2K:MC*0)TXI_+/$IAHLS *+XF7ZEAJFT!Y MVM C_ #]VFREB5"OLJ\XU*H2=2#AD(7/T6)#+-X!?E;0JL$\L)7LA'BSP==] M%LZL(6!0:*M S7"&%3!FA8R-WUXS[+>TQ.'\HO[9U6YJV5$%*\%^57M=9N%3 M&.SA0$],OXCV"_AZXC#PQ7^#,S #MT[,'H5@RGV#XJ2TX%[%6.'TO1NKVHVM MU[_0;A.P)^">8/:^1R">0#X(\[N$N2?,_W>'V!/BT0ZHJ]T=YIIJFJ=2M('L MVJ&AMNNB16Q^5V&3[N^X-7.>RF3/.7["*3I;(8]9=A@\P"3Q-60]A40] AD# MO0M\R\423^@C#ZLI(GD<>?BGR.:NR)5-VF M47X9+5;1C?S:O!;=Y?Z0[YZ:[U0>JUH%.Z%-#[M..PBAP9B?/1C?I7G=^H#! M0=MI8N:RN^-=H$7CGR_4OZ'Y7U!+ P04 " !Z2FE+KET%2#\" #Q!@ M&0 'AL+W=OS,SN[,XZ[3CXDV6 "IX MKUDCEV&I5+M 2!8EU%0^\18:_>; 14V5WHHCDJT NK>DFB$\F4Q13:LFS%(; MVXHLY2?%J@:V(I"GNJ;B3PZ,=\LP"B^!U^I8*A- 6=K2(WP']:/="KU#H\J^ MJJ&1%6\" 8=E^!(M-L3@+>!G!9V\6@?&R8[S-[/YLE^&$U,0,"B44:#Z<885 M,&:$=!F_!\UP3&F(U^N+^B?K77O940DKSGY5>U4NPWD8[.% 3TR]\NXS#'Y( M& SFO\(9F(:;2G2.@C-I?X/B)!6O!Q5=2DW?^V?5V&"'@D1.0A M(1X(\0 4A(!D+ROQG(0"!.!M1[M\U<4T6S5/ N$/UQ:*DY==&"Z+^K,$'[ M[]AWNI]21\\9GB$HT(I L8J\"^*G)\1\>W"5;W MB-G4J>&?(IN'(C=EQMYFQ9:?W#3+Z43>8XC%-'T./'4ZNO* HF>WISZE9.)8 M\BG-8[^IQ&LJ\9AR6ILG=UGFSXXE#V3F&/) G$0;#P3[S1"O&>(QXY21D_N6 MQ21V['A >.Z)HAZ<,"GYJE#F-5]%Q/K]@\[T[ M\3Q:K")/?*WG>3]^/^3[R^ ;%<>JD<&.*SUE["PX<*Y USYYTF67^OX9-PP. MRBQG>BWZ*=QO%&^'"P:-MUSV%U!+ P04 " !Z2FE+&'E_OOL# "I$P M&0 'AL+W=O5;4,_?0-*>)Y]6;@\[3^DMYTD7[GUU9Y6G3WE9[KSY5.MWV07GF MD>]'7IX>"W<^[<=>J_FT/#?9L="OE5.?\SRM_EOHK+S,7.%^#'P[[@]--^#- MIZ=TK__2S=^GUZJ]\VXJVV.NB_I8%DZE=S/W14S6E'0!/?'/45_JNVNG2^6M M+']T-[]O9Z[?S4AG>M-T$FG[\:Z7.LLZI78>_PZB[NV97>#]]8?ZUS[Y-IFW MM-;+,OM^W#:'F1N[SE;OTG/6?"LOO^DA(>DZ0_9_Z'>=M7@WD_89FS*K^[_. MYEPW93ZHM%/)TY_7SV/1?UX&_8\P'$!# -T"VF<_"PB&@.!70/@T(!P"PK%/ MD$. -)[@77/OB[E*FW0^K.J]=T(#L[@R=,&;6Z(JI'BAX)9!2'1C: 4D2^D1"GA/ C"HRL .8G$5DR"V%F M( BMFK6 -*)63)C+ =$[?C0/@6"6S'Q.V8MPV F%N:"!D+JHQ2FL(6?R& ML!,3=^) 6/R&L!/3B$TP\2TI2;;50Y1*6&DXI:*[AAAJPZDX#&V_0; 9$S!C M87$;PF9,8[;! K,U;*$D/DU!2%EE@9!ELT)81\FX,/"MB:Q#].([3#QW6GK M(XE9&4 I\\ML!:A82+:D "6M[QQ;,0$K)IO;8"NF,5MB 7$UA2 >-L@)?9; M&4&FVWAWQPRYKO;]F4_M;,IST70_HN]&;^=*+]0=4QCC"S%9"C"^$I/U]=3H ME_SU$.O/M-H?B]IY*YNFS/LCC%U9-KJ=N_^E;?F#3K>WFTSOFNY2M=?5]?#H M>M.4I^%@S+N=SLW_!U!+ P04 " !Z2FE+/Y*WU0\" #B!0 &0 'AL M+W=O4A+S'K&WT0-(+UW2EJQ\&LI MNSE"HJR!8O' .FC5R9YQBJ4R>85$QP'O#(D2% 7!(Z*X:?T\,[X-SS-VD*1I M8<,]<: 4\W\%$-8O_-#_<+PT52VU ^59AROX!?*UVW!EH2'*KJ'0BH:U'H?] MPG\.Y^M$XPW@=P.].-E[NI(M8V_:^+Y;^($6! 1*J2-@M1QA"83H0$K&7Q?3 M'U)JXNG^(_I74[NJ98L%+!GYT^QDO?"_^-X.]OA Y OKOX&K)_4]5_P/. )1 M<*U$Y2@9$>;KE0I^EVE=IJ_8\Y4/X7R M'O,X2C)TU($E)9.E M)1.EC1I<)'>)OH6R8M#)!:7 *S,MA%>R0RMU^T^\PT!ZCO0%'_F+<+X,)_PK M-<#LO/D,;Z??3\RKIA7>EDGUK,SEWS,F08D/'M1SJM7 '0P">ZFW,[7G=NQ8 M0[+.350TC/7\/U!+ P04 " !Z2FE+KJEJBOL" L#0 &0 'AL+W=O M[-2<\_U9L7. M(L]*^EQ;_%P4I/ZWI3F[KFUDWR9>LN-)-!/.9E61(_U)Q:_JN98CI\^RSPI: M\HR55DT/:_L)/:98!2C%[XQ>^>#=:DIY9>RM&7S;KVVW(:(YW8DF!9&/"TUI MGC>9),??+JG=K]D$#M]OV;^HXF4QKX33E.5_LKTXK>W8MO;T0,ZY>&'7K[0K M*+"MKOKO]$)S*6](Y!H[EG/UU]J=N6!%ET6B%.2]?6:E>EZ[_+]EX.%HYER91I]FV&CS0H+$B-14>CGN-(PEZ# QA;+&1 &M+F K/A5?PP$(] M%>^/$!.M4%,3^!K&K&2$X8,8OHDQJ*/%:#61TI3M9B2Q]E'2.Z(12@"B! "* M]F&WK288K/())VZLL4"J,$Q@F!"$"0$8K06VH5%RI'W!U)1X:*(1(Y C C@\ M.$$,)H@7]!F@\?1&F]>,0!(0)%G0:8FQ7;X.F\YK1B#(A3W&7=!IG6C41";, M/=489\+RT()> T2&%\QKQBB@[3TA#* $$RE@7T-+C T2>:%>SKQH# .[&UIB M;\BTK@#I=G]'-(:!_0TM,3@$>)>?&%L#J?RIMH,=#BVQ.&0:&#)@3$TX85$( M-CD$N=S$_PX$VQQ:XG.0R&R[>=$8!K8ZM,3KD&EDV/4-FCNJ\5D&]CN\Q.\P MX&0HB3V-!Y1%"9H @AT/+W&\3C315AV-J<&![E?.X.Q9T/JHCNGX( M@]G^*O"$U=GU0][>(WZ0^IB5W'IE0IZ U3GUP)B@DL5]D'MRDE>7?I#3@VA> M(_E>M^?W=B!8U=U-G/Z"M/D/4$L#!!0 ( 'I*:4N6^I)!6P( +@' 9 M >&PO=V]R:W-H965T@?]H=E2L4)_E4%10 MLX+4%H7CPGYVY]M8XA7@9P$M&\PMZ61/R)M1=>]IC!BI2_B@//%_;,M@YPQ.>2OY#V"V@_H6UI M\]_@ J6 2R6B1D9*IKY6=F:<5#J+D%+A]VXL:C6V.O^59B9XFN#U!%'['L'7 M!/^#$-PE!)H0/$H(-2%\5%*D"=&H NHV2^W^&G.<)I2T%NWN3X/E-77GD3C? M3 ;5<:I_X@"8B%Y2WY\EZ"(3:0C93B-LCD!#0J_!,*I;>A.[= M%EA-$7%T"UE/(;[_>:3SOX6V=PO=6/&-&^HK?C!4$3BC#35AW)%A$V:D=6/" M^",_)DQ@-A08#06&!*/C7W:86&%JA9F%D>.,?*^F,#?PXPEN,\7Y7C";X+8& M7!@Z0]R-O]#H+S3X&U^M<%(H^'>9R%@F,I2)S0EB8X+X@7.()SH_F?;7 ',C M;VH(#5Z1"NA)]0!F9>1<^15VU9,TH+*K&M+RBK8.(_NY^\E_7OF! M(FC$SXJ<^=7:458VE+ZKS9?=W$4J(U*3K5 26#Y.9$GJ6BG)/'X;47>(J8C7 MZXOZ2IN79C:8DR6M?U4[4<[=S'5V9(^/M7BCY\_$&(I=Q[C_2DZDEG"5B8RQ MI377O\[VR 5MC(I,I<$?_;-J]?-L]"\TF! 80C 0@N@N(32$\!_!OTN(#"%Z ME! ;0OPH(3&$9$+P^F+IZK]@@8NHP^H]]9\3V=^M.M3MU/_)!G!Y M>BK"*,N]DQ(RF$6/"4:8V1BS!# Q&F->((P_QKP^H+.ZK^-)OX/I #0=:(%H M)!!,#-F8.)KXZ2&IAK0:$L0(3;)]M5%):*%6@!8:P4:V0M!6"-@*88$(%(@ M@8GI18^)KQ+UP_1FHC$8)_Y__1>Q71 ?(:MP2UO+ZA,@!?3)1D%] K3N]"D! M[2> _7AB/['*'*"Q_5&@% R4 H$26" #!3) ()UDFMDO1'8[T1D89P;$R6 ! M'\%S##V0J@&-[GM*!9&:Z$F:+^4=9-C49"_4,I5KUG^(^XV@G;ED>,--I_@+ M4$L#!!0 ( 'I*:4M/5%%^& ( / & 9 >&PO=V]R:W-H965TBJ7G^39!-;AXT+ M)+Z^?0%S5AQ0DC^&76:&G<4V1<_XNZ@ 9/#1T%8LPDK*;HZ0V%70$/'$.FC5 MRH'QAD@5\B,2'0>R-Z2&HB2*G(_HUC>>Y.M^=3IKC-&OJ (3*GLLTCPITUD(6 MLQPPR0033S$K%Y-,$<\N8I9/(2]W1=8W19!R.MI-O'83P\\F5J[V6+D8G%UY M&2 S VF'0G$47?7MQ47EJ8-:>[2B"6QB*_7:2EU;./4+9%Z!S-.7]*HO+L;I MRP#!=_KBHGQ]\6C=Z OVVL+WCWN)W?['4>34LW*U'/L>*8]]%^6S[]'RV4<7 M'[J^"WX2?JQ;$6R95/\,\V4?&).@)*,GI5FIZV<,*!RDGL[4G \_X2&0K+/W M"QHON?(_4$L#!!0 ( 'I*:4O ;I"+O0$ -@# 9 >&PO=V]R:W-H M965T8B==)FKP7(FX:21&82@^L\1 MN!H+O,'7P!-K.^L#I,Q[VL)/L+_ZDW8>F5EJ)D :IB32T!3X?G,X9AX? +\9 MC&9A(]_)6:D7[WRK"YQX0<"ALIZ!NN,"#\"Y)W(R7B=./)?TB4O[ROXU].YZ M.5,##XH_L]IV!;[#J(:&#MP^J?$1IGYN,9J:_PX7X [NE;@:E>(F?%$U&*O$ MQ.*D"/H63R;#.4[\U[3UA'1*2.>$-/82"P7E7ZBE9:[5B'2 M1.>UO4_#S;S#X\[_H+IETJ"SLNY^PRTT2EEP:I(;MTB=>V:SPZ&QWMP[6\=E MBXY5_?2.R/R8R[]02P,$% @ >DII2V\?CB(- @ E04 !D !X;"]W M;W)K&ULC53;CILP$/T5Q >L@9"P&Q&DS:5JI5:* MMFK[[)#AHK4QM9VP_?OZMBP!E#8/L3T^Y\R%\:0=XZ^B I#>&R6-V/B5E.T: M(9%70+%X8"TTZJ9@G&*ICKQ$HN6 SX9$"8J"8(4HKAL_2XWMR+.4722I&SAR M3UPHQ?S/%@CK-G[HOQM>ZK*2VH"RM,4E? ?YHSUR=4*]RKFFT(B:-1Z'8N,_ MA^M#K/$&\+.&3@SVGL[DQ-BK/GPY;_Q !P0$2_PA6(@NM( ME(^<$6'^O?PB)*-.185"\9M=Z\:LG;U9/3G:/"%RA*@G*-_W" M'6'P0XKN$ MV!'B__6P=(3ER .RN9MB[K'$6NE^ISY=IHOHZY4_44RGK- M%JO'%%VUD,-L+28:8)+E+60_A80] JD ^BBBN2BVT80>W3K831'):A3#/T4. M=T5NPES,%FMA^/%-L9[F!>)9@7@JD 2C:EM,8C"-P8P0NRDB3 +]&Q5D!A>% M$]AA"C.H 71NJ*#:S]#'F.=$^.[-MPO0MG['LU<^R( M^)"W ^L;YF7="._$I'H)IE\+QB2H\(,']0(J-2/[ X%"ZFVB]MQ."GN0K'5# M$/63./L+4$L#!!0 ( 'I*:4MG \&PO9QSL[B.;N(\S#? MLJM8C!DF,3MEV?;C\_S5C\^QC^@W8^^3.%]ET&?.Y[MO;_FFQP9]AWE] M=[+[\CJY[['^V/RRA$<'XN=W8^VN^V^KS MY0W[=''^U^L/[SZ\O;JX95?7YY:1SF'VU(\ @#G_ROZ3;W?;?4K]>1@OV>UV M?9=$NV^+Q2;??79>I"FNZ3+, ACY']Q/$6_LC9\W(#T]=;W3@6L![C*,>,K. MH=\R21N0G04!A_?P=BY:VI8HX?G(-TF:TUIR/R\:1/Y'D^YRA"])!*SDIQ*B M1K/KQ-+Q)QY%I[_$R4/,;KF?)3& >I5EA1W69+T&%KC-D^ 7A]T2,[(/19[E M?DQD. YCR:,G5F;ZM-TT$.WV3_]N[7##TS"96XFD^/L__O"'5B;6"7X)#QMX MVFTIYS6V_?N@06_H.A?=(W^Y^W;A1UD#\O,$V#K. .OP*4NB<$[<\MJ/_#C@ M@%\0'1D[5APBX?D<^\4\A(8G(! ^W[YAQT2!803ZP>5+< MY8LB8GX0H'#+6+)@1^.^Q_P<&&P#(N,.-HP2133GT6@\P=< H7QK@?(JO@>8 MDC1L;H.;E&_\<,[XUPUBTP#WHHCG"#<@*4C6G.7^UV:S3TD.1 \DLOTLXTT4 MW*0@Z--\Z[!-A.(-EX 8VR#A=QN_(Q0%P%1%1(2=AKA\L2B'Q;S1^T.^ NR;5RTP8WZGF#,* M_;LP"G.@SPN#*!3\L/&W2 ;#^[3@=@+>K@!-ISE/UX#"NP;H=<)I@#2WP8)# MHWDK&UPG\>F_"C\*%R&13':!#@B>T_<&ZIOK.MV-AU_W*-W3JNM;[) MRMZMLQEY&0U\+N0\6$A70AD=&^TZM3"-;9T];#SH[ TV=CG:'!D8?P;5!)XO MP&I\^39-P- !6V41-G3S+;@8)!U!C7'TY/[DKS<@9N?K,"8?$>5EB^4&38H@ M+U(D#8JT1I/W@,HTA(&3>YX&@*TE9V"GY!$WFF0(Z?%;$*8G#-D EH/+6H1? M4:(;#9P/&W3B<'YA-1C,*PXDRO>]EFMLOB?JWW$0,[I]NJ=]2PLDHAF6ZDVU M)QMVP&L_"X..^_=-&!6YW'#[6__$P^4*F_M *A_H%,C-V-B%+4#9O$L-DJ=L M1G*&+D'T9Y8-V;[WSN;_+#)IPN4)F 1@PP7@E*/%71(WH6_D;<&FN0]AE[*[ M+4M*1O/1BC";TF\.<2'(03^]\[,=^[7AW7\-T%5!GKJ#;0K;F"FR=.A]O@+W M0L@H;0FTEPC"-L^@IG(-7DE78UQ88_LL\.NN:#>ZR OBBD6:K&&I]["E]Y!* MF7?$"0=Y "?^GD.X!O9[49,*OKZ>9$GH)$? MPGR%=B7:QF2PU88M)Q16.XKC- QR9?-@0!86@0AKZLL&9DU8L@A:M!=0IHL! MNH18K+$8M-WO^#*,T?S'M6_([CVH/\<]8NMYG>27 AO #I4<;6C0=.G'4D0YFO!5(DR?""A%D0)6!^?V78&UN_'A+W]R7)VPCIH9!05+Q$+"Q ET(A.4QO@/S&5YM MBC0K4$8 >G&LM(@X38A?;GD QE#I4('D)NE+D5FP?G%)R/X@,U-8%#BB*865 M,Q3HEPGL3K?/XL3@G(J_^!I18D'%G73"**D!H@BA:GJ4#D":;9" F&2)5&*?KK08"@T Y' M/'^.P](XH&6>K8%' A_P"9L*S96U'X,-0Z(("+7V?P$S%B3NFCJ09@9G9"T% M4+Z"_>.NPZZ=$GUI\YT)56(?0.B![P. +H0#QQ#J8: M&&1@LR["%"QTZ#0%0F[IG^(WN87!O(75XT-\"?-=\KNTP)R+X&8YZ9CU/8>] M0[F?]=ATV%=?] ;5$MT1+7'JB!6 _](8#M9PM49[A9=6Y<5Z$R5;SD4"!@4; M4$ZI10U)?_-C@K#$(X(/" DSHLDYV"/@""&AY9-*&*W].5?RA^ X&@"L&(Y3 M'WKXB4*",*Q1F7B@3&Z+S49X8L!XI6VMYQ.-&@P;.?7.E?S/'J4 O ZPL&MD M3-U[UD32,4D&:?>?B $H[0#=7[#2S3MB@PG\&;GL2@LREX9-2KF(C T<=PP# M.^YDRM#()7VM&6WQW&R.P;P4(00/6EF7OHR>WQ4Y47B+B0,$#*#P$!:@4R,P M3!0: (4N_3!E7RAF4U.]5S&ZWD9]KG5Y*E4&7>:O[<.5GVFR+*Q:.2PK8/_X M695^2DOOPJD>RAR$(V3T3N;!80^K$$>!?45RX"]A/&,$ 9T=.$K,(2XD&]J^DUO"?)*Y,XP I4YM1%OE/OQ&,X;RJ%>-X!C-K>9 M@?VXIA"@8 O$P)*J'$C1B@X2QQHI)"']!S\5_D=(G)DL8XIQ(L/&B@$IBB6U M*]@9&1@A#&$. RZU+#NNC!9LIR2&?"LG$Z%U =U)K[:!*$::U;Q[ @VY($V* MY0HFO*=0'7JJBM=39)LL2,,[82/-,2,1*6LI5NY +FS'/<:SL@:VF(KG)&<; M!A\"C;9"31HWY;.55JGDFSQYH0GQZI,>"!9XHL8$U^L$206H? .67@ .9@92 M]%3^<_LC^;=MB/-5R!=@GH.Y3A'.#XL%T! T/NA+_#>0_VYK?JHVR+R<^A3^ MP^GPG[4YES9!!HP]&#(/FT_8Q\K3%3W1K"W)K?=RP2R9C0 D0,]HR&2ZQX;< M(\#A&/]Z,_@['7KX=^(2G^7450MDJI"2QO.2;2Q>1MW-DB.14V^#!T0G>D&B MSP/NJ$JZP3XYB1ZN[@NM>))@QHC@Q MS _*:+U&XVLGQ*%T^9:!&8 )]TCML[J);)A)EMM\IGX?) N4,=4S&5.]4+&5 MFQ2%QG$5CFVV_L?([%? MRB2/9A+IA4"F_"?S!IXS H,'ML^X-QJPMY)_7<\9#.#UI >/>= IO-B&*WN.!,QGUX;$[[<'KG6D-F'.G,V8FP3C4PP+('(8?;+Z0)YJFX,N+WI M\%G%+AMBER-% [42-#0T7ACUIB4;G:HPOJ8#-;5W-.V-A$00_*\!C*S.?3"S M1$_8+Z!.8"9*<9=JU"?/A#^4.NTKZCB.\0?YY&$WH0#/5V&&54)8OS4'#;65 M"PMDD-IB506Z*"]U<$E0N7<11J=RFBV(A>743('/O5M09BIWN UY-$>;ZIXB M@US$!*0U 188+4+@!=$DU#H"F&)]02+8G-S7&H1$*+DX :W0^O4& )IFYBD@ M-93)A98!6B6M>NQ-Y?BWBL*CT60B1.=(BF8V<$>RHCBQ/$ MG+"S,+PO"0PB]1>JBPH%%X!\[@UA6YC'PZ@1[JC*5U>^,(IX45^"W_L#=-9 M>:"FO@%I+' G\U)84P5*3"67@6A*LBF_NB[^92 M%4KW*\0]!RM*15!0FG551)W%!:V/XG%:&K/S3G'8T!E,)FS@3*> %L#P".T- MKS?U''9F#:T>34:TK5!M&/VN$9B++<62ZM7VJ1'UD3Y+[7/=>48\P,Y0J (I M>2SC;>)O?9%-QOSH/Z#[3$E^M,/'SIC4[\1Q053\E*2_X);<8((I SO6<<CB@>.BGF7NT'%'EH#)&'!; M%]8P+GQ!3D2%^ \0A0=#((LO:M*K%H]8Y:4S$1/9_MW*A MH6@;YD"U156)P6)'TU>F(^Q;64)@GZ?8[)_)6M,@ _F1\ =K8&A2Q=!/RGTR MF/1(^_[E4LJ2!.)Z4X@(!>"QA ->QH:*$'+&0I+D*G=0ZK:ZQ?^BFX]N!+VA]@3CF U&P"4#-O)0P3I&@3;% MZ"1?KFLG;YK%:SL-GBK#I\TY:[$YN?-$.I!E\!I+/ZH"%2I>P(["Q!1C]522 M2U97!&5:"S$.KJ"B5#VGJ;!^G3"W_ZP=^;4(8FFK@!8$ ZTN&?)YS^?H:(@R@&*--O19 TB%O5([NZ4=I36F$&4U=L:@H\6'ZCZ]%[ M@;#=$FS/.GV66*) B3-Q/;#.P?%^)KZ/AE,V!&N1O@./@Y_ AI/>A+X/I\X, MQ!"\Q^\*R0S#7V.,NN H8 +!$.ZHY\$7=P03#,#J4=\&??K6AV\59:"/.QGB MD/Z/ (K<4+@5"0Y0IDRG@XQ=DNHP32? [Z:]L!U^P## M0'\")MG8&Y=/5,95I9&ZL.?8;(G.0'Z)$R?:\9XS8VU8H\%3I=C,-G,]CT5A M(&O$9/QK+E4$S"G:I$>!4L'(''.])E5_JQ*^QA8RI 9F%! :F\^ MP!N(=FTJI&?TUP6EQ#1FW\KM5\[5)].)M.K=DZO@^K6)9/7;;D&YM"*K/ WF MSFGWXK8N5%7T0>F;C2H;I9*TR-?RA0:S@FRC),9HJC"+E0F<\E,$5 Z*PR-9 MP=V.MJ?) X:/L^(.;)[0QTB$,%M4;+DTOPTK1DFLR@"UNJ8BW209G2O9]0"K M,*HPTE%'XH 4 =;SFP[SJ2:R8D%VE*20 M:5[X)AK"LRU+8#^F]2PO)MLH@*>O$F>LL?]@T!L_ ]76*PU *V\?#2;M.T4K M6=JM/*+Z2YAK0',-G^W91D?NV&O=;?NF.AJ*HX,8W2A+N\:6W8\&JV>?)V=(TSL_JQ%ZI\V WV8.68*TFBT]V/,CQV & (Z1Q%>AD>%H;# M6']%)W 51F"&OP?1Z >K J.GF0B'OMXN,$?1>+?P [TFL9HDD&9-=:1MMBU+@FC_<%>D6MYW@XA) '2 U(TT CJEPJR/<.@:E ?BA1)K1A4$1 M4% D;4<=>& ;4I3,G0H6.G)[6/PVEM^\7M^RS6IADK1Y;@EU4(('-Z!QF;ZI MX423HMUK)E7^N4NI1*US_9N)XTS^S,>2!%(G>Z-2,8/?("PNTQLQ9/!>\$?I&+-JJFM M7-/%:L#R--V'ZC3=K?TT'5]"T_=X6",50N%&QTSQ$ MZP+S-HCB(/+IZ@5BU,A_R HL>UGZ6'0'KZM Z2:)ML $&.+"_>NOP7[8;*(0 MUZ.R<>2TSF'L*B='-5$XMT@ZS?6@5X9GON92E6G:R9W-9N!1+PNACH F>XJA MCU#Z>*Y>L&)Q$1T44Q,AO0[?6K?A,@X78>#OE%B#*"(J'JM/C1-UIM8_G]UE M5$K2N!P(I+R]A-L1(VS9S_+_=M9Y]7LY^#SX$QTH M;+"K.+0D7C8V0;#B\T(K9-F9*KEY++/\7JKY M&RC5;!-;AF,*HJ2JP6M('L'&9]IYP<I:3O=S4S?ML%-=WK.3K1 M4KF$=UMPN?Z9I)H?>+?5;V45HW]3TOY>8/![@<$W+# XM%*@T_ZXI#3]Z3M* MTS>'>.QN^#UE_QM,V1^6@;.R9SU;00I'/R7\G7W\_\LTRF&W]K#C-W1,-R-4 M@,.H761F*#(0UQ5!'_'I! VQ6KE =5M7Q][J8M]W]CNYRD/<8$BVVK(^\K#A@U?UK[.?W1)=F&/J 2"(TTAV2#J%'B?#N-\;5HWRV MVP/MMP V(W^F.]2Z!O^:T'6-!3XB_->=.?]6Q/9?*;CD=SWFN>:7!\0/L;[F MM3RK+/,#&K07YLL6K:L[JXXDHQW9$A H0P$48Z'U=;^(R]Q;^$(HKLLD7? P M+PP_;;-?C9SN)'[VZIL3"A7(:XG?RFN)$0EG]4N)+]2=9R5*.O_<$+53L,GZU&S41:!W!Q@O?">"+,K/S:(B-0SQN9W?AJ1I,94C9 M;-X]UV[I)@#VW=#=\1=S/NA1L<9IOYW36-VN8%9IG)9999-O-:.6([+/63;Z M=K/*_%/;G-3D6\W83JSJ>'F@I>^$IX\_2-083NDT$.Y&G5:;SB_3?F%I+-V; MC"4]@;:?'.*:M&_*!I8A'X\>=V9$3VVZSNAI2Q"VH*NEV[="WV%3'(S.UN$[ MHZ^+7)42%8T9A$_/>9;"M7D,4_L!NTK<[C;KF'CLR*^'*:=FVG6W"69A^XT( M;3,KVS!>S?G9W6:4KK6)U4-%IY[<-?++2&V_F=GB[L()YFH0HZI]I %O9ALS M\Y2)5VV?@X'1WMBP]<0M?]UX#L:W<[-*'G>!1[;]GN#LI*T[ -7L<>"4QFPV MANW*B]6JNTP.C[O5\M -45)/0SCC M];&/H6L_^6='\BX0;ZKJD#*EK;4A'_6FP*KL#&M'@-NHF!ZVYUVACBK1316W MZMQ6S8_XL/<'P>1O2][X*?Z V*VX1D;4,%EO'ME9Q.-[&Y9G=Z&HQAR+ >CV MP1PGI![.;KRG:I.5C9IQ8/MP6G%!=?O[N1]AX?G=EET@NG=[V;A:"N[^"I/'Y9!6.WJC.8E,PX> M!"V::0$[B*<=ZC<^RZM3SN75*1BIN+BYK0D:Z?49?J+)9IIT+\YH,3>_57W& M(Z9H*]=H&:ZE0N-4RX%3!0;%N@X7YV($6*QC4.N+5?PT+#'/P30M/55K8IME]#]!^^[5@=4<3-*SQ,#R=]";& MMH:G9?F'54CN-O@NRW.-R\/Z$\/3H>6I@79:>8IM:D.3[[-$(ZVP"L;P=-P; M&!9C*96QKFQ/^^^RS(EIE4;J3DQDU,IX;#,8FGRGE1AH,.[-3"LQT%"O*K)Z MG88VWVDM!M=UTAN:'AI(M;\,J7LFN';I [D >VX_:2]??" M)-!^./S@I9WBOA$7G=@JJ Y7=J[7^A./EHHBHR>O5Q4U<&VI&6H@H:H%:BA1 M6>5E%VLBDM#$:TQ'/ !M9\N4RYRV;921>9"2U=_1G5JMMFSC$HY#F)(<,]LO MYUZ4]T-H]WA\1(_\H_QUP%!FP_R<7?(YI:-NRU\VV^E$.=' 4 6#5SDTMQY> M[6!X.C ))[R:P212R_GE[F#'LDJB^0.IT$C[!41'.[4K[Q;X'!<9QB)O\ ?X M,M.A;>W XBW:F'0XZ/.&0AB(WM/^; \E[>5D!SC8[DC2>I'_Z8_N9/JR-;ID MX8O:;ZU:VNR4C-%I9\/OR947).QV!7 M..&5+<96*#^@@EH+)-0-PO2K_!IB,7Z-W6TD(G'%&@QG*NTLYIV;%Q?D.FW M'SM>IG"(@KG1KRFXQ&L*,'@"-,YR]DY>;V"#_5V8ATOYPS;EY"IH4IY1HI4) M(X8(58WR/,OR5_\#4$L#!!0 ( 'I*:4MXRRZD/ ( %\* - >&PO ML/0=!D M%7#27,@:A(D44G&BC:O*H*D5D+RQ29P%\S!/$$]3+=<8^YA\M(F!_T&I'$AQ?X^6,"P$PYH0UB"KPFC:T5M5D$X M95L/SRV02285TN8 3/7((LVC#T?>LV?3\W JI'*U?07_7??3#P*#9P52QD:! M<^R!-*Z)UJ#$C7'<9 ?^$D*]O=K61F&IR#::+_"4X 939"U5#FHL$^$!2F,& MA96C:%G94,+09,'9O+^ZW8H^[*Y"?8X\DQ,BJ M&$RSZMZ<3BUTDG?9//'"GH*"=\[MB%̹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how.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 58 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 60 FilingSummary.xml IDEA: XBRL DOCUMENT 3.8.0.1 html 128 184 1 false 32 0 false 5 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.ufpt.com/20170930/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) Sheet http://www.ufpt.com/20170930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited Condensed Consolidated Balance Sheets (Current Period Unaudited) Statements 2 false false R3.htm 002 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) Sheet http://www.ufpt.com/20170930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited-parentheticals Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Condensed Consolidated Statements of Income (Unaudited) Sheet http://www.ufpt.com/20170930/role/statement-condensed-consolidated-statements-of-income-unaudited Condensed Consolidated Statements of Income (Unaudited) Statements 4 false false R5.htm 004 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://www.ufpt.com/20170930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 5 false false R6.htm 005 - Disclosure - Note 1 - Basis of Presentation Sheet http://www.ufpt.com/20170930/role/statement-note-1-basis-of-presentation- Note 1 - Basis of Presentation Notes 6 false false R7.htm 006 - Disclosure - Note 2 - Supplemental Cash Flow Information Sheet http://www.ufpt.com/20170930/role/statement-note-2-supplemental-cash-flow-information- Note 2 - Supplemental Cash Flow Information Notes 7 false false R8.htm 007 - Disclosure - Note 3 - Fair Value of Financial Instruments Sheet http://www.ufpt.com/20170930/role/statement-note-3-fair-value-of-financial-instruments- Note 3 - Fair Value of Financial Instruments Notes 8 false false R9.htm 008 - Disclosure - Note 4 - Share-based Compensation Sheet http://www.ufpt.com/20170930/role/statement-note-4-sharebased-compensation Note 4 - Share-based Compensation Notes 9 false false R10.htm 009 - Disclosure - Note 5 - Inventories Sheet http://www.ufpt.com/20170930/role/statement-note-5-inventories- Note 5 - Inventories Notes 10 false false R11.htm 010 - Disclosure - Note 6 - Preferred Stock Sheet http://www.ufpt.com/20170930/role/statement-note-6-preferred-stock- Note 6 - Preferred Stock Notes 11 false false R12.htm 011 - Disclosure - Note 7 - Income Per Share Sheet http://www.ufpt.com/20170930/role/statement-note-7-income-per-share- Note 7 - Income Per Share Notes 12 false false R13.htm 012 - Document - Note 8 - Segment Reporting Sheet http://www.ufpt.com/20170930/role/statement-note-8-segment-reporting Note 8 - Segment Reporting Uncategorized 13 false false R14.htm 013 - Disclosure - Note 9 - Other Intangible Assets Sheet http://www.ufpt.com/20170930/role/statement-note-9-other-intangible-assets- Note 9 - Other Intangible Assets Uncategorized 14 false false R15.htm 014 - Disclosure - Note 10 - Income Taxes Sheet http://www.ufpt.com/20170930/role/statement-note-10-income-taxes Note 10 - Income Taxes Uncategorized 15 false false R16.htm 015 - Disclosure - Note 11 - Plant Consolidations Sheet http://www.ufpt.com/20170930/role/statement-note-11-plant-consolidations Note 11 - Plant Consolidations Uncategorized 16 false false R17.htm 016 - Disclosure - Note 12 - Related Party Transactions Sheet http://www.ufpt.com/20170930/role/statement-note-12-related-party-transactions- Note 12 - Related Party Transactions Uncategorized 17 false false R18.htm 017 - Disclosure - Note 13 - Material Overcharge Settlement Sheet http://www.ufpt.com/20170930/role/statement-note-13-material-overcharge-settlement Note 13 - Material Overcharge Settlement Uncategorized 18 false false R19.htm 018 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.ufpt.com/20170930/role/statement-significant-accounting-policies-policies Significant Accounting Policies (Policies) Uncategorized 19 false false R20.htm 019 - Disclosure - Note 2 - Supplemental Cash Flow Information (Tables) Sheet http://www.ufpt.com/20170930/role/statement-note-2-supplemental-cash-flow-information-tables Note 2 - Supplemental Cash Flow Information (Tables) Uncategorized 20 false false R21.htm 020 - Disclosure - Note 4 - Share-based Compensation (Tables) Sheet http://www.ufpt.com/20170930/role/statement-note-4-sharebased-compensation-tables Note 4 - Share-based Compensation (Tables) Uncategorized 21 false false R22.htm 021 - Disclosure - Note 5 - Inventories (Tables) Sheet http://www.ufpt.com/20170930/role/statement-note-5-inventories-tables Note 5 - Inventories (Tables) Uncategorized 22 false false R23.htm 022 - Disclosure - Note 7 - Income Per Share (Tables) Sheet http://www.ufpt.com/20170930/role/statement-note-7-income-per-share-tables Note 7 - Income Per Share (Tables) Uncategorized 23 false false R24.htm 023 - Disclosure - Note 8 - Segment Reporting (Tables) Sheet http://www.ufpt.com/20170930/role/statement-note-8-segment-reporting-tables Note 8 - Segment Reporting (Tables) Uncategorized 24 false false R25.htm 024 - Disclosure - Note 9 - Other Intangible Assets (Tables) Sheet http://www.ufpt.com/20170930/role/statement-note-9-other-intangible-assets-tables Note 9 - Other Intangible Assets (Tables) Uncategorized 25 false false R26.htm 025 - Disclosure - Note 11 - Plant Consolidations (Tables) Sheet http://www.ufpt.com/20170930/role/statement-note-11-plant-consolidations-tables Note 11 - Plant Consolidations (Tables) Uncategorized 26 false false R27.htm 026 - Disclosure - Note 1 - Basis of Presentation (Details Textual) Sheet http://www.ufpt.com/20170930/role/statement-note-1-basis-of-presentation-details-textual Note 1 - Basis of Presentation (Details Textual) Uncategorized 27 false false R28.htm 027 - Disclosure - Note 2 - Supplemental Cash Flow Information - Schedule of Supplemental Cash Flow Information (Details) Sheet http://www.ufpt.com/20170930/role/statement-note-2-supplemental-cash-flow-information-schedule-of-supplemental-cash-flow-information-details Note 2 - Supplemental Cash Flow Information - Schedule of Supplemental Cash Flow Information (Details) Uncategorized 28 false false R29.htm 028 - Disclosure - Note 4 - Share-based Compensation (Details Textual) Sheet http://www.ufpt.com/20170930/role/statement-note-4-sharebased-compensation-details-textual Note 4 - Share-based Compensation (Details Textual) Uncategorized 29 false false R30.htm 029 - Disclosure - Note 4 - Share-based Compensation - Allocation of Share-based Compensation (Details) Sheet http://www.ufpt.com/20170930/role/statement-note-4-sharebased-compensation-allocation-of-sharebased-compensation-details Note 4 - Share-based Compensation - Allocation of Share-based Compensation (Details) Uncategorized 30 false false R31.htm 030 - Disclosure - Note 4 - Share-based Compensation - Stock Option Activity (Details) Sheet http://www.ufpt.com/20170930/role/statement-note-4-sharebased-compensation-stock-option-activity-details Note 4 - Share-based Compensation - Stock Option Activity (Details) Uncategorized 31 false false R32.htm 031 - Disclosure - Note 4 - Share-based Compensation - Option Pricing Assumptions (Details) Sheet http://www.ufpt.com/20170930/role/statement-note-4-sharebased-compensation-option-pricing-assumptions-details Note 4 - Share-based Compensation - Option Pricing Assumptions (Details) Uncategorized 32 false false R33.htm 032 - Disclosure - Note 4 - Share-based Compensation - Restricted Stock Unit Activity (Details) Sheet http://www.ufpt.com/20170930/role/statement-note-4-sharebased-compensation-restricted-stock-unit-activity-details Note 4 - Share-based Compensation - Restricted Stock Unit Activity (Details) Uncategorized 33 false false R34.htm 033 - Disclosure - Note 5 - Inventories - Summary of Inventory (Details) Sheet http://www.ufpt.com/20170930/role/statement-note-5-inventories-summary-of-inventory-details Note 5 - Inventories - Summary of Inventory (Details) Uncategorized 34 false false R35.htm 034 - Disclosure - Note 6 - Preferred Stock (Details Textual) Sheet http://www.ufpt.com/20170930/role/statement-note-6-preferred-stock-details-textual Note 6 - Preferred Stock (Details Textual) Uncategorized 35 false false R36.htm 035 - Disclosure - Note 7 - Income Per Share (Details Textual) Sheet http://www.ufpt.com/20170930/role/statement-note-7-income-per-share-details-textual Note 7 - Income Per Share (Details Textual) Uncategorized 36 false false R37.htm 036 - Disclosure - Note 7 - Income Per Share - Weighted Average Number of Shares Used to Compute Net EPS (Details) Sheet http://www.ufpt.com/20170930/role/statement-note-7-income-per-share-weighted-average-number-of-shares-used-to-compute-net-eps-details Note 7 - Income Per Share - Weighted Average Number of Shares Used to Compute Net EPS (Details) Uncategorized 37 false false R38.htm 037 - Disclosure - Note 8 - Segment Reporting - Net Sales by Market (Details) Sheet http://www.ufpt.com/20170930/role/statement-note-8-segment-reporting-net-sales-by-market-details Note 8 - Segment Reporting - Net Sales by Market (Details) Uncategorized 38 false false R39.htm 038 - Disclosure - Note 9 - Other Intangible Assets (Details Textual) Sheet http://www.ufpt.com/20170930/role/statement-note-9-other-intangible-assets-details-textual Note 9 - Other Intangible Assets (Details Textual) Uncategorized 39 false false R40.htm 039 - Disclosure - Note 9 - Other Intangible Assets - Definite Lived Intangible Assets (Details) Sheet http://www.ufpt.com/20170930/role/statement-note-9-other-intangible-assets-definite-lived-intangible-assets-details Note 9 - Other Intangible Assets - Definite Lived Intangible Assets (Details) Uncategorized 40 false false R41.htm 040 - Disclosure - Note 10 - Income Taxes (Details Textual) Sheet http://www.ufpt.com/20170930/role/statement-note-10-income-taxes-details-textual Note 10 - Income Taxes (Details Textual) Uncategorized 41 false false R42.htm 041 - Disclosure - Note 11 - Plant Consolidations (Details Textual) Sheet http://www.ufpt.com/20170930/role/statement-note-11-plant-consolidations-details-textual Note 11 - Plant Consolidations (Details Textual) Uncategorized 42 false false R43.htm 042 - Disclosure - Note 11 - Plant Consolidations - Restructuring Costs (Details) Sheet http://www.ufpt.com/20170930/role/statement-note-11-plant-consolidations-restructuring-costs-details Note 11 - Plant Consolidations - Restructuring Costs (Details) Uncategorized 43 false false R44.htm 043 - Disclosure - Note 12 - Related Party Transactions (Details Textual) Sheet http://www.ufpt.com/20170930/role/statement-note-12-related-party-transactions-details-textual Note 12 - Related Party Transactions (Details Textual) Uncategorized 44 false false R45.htm 044 - Disclosure - Note 13 - Material Overcharge Settlement (Details Textual) Sheet http://www.ufpt.com/20170930/role/statement-note-13-material-overcharge-settlement-details-textual Note 13 - Material Overcharge Settlement (Details Textual) Uncategorized 45 false false All Reports Book All Reports ufpt-20170930.xml ufpt-20170930.xsd ufpt-20170930_cal.xml ufpt-20170930_def.xml ufpt-20170930_lab.xml ufpt-20170930_pre.xml http://xbrl.sec.gov/dei/2014-01-31 http://fasb.org/us-gaap/2017-01-31 true true ZIP 62 0001171843-17-006795-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001171843-17-006795-xbrl.zip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end